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Abstract
Bioactive glass (BG) reactivity is the result of a special silicate structure, disrupted by the
presence of alkali and earth-alkali metal ions. These glasses dissolve in body fluids and
form a hydroxy-carbonated apatite (HCA) on their surface, which mimics the composition
and structure of the mineral phase of bone. This feature, coupled with the release of
biologically active ions, explains their excellent osseointegration.
In the first part of this thesis, we investigated the effect of substituting strontium for cal-
cium in a BG system based on SiO2-P2O5-Na2O-CaO. The reason for introducing stron-
tium in a BG was driven by its strengthening effect on bone in the treatment of osteo-
porosis. The glass structure and physical properties were investigated by X-ray diffrac-
tion (XRD), solid state nuclear magnetic resonance (NMR), Fourier transform infrared
(FTIR) spectroscopy and thermal analysis. Dissolution profiles and in vitro bioactivity of
Sr-BG were investigated in Tris buffer and simulated body fluid by inductively coupled
plasma (ICP) spectroscopy, XRD and FTIR. Glass cytotoxicity was assessed by culturing
osteoblast-like cells (SaOs-2) on Sr-BG discs for 14 days. It was found that substitution of
Sr for Ca does not modify the Q2 silicate structure of the glass, nor its orthophosphate en-
vironment. However, it expands and weakens the glass network, thus the glasses dissolved
more rapidly with higher strontium content and formed more HCA. A live/dead cellular
assay showed an increased cell proliferation for higher strontium containing glasses.
Glass polyalkenoate cements (GPCs) also use the potential of reactive glasses to release
multivalent cations, which cross-link the carboxylic groups of polyacid chains in aqueous
solution to form a hard cement. GPCs do not shrink, do not have significant exotherm
and have good adhesive properties. However, the use of commercial GPCs, based on
fluoro-alumino-silicate glasses, has been limited to dentistry and minor surgery due to
biocompatibility issues. Aluminium is known to have neurotoxic effect and inhibits rem-
ineralisation.
The aim of the second part of this study was to investigate new glass compositions for the
development of aluminium-free GPCs for orthopaedic applications. Sr-BG compositions
were adapted for cement forming purpose by removing soda and including Mg2+, Zn2+
and Fe3+ to provide an alternative to Al3+. The selected cations are all naturally present in
the body and can potentially enter into the glass network, mimicking the formation of Al-
O-Si bonds present in conventional GPCs. The mechanical properties of the cements were
assessed by performing compression and bonding strength tests, whereas their working
(WT) and setting times were measured with an oscillating rheometer. Finally, cement
cytotoxicity was evaluated by culturing SaOs-2 cells on cement discs. It was established
that only high zinc containing glasses lead to cements with suitable mechanical properties
to be used as bone cements. WT was short but increased up to two minutes by using citric
acid as a chelating agent. The high Zn release from the cements induced cytotoxicity and
predominated over the potential positive effect of Sr on cells.
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Chapter 1
Introduction
1.1 Background and Motivation
Osteoporosis is a disease affecting many millions of people around the world. The disease
has an effect on the normal behaviour of bone, which results in a bone mass loss and
micro-architectural deterioration of tissue. The quality of bone progressively degrades
and leads to the multiplication of the risk of fracture [6]. It affects primarily the wrists,
spine and hip. The condition increases exponentially with advancing age, especially for
women after the menopause [7] and is responsible for about 1700 fractures a day (650
000 a year) in the European Union alone [8].
The fractures associated with osteoporosis are a major public health concern, because of
related disability, diminished quality of life, and mortality. An estimated 1.7 million hip
fractures occurred in 1990 throughout the world. The number is expected to exceed 6
million by 2050 [9]. Such fractures impose a considerable economic burden on health
services worldwide. As an example, the cost of treating one hip fracture is estimated to
be about US$ 20 000 during the fist year [10].
Solutions for the prevention of osteoporosis usually focus on a healthy lifestyle, which
involves being physically active, not-smoking, and taking adequate amounts of calcium
and vitamin D. Pharmaceutical treatment in high-risk groups and measures to prevent falls
are also proposed as important measures for preventing fractures [8]. Bone density is the
common screening methods use to identify people at risk for fracture.
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When a patient experiences bone loss following disease, the conventional approach is to
use transplants where bone is moved from one body, or body part, to an other. The most
common of transplants are the allografts, where patient and donor are different people;
but, due to the risks of disease transmission, lower mechanical properties after sterilisa-
tion, high cost, and variability of results [11], transplant of bone tissue from one part of the
body to another location in the same person is preferentially employed. However, the use
of autografts is hampered by the creation of additional surgical sites, limited availability
and deterioration of the donor site [12].
All the risks and limitations of transplants have led to the rapid increase in the use of allo-
plastic (non-living) implants and prostheses to repair, augment or replace skeletal tissues.
An implant is defined as "A man-made material or device inserted or embedded surgically
in the body", whereas a prostheses is "A man-made device used inside the body to replace,
repair or augment a diseased, damaged or missing part" [12]. The first generation of bone
replacement materials was designed to be chemically inert in the body as the body fluids
are highly corrosive saline solutions. The first materials used in orthopaedic surgery were
metals optimised for strength and corrosion resistance such as special grades of stain-
less steal, cobalt-chrome alloys, titanium alloys and various polymer materials such as
ultra-high molecular weight polyethylene (UHMWPE), and poly(methyl methacrylate)
(PMMA) [13].
Bone at the implant site is often structurally weak because of disease and/or ageing. The
volume and strength of bone decrease radically for these reasons [4] and the presence of a
foreign material, such as wear debris from the implant, can elicit an immune response. All
these factors limit the formation of a stable interface between the tissue and the implant.
Another risk is to introduce an implant whose Young’s modulus is higher than bone.
Bone, to remain healthy must be loaded or stressed. Most of the time the implant is
carrying nearly all the load and the bone is unloaded. This phenomenon is called stress
shielding and leads to bone resorption and then loosening and/or fracture of the bone, the
interface, or the implant [13].
Several solutions have been found to provide better interface attachment between the im-
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plant and surrounding tissue by the use of bone cements. The two-part self polymerising
PMMA bone cement emerged to limit implant motion. This cement is mouldable and
has adequate mechanical properties. This is the reason why it is still the most commonly
used bone cement for fixation of the prosthesis in hip replacement surgery, since its first
utilisation in 1960 [14]. However, in recent years it has been recognised that to achieve
a long lasting bone replacement requires the establishment of a stable-bone-implant in-
terface. Therefore, because of the non-bonding character of the PMMA cement, aseptic
loosening is reported to be the most common cause of failure in cemented arthroplas-
ties. Furthermore, the acrylic cements exhibit a significant exotherm typically about 90◦C
on setting and the presence of un-reacted monomers elicit neuro-toxicity [15]. The ex-
isting acrylic cements are not approved by the Food and Drug Administration (FDA)
for vertebroplasty because of the problems cited earlier. In the US Orthovita has devel-
oped a cement Cortoss™, which is based on Bisglycidyldimethacrylate (BisGMA) and
semi-crystallised bioactive glass 45S5 of molar composition: 46.1 SiO2 - 2.5 P2O5 -
24.4 Na2O - 26.9 CaO. The polymerisation of BisGMA monomer is less exothermic than
methylmethacrylate, however whilst BisGMA has been used widely in dentistry, there are
toxicity issues with using BisGMA internally in the body.
Following their development in the field of dentistry around the late 1960’s by Smith,
the good biocompatibility (non-toxic in vivo) of zinc polycarboxylate cements made it
the focus for use in bone implants [16]. However, a mild inflammatory response at the
surface of the cement occurred and a fibrous connective tissue layer formed after 1 week
implantation in adult white New Zealand rabbits. Around the same time, investigations
were being conducted on another widely use dental cement, in order to evaluate its prop-
erties for use in orthopaedic applications. Glass polyalkenoate cement (GPC) or more
commonly called glass ionomer cement (GIC) is formed by the combination of concen-
trated polymeric acid (usually poly(acrylic acid)) with an acid degradable fluoro-alumino-
silicate glass. Set GPCs can be simply described as glass polymer composites consisting
of inorganic glass particles in an polysalt matrix held together by a combination of ionic
cross-links and chain entanglements [17]. Setting occurs by gelation of the cement via
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acid base reaction resulting in transfer of ions from the glass to the polyacid matrix. The
working and setting times of these cements allow for filling tooth cavities. In contrast
to the acrylic cements, this setting reaction occurs with minimal generation of heat and
shrinkage and so does not cause thermal damage to tissue at the implant site, therefore
these cements held great promises for use in bone replacement surgeries. It was shown
by Wood and Hill [18] that GPCs form adhesive chemical bonds with bone and medical
alloys and Hatton and Brook [19] also found that they release osteoconductive (increase
bone growth on a surface) ions such as calcium and fluoride. However, it was suspected
that the aluminium leaching from GPCs would affect their behaviour and success in vivo.
Therefore, GPCs were implanted in female New Zealand White rabbits in order to ex-
amine the in vivo biological and biomechanical behaviour of these cements [15]. It was
concluded that aluminium ions, released from the setting cement, accumulate in regions
of bone formation, locally and at a distance from the implanted material. This effect leads
to the inhibition of mineralisation of osteoid and remineralisation of previously deminer-
alised bone, therefore their use has been limited to minimal surgery. Serenocem™ based
on the following glass composition: 4.5 SiO2 - 3 Al2O3 - 1.5 P2O5 - 3 CaO - 2 CaF2, is
used for the fixation of the transducer of a middle-ear implant to the ossicular chain.
During the 1970’s, in the University of Florida, Hench and co-workers showed that a crys-
talline hydroxy-carbonated apatite (HCA) layer of formula Ca10(PO4)6−x(CO3)x(OH)2+x,
developed on the glass surface of certain composition of glasses and partially crystallised
glass-ceramics in the SiO2 - P2O5 - Na2O - CaO system when exposed to simulated body
fluid in vitro. Subsequent to the discovery of exact compositions to which this effect oc-
curred, efforts were devoted towards understanding the interfacial bonding mechanisms.
These group of glasses became known as bioactive glasses, due to the fact that they chem-
ically adhered to the adjacent bone, based on the definition of bioactivity described in
Section 1.2.2.3. The discovery of such an interfacial bond between the bone and these
bioactive glasses heralded a new direction in the research and development of a bone
cement material such as calcium phosphate cement and synthetic hydroxyapatite (HA,
Ca10(PO4)6(OH)2) - ZnO based polyalkenoate cement.
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Calcium phosphate cements have good osseo-integration [20, 21] as they mimic the min-
eral phase of bone, but have very poor flexural strengths [22]. Furthermore, they would
not have the stimulatory action of a bioactive glass on bone tissue with the ability to pro-
mote mineralisation via the release of chemotherapeutic ions (Ca2+, Sr2+, Zn2+ and F−).
In addition they have limited adhesion with less than 110 of the bond strength that can
be achieved with existing glass polyalkenoate cements. They can be combined with a
polymer matrix to enhance the adhesive properties [23].
The incorporation of specific amount of HA in zinc polyalkenoate cement has been shown
to have a positive effect on the cement mechanical properties [24], and increased the re-
lease of calcium in a dissolution study carried out in de-ionised water [25]. Unfortunately
no results about the toxicity nor suspected bioactivity could be found in the literature.
Therefore, by consideration of the disadvantages and advantages of the different materials
set out earlier, it would appear worthwhile to investigate a material designed to achieve
interfacial bonding while matching the mechanical requirements of bone, as well as being
injectable, allowing many orthopaedic procedures to be carried out non-invasively. The
cement under scrutiny in this study is based on an aluminium-free GPC. In order to create
non-toxic GPCs, two ions have been previously used to replace aluminium. Studies have
focused on zinc or iron based glasses coupled with poly(acrylic acid) with the following
glass compositions: 4.5 SiO2 - 3.5 CaO - 3.15 CaF2 - x ZnO [26] and 4.5 SiO2 - 3 Fe2O3
- 1.5 P2O5 - 3 CaO - 2 CaF2 [27]. Both cements give chemical adhesion with bone.
In zinc based GPCs, cell cultures show that the cement elicits a toxic response. With
this glass composition, the zinc release is too high which is known to be cytotoxic. The
biocompatibility is better with iron based GPCs, with the presence of hydroxyapatite de-
position. However, the reduction of Fe3+ to Fe2+ leads to the crystallisation of magnetite
(Fe3O4), which has the disadvantage of masking the glass structure - cement properties
relationships.
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1.2 Literature Review
In this thesis, two related projects were undertaken, each devoted towards a particular
use of glass as a potential biomaterial; namely bioactive glasses and glasses for form-
ing GPCs. It is important to understand the environment in which these materials are
introduced in the body to be able to tailor their structure and properties to minimise the
risks and maximise the benefits when implanted in a living body. Thus, the following
background section details the structural and biological properties of bone and provides a
structural description of both bioactive glass and GPC.
1.2.1 Bone Biology
1.2.1.1 Bone Function
Bone performs several functions and notably provides to the skeleton the necessary rigid-
ity to function as an attachment and lever for muscles and supports the body against
gravity. Furthermore, bone is the primary reservoir of calcium and phosphorus in the
body, whose concentrations in the body fluids are tightly regulated. Bone also houses
and supports hemopoiesis (formation of blood cells); flat bones and ribs have marrow that
produces red blood cells and fourth, protects the central nervous system. Bone function
is site dependant explaining why the structure of bone varies with location.
1.2.1.2 Bone Mechanical Properties
Bone can be described as a two-phase composite material, since the major components
are the mineral and the matrix phases [28] and, Burstain et al. demonstrated that the major
determinant of the modulus of elasticity is related to the mineral phase, while the ultimate
yield strength is determined both by the mineral composition and the integrity of the
collagen matrix [29]. The water component contributes mainly to bone viscoelasticity.
The mechanical properties provided by bone are dependent in part upon the molecular
structure and arrangement of mineral crystals within their organic matrix [30]; therefore
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the mechanical properties depends on the location in the skeleton (Table 1.1). Differences
in mineral structure, such as those seen in a variety of bone diseases, ageing and sex,
significantly affect both the modulus of elasticity and the ultimate strength. This occurs
via factors such as crystal size, crystal structure, and the way in which hormonal changes
affect bone resorption and thereby the differential removal of mineral phase components
[31].
Table 1.1: The mechanical properties of skeletal tissues [4].
 






  
    
    
    
 
 
 
 
1.2.1.3 Bone Structure
Bone is comprised of approximately 70%mineral, 22% protein, and 8%water [32], which
are organised in three-dimensions. Mature bone exists as as compact bone or as trabecu-
lar bone depending on spatial organisation of its mineral and organic elements, and by its
specific locations in the skeleton. Compact bone is also called cortical bone, and trabecu-
lar bone can be named spongy or cancellous bone. The macro and microstructure of bone
is represented in Figure 1.1 and detailed in the following paragraphs.
Compact Bone Compact bone comprises the outer tubular shell of the long bone and
the outer surface of the small bones and flat bones. It consists of parallel cylindrical units
called osteons (or Harversian systems) with a diameter of about 200 µm. Osteons run par-
allel to the surface and along the long axis of the bone. Between the rings of matrix, the
bone cells (osteocytes), are located in spaces called lacuna. Small channels (canaliculi)
radiate from the lacunae to the Harversian canal to provide passageways through the hard
matrix. A second system of canals, named Volkmann’s canals, connect Harversian os-
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












Figure 1.1: a. Macrostructure of a long bone; b. 3D sketch of the microscop-
ical structure of bone; c. Cross-section sketch of the microscopical structure of os-
teon. Inspired by: http://faculty.irsc.edu/FACULTY/TFischer/AP1/AP%201%20resources.htm
and http://eatwellgetwell.wordpress.com/.
teons with capillaries and nerves, allowing a connection with the outer and inner surfaces
of the bone. Compact bone is anisotropic [33], and the directionality of its mechanical
properties are greatly dependant on the orientation of the osteons. Cortical bone is the
denser bone and is stronger in compression than tension [31].
Trabecular Bone Less dense than compact bone, trabecular bone is located near the
ends of long bones, as the interior of small bones, and between the surfaces of flat bones.
Trabecular bone accounts for 20% of bone mass and whose structure resembles honey-
comb. The orientation of the mesh-like structure is such that the trabecular bone is also
anisotropic [33]. It optimises resistance to the usual stresses that occur for each bone spe-
cific location. Trabecular bone has a lower modulus of elasticity than cortical bone due to
its greater porosity; however trabecular bone can withstand greater strains, fracturing at
changes of approximately 7% of its original length, while cortical bone will fail at strains
of only 3% [12,34].
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1.2.1.4 Bone Cells
Bone tissue contains very specialised cell types embedded in both organic and inorganic
matrix components:
• Mesenchymal precursor cells Located in the periosteum, endosteum and connec-
tive tissue lining bone, these cells have the potential to differentiate into osteoblasts,
fat cells, chrondrocyte, or muscle cells [35].
• Preosteoblasts Considered as the intermediate precursor of osteoblasts, they are
located in the adjacent cell layers distant from the osteoblasts at the bone formation
surfaces [36].
• Osteoblasts These bone forming cells of about 10 - 20 µm size, are fully differen-
tiated cells and are responsible for the production of the unmineralised bone matrix,
the osteoid [37].
• Osteocytes During the osteoid mineralisation, the osteoblasts are trapped in the
bone tissue they have secreted in small cavity called lacunae. The osteoblasts, at
this stage, are less active and are called osteocytes and perform upkeep of the bone
matrix by influencing mineral content and regulating calcium release into the blood.
Osteocytes account for about 90% of the cells in the adult skeleton [38].
• Bone lining cells These flat and elongated, inactive cells cover bone surface and
are undergoing neither bone formation nor resorption. As speculated by Aubin and
Liu, bone lining cells can be precursors for osteoblasts cells [36].
• Osteoclasts They are relatively large cells (20 to 100 µm) and multinucleate (30
to 50 nuclei). Osteoclasts are principally responsible for bone matrix resorption
via weak acid, which solubilise the mineral crystals and degrade enzymatically the
collagen [39].
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1.2.1.5 Bone Matrix
Bone matrix consists of an organic and inorganic component and therefore can be viewed
as a composite material. The inorganic phase contributes approximately 65% of the wet
weight of the bone. The organic phase usually contributes about 20% of the weight, and
water contributes approximately 10% [40]. Produced primarily by the osteoblasts, the
organic matrix is made of approximately 90% type I collagen and proteoglycans and gly-
coproteins [41]. The inorganic component is largely composed of carbonated hydroxyap-
atite of formula Ca10(PO4)6−x(CO3)x(OH)2+x, whose long and plate like shaped crystals
measure approximately 7 nm in diameter and from 20 to 300 nm in length. The orienta-
tion and size of the crystals are constrained by the collagen fibrils of the osteoid before
mineralisation [?].
1.2.1.6 Bone Remodelling
Bone has the ability to modify its microstructure according to the mechanical and physi-
ological environment, which is called bone remodelling. Hence, bones can grow, change
their shape by external remodelling (or modelling), continuously renew themselves by
internal modelling and self-repair when fractured (fracture healing). Bone formation is
carried out by the osteoblasts and bone resorption by the osteoclasts at a rate of 2 - 10%
of the skeletal mass per year [36, 42]. This balanced process is described as coupling. A
coupling imbalance between formation and resorption can lead to skeletal diseases such
as osteoporosis where resorption is greatly higher than formation. Bone remodelling is
highly dependant on bone type. As examples, the ear bone is not remodelling, the cranium
bone undergoes very low changes whilst the femur is affected at higher rate.
The process is not performed individually by each cell but by groups of cells. The re-
modelling cycle [43] can be described in the following steps and is illustrated in Figure
1.2:
• Resorptive phase: osteoclasts resorb bone surfaces to form an erosion cavity
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• Reversal phase: preosteoblast cells then fill in the cavity, differentiate into os-
teoblasts and begin to lay down new matrix.
• Formative phase: this long process involves mature osteoblasts secreting matrix
for up to 100 days.
• Resting phase: once embedded in osteoids, the osteoblasts mature into terminally
differentiated osteocytes.
   


 
 
Figure 1.2: Schematic representation of bone remodelling. Inspired by:
http://www.ns.umich.edu/Releases/2005/Feb05/bone.html
1.2.1.7 Ionic Influence on Bone Mineralisation
The mineral phase of bone is principally composed of calcium and phosphorus but in the
process of mineralisation, a variety of metal ions can be taken up from the bloodstream
as the blood plasma runs over the skeletal tissues. The uptake by the bone mineral is a
function of the specific ion concentration in the blood plasma and the degree of mineral-
isation of bone [44]. Furthermore, the metal ions can interact with bone cells, affecting
their metabolism, which in turn may alter the osteoblasts and osteoclasts behaviour. Once
a metal ion is incorporated in the bone mineral, its return to the circulation will depend
on when the bone mineral containing the metal will be resorbed [45]. Metals deposited
or exchanged with other metals on the surface of the bone mineral tend to be exchanged
rapidly; especially if the metal ion forms a solid solution in the hydroxy-carbonated ap-
atite lattice.
33
CHAPTER 1. Introduction
Calcium and Phosphorus Solubility The calcification of bone matrix depends on
specificity of crystal growth and takes advantage of the solubility characteristics of cal-
cium phosphate minerals. While calcium (Ca2+) and phosphate (H2PO4 and HPO2−4 ) do
not precipitate either in extracelular fluid or in healthy body tissues, the same minerals, in
exactly the same concentrations (1 - 2 mM), support mineralisation when such flow passes
a bone-forming site [46]. In parallel, in vitro experiments in a rat osteoblast-like system
showed that supplementation of 1.8 mM of Ca2+ and 5 mM of β -glycerophosphate (β -
GP) was able to induce mineralisation, whereas spontaneous mineralisation was not de-
tected in the same condition in the absence of cell culture [47]. Furthermore, the solubility
of crystals like hydroxyapatite or tricalcium phosphate [Ca9(PO4)6] limits spontaneous
formation below pH 8 [46], showing that the presence of templates is necessary for bone
mineralisation. Thus, vertebrates have been able to control deposition of such mineral by
placing them only in specific loci, where it is needed to provide the necessary mechanical
properties for the structural role of bone. Non collagenous matrix proteins are believed
to play the critical role in tailoring a spacial arrangment of Ca2+ and PO3−4 ions to create
the hydroxyapatite template. Notably, alkaline phosphatase, produced by the osteoblast
late in the matrix deposition process, is believed to make extra phosphate available and
remove components that otherwise function as inhibitors of crystal growth [48].
Calcium Trials in humans [49] have been published in recent years, showing that el-
evating calcium intake enhances bone acquisition during growth, reduces bone loss in
postmenopausal women, fracture rates at spine, hip, and other extremity sites. In one of
these studies [50] involving nearly 1800 French women, average age 84, elevating calcium
intake from ~ 13 mmol/day to ~ 42.5 mmol/day reduced fracture rate at both hip and other
extremity sites by 20% to 40% within 18 months of starting supplementation. Regarding
the effect on bone mineral density, control subjects lost ~ 4.6% of the bone from the hip
site over the 18 months of observation (an annual rate of ~ 3% per year), whereas the
supplemented individuals gained 2.7%. The evidence is showing that low calcium intake
weakens bone and contributes to the growing osteoporosis problem. A fully adequate cal-
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cium diet for persons age 65 and older, consuming otherwise typical Western diets, would
contain more than 37.5 mmol Ca/day and perhaps as much as 60 mmol Ca/day. In another
study, the dietary phosphorus net absorption was studied as a function of calcium intake
(12.5 mmol/day - 62.5 mmol/day) in human [51]: in a 93 men and women aged 19 - 78
data set, each increase in calcium intake of 12.5 mmol decreased phosphorus absorption
by 5.4 mmol. The study underlined the risk of phosphorus insufficiency when calcium
intake therapy are given without phosphorus supplementation.
Phosphorus The adequate quantities of ingested phosphorus for bone building during
growth is situated around 1.5 - 2.0 mM (expressed physiologically as a serum phosphate
concentration) [52, 53]. Hypophosphatemia (abnormally low level of phosphate in the
blood), limits mineralisation at new bone-forming sites at all ages, impairs osteoblast
function, and enhances osteobleastic resorption [54]. Addition of organic phosphates in
culture medium, have been used to modulate or enhance mineralization [55–63]. Organic
phosphate is hydrolyzed by alkaline phosphatase to release free inorganic phosphate. In
vitro studies [64, 65] used periostea (osteogenic layer and the fibrous layer of the pe-
riosteum) dissected from 17-day-old embryonic chick calvariae, leaving the osteoblasts
behind on bone. The dissected periostea were folded with the osteogenic cells in appo-
sition. The explants were cultured on plasma clots for up to 6 days. Osteodifferentiation
and osteoid formation in between the two layers showed that 5 to 10 mM of β -GP is
capable of inducing mineralization in vitro.
Aluminium Aluminium accumulation in bone increases as the concentration increases
in the blood plasma [66] and inhibits mineralisation and acts on bone cells [67]. Alu-
minium appears to enter the skeletal tissue along with calcium, competing with it, in-
hibiting hydroxyapatite formation in vitro [68]. In vivo, Bouglé et al. reported that both
the mineral density and mineral content of lumbar spine decreased significantly as serum
aluminium levels increased in healthy premature infants [69]. The effect of aluminium
on bone may require concentrations of 30 to 40 mg Al/Kg of dry bone, a concentration
equivalent to 1 to 2% of the calcium content, whereas the aluminium concentration in
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bone of normal subjects is only 5 to 7 mg/kg dry bone [45].
Silicon The silicon concentration in soft tissues varies between 10 and 20 mg/Kg.
Carlisle [70] showed that silicon hastens mineralisation in the bone of young mice and
rats. It increases the uptake of calcium and magnesium into the femur when fed to wean-
ling rats at the rate of 25 mg/Kg fresh diet. An other study on ovariectomised rats, showed
that silicon supplementation overcame the losses of bone mass in the femur and fifth lum-
bar vertebra [71]. Eisinger and Clairet [72] found that 15% of women with osteoporosis
treated with silicon supplement induced a statistically significant increase in femoral bone
mineral density suggesting a potential therapeutic application of silicon to treat osteoporo-
sis.
Strontium Strontium is an important source of interest in recent years because of its
positive effect on bone cells. Like calcium, strontium is an alkaline earth metal and is a
bone-seeking agent. Strontium is naturally present in the liver, muscles and physiological
fluids, but is mainly present in bone. However, the amount of strontium in bone is typi-
cally only 3.5 weight % of its calcium content [73]. It is preferentially found in new bones
than old and more in cancellous than cortical bone. It is currently used in a drug (Stron-
tium Ranelate - Protelos®) aimed at treating osteoporosis. In vitro and in vivo it enhances
the replication of pre-osteoblastic cells and decreases the osteoclast activity and number.
The intake of these strontium containing drugs leads to a greater deposition of calcium
in bone, enhances DNA and bone collagen synthesis [73–76]. Furthermore, in rats and
in postmenopausal woman, improvement of bone quality due to strontium intake leads to
bone anti-fracture efficacy [77–79]. It worth pointing out that in vitro studies on rodents
show that high strontium concentration may disrupt bone nodule mineralization [80, 81].
Fluorine Fluorine has a well known effect on the reduction of dental caries. Popula-
tion and individual studies exposed to fluorides indicate that doses above 30 mg daily
can result in fluorosis, characterised by increased bone fracture risk [82, 83]. However,
other clinical studies have demonstrated increased bone mineral density in subjects treated
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with the appropriate doses of fluoride. Alexandersen et al [84] shown a notable increase
of 2.4% of vertebral bone mineral density per year. Fluoride is an anabolic agent and
increases osteoblast activity [85]. Clinical studies show a positive effect on both bone
mineral density and fracture risks when the fluoride is given with an osteoclast inhibitor
such estrogen [84, 86].
Magnesium Magnesium is naturally abundant in the body and about 50% is located
in the skeleton. Dietary magnesium deficiency has been implicated as a risk factor for
osteoporosis [87, 88]. Studies on rats have shown that magnesium intake has a positive
influence on bone strength [89–91].
Zinc There is no dedicated zinc storage system in the body. Therefore a steady state
of zinc intake and excretion occurs. The amount of zinc in the body depends on the
composition of the diet, the constitution and age. Zinc is a cofactor for many enzymes,
stimulates protein synthesis and is essential for DNA replication [92]. Zinc is thought to
activate bone formation and inhibit bone resorption [92,93] and Zinc deficiency has been
shown to be associated with skeletal growth retardation and alterations in bone tissue
calcification [94]:
Zinc, when used as a component of an implant can have different effects on bone cells. If
the release is significant, zinc elicits a toxic response associated with oxidative stress on
cells [95]. At low release levels, zinc promotes implant osseointegration [96, 97].
1.2.2 Biomaterials
The term biomaterial or biocompatible material can be defined as a natural or synthetic
material that is used to replace a part of a living system and thus which is in contact with
the human tissue [98]. In this section the different reactions at the implant site when a
biomaterial is introduced in the body are described.
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1.2.2.1 Tissue Response to Implant
There are four general types of implant-tissue response, as summarised in Table 1.2.
Table 1.2: Consequences of Implant-Tissue Interactions [4].
Implant-Tissue Reaction Consequences
Toxic Tissue dies
Sequestion of implant
Tissue forms a non-adherent fibrous
capsule around the implant
Bioactive
Tissue forms an interfacial bond with
the implant
Dissolution of implant Tissue replaces implant
The most common response of tissues to the presence of an implant in the body is the
formation of a non-adherent fibrous capsule. The fibrous tissue is formed in order to
“wall off” or isolate the implant from the host. It is a protective mechanism and with time
can lead to complete encapsulation of an implant within the fibrous layer [4]. The relative
level of reactivity of an implant influences the thickness of the fibrous layer between the
material and the tissue. A nearly inert implant forms a non-adherent fibrous layer at the
interface. Such materials need to be tightly mechanically held (morphological fixation).
If interfacial movement occurs, the thickness of the fibrous capsule can reach several
hundred micrometers and the implant loosens very quickly. Loosening invariably leads to
clinical failure [99].
No materials implanted in living tissues are inert; all materials elicit a response from the
host tissue. The response occurs at the tissue-implant interface and depends upon many
factors (Table 1.3) [4].
Engineering the surface morphology of the bone implant can improve biological fixation
by bone growth into features such as connected porosity. The pore needs to be at least
100 µm in diameter in order to allow blood supply to the ingrowing tissues [100]. If
micro-movement occurs at the interface of a porous implant, the capillaries can be cut
off, leading to tissue death, inflammation and destruction of the interfacial stability.
Resorbable implants are designed to degrade gradually with time to be replaced with
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Table 1.3: Factors affecting implant-tissue interfacial response. Adapted from [4].
Host Implant
Type of tissue Chemical composition
Health of tissue Structural composition
Age of tissue Phase boundaries
Vascularity Surface topography
Motion at interface Porosity
Closeness of fit Surface chemistry
Mechanical load Dissolution rate
Site of implant Size
Mobility of patient underlying disease Mechanical properties
natural tissue. This approach is the optimal solution to the problem of interfacial sta-
bility, where the tissues are regenerated of tissues rather than replaced. The difficulty is
having a suitable evolution in strength and mechanical performance of an implant while
regeneration is occurring. The resorption rate has to matched the repair rate of body tis-
sue. The products of the resorption process or the material itself should be non-cytotoxic
and/or preferentially activate controlled pathways. Successful examples of resorbable
implants include specially formulated polymers such poly(lactic acid) and poly(glycolic
acid) which are metabolised to carbon dioxide and water. Tricalcium phosphate (TCP)
ceramics degrade to calcium and phosphate salts and can be used for space filling of
bone.
1.2.2.2 Biocompatibility Assessment
Amajor requirement of a biomaterial that is to be implanted is that it must be biologically
compatible with the human body. The biocompatibility testing of materials is therefore
intended to guarantee the maximum benefit with the minimum risk for the patient [101].
Three levels of testing are recommended for regulatory approval:
• toxicological effects using in vitro system
• in vivo tests at the site of potential material use using animal model
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• clinical trials in humans
The results from the consecutive execution of these tests aid in defining the biological
tolerance of materials.
1.2.2.3 Bioactivity of bone implant
A bioactive material undergoes surface chemical reactions when implanted in the bone,
which lead to bonding of tissues at the interface. Thus, the concept of bioactivity was
defined as:
"A bioactive material is one that elicits a specific biological response at the
interface of the material which results in the formation of a bond between the
tissues and the material" [4].
A bioactive material provides an environment compatible with osteogenesis (bone for-
mation) with the formation of a mineralised interface, which acts as a natural bonding
junction between the living and non-living materials. Amongst bioactive materials, the
mechanism, the time dependence, the strength of bonding, as well as the thickness of
bonding zone are different [102]. The level of bioactivity is related to the rate of develop-
ment of the interfacial bond.
A common characteristic of most bioactive implants in the bone-implant interface is the
formation of a hydroxy-carbonated apatite (HCA) layer at the surface when implanted
[103]. The HCA phase is similar in composition and structure to the mineral phase of
bone. The HCA layer grows as polycrystalline agglomerates, which incorporates collagen
fibrils thereby binding the inorganic implant surface to the organic constituents of the
tissues [103]. Thus the interface between the implant and the tissue is similar to the
natural bonds and structure present in the body. Due to the large difference in rate of
bone bonding to bioactive implants, Hench proposed a new hypothesis where bioactive
materials are classified into two types depending on biochemical factors occurring at the
implant-tissue interface [102]:
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• Class A materials induce both an intra and extracellular response at the interface
with the tissue and can bond with soft tissues as well as bone. Furthermore, these
materials are osteoproductive, i.e according to Wilson definition, the surface of the
implant is colonised by osteogenic stem cells.
• Class B materials are defined as osteoconductive and they display only an extracel-
lular response at their interface.
1.2.3 The Use of Glass as Biomaterial
1.2.3.1 Definition of Glass
A glass is a non-crystalline material made typically from a super-cooled liquid, i.e. the
disordered structure of the liquid will be frozen into the solid material through extremely
rapid cooling (or quench). The process of solidification without crystallisation is called
vitrification. Tammann, in 1991, was the first to define glass as a vitreous state of matter
[104]. A glass is an amorphous solid i.e a solid in which there is no long-range order of
the positions of the atoms.
There are four main processes to produce glass: the melting route, the irradiation of a
crystalline phase, the condensation of a vapour phase on a cold surface and the sol-gel
process which consist of polymerisation of non-organic monomers.
1.2.3.2 Structure and Theories of Glasses
Goldsmidt’s Criterion Goldsmidt (1926) set vitrification conditions for simple oxides
with the stoichiometric formula AmOn. The ratio of the ionic radii rArO must be between
0.2 and 0.4 for glass forming oxides. This range of values indicates that the central cation
has coordination number corresponding to a tetrahedral a coordination [105].
Zachariasen’s Rules Zachariasen (1932) proposed an elaborate model to explain that
some oxides verify Goldsmidt’s criterion but do not form a glass. He assumed that the
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glass structure forms a three dimensional network like crystals [1, 106]. However the
atoms of the glass are distributed around an equilibrium position, breaking the charac-
teristic periodic and symmetrical arrangement of crystals (Figure 1.3). Zachariasen [1]
described silicate glasses as a vitreous three dimensional network built up of oxygen tetra-
hedra which surround the silicon atoms.
 
Figure 1.3: Two dimension schematic representation of the structure of: a. hypothetical crys-
talline compound, b. the vitreous form of the same compound [1]
The structure can be analysed in terms of coordination polyhedra of cations surrounded
by a variable number of oxygens. After systematic examination of the structure formed by
different coordination polyhedra, Zachariasen showed that a simple glass-forming oxide
must satisfy the following rules [107]:
• an oxygen atom is linked to not more than two cations
• the number of oxygen atoms surrounding cations must be small
• the oxygen polyhedra share corners with each other, not edges or faces
• at least three corners of each oxygen polyhedron must be shared.
Among all the oxides used as glass components, Zachariasen set three categories: network
former, network modifier and intermediate depending on if the oxide enters the network,
disrupts the network or may have a dual role respectively (Table 1.4). A network modi-
fying oxide will replace bridging oxygens (BOs), an oxygen atom bonding to two silicon
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atoms, by non-bridging oxygens (NBOs), oxygen atoms only bonding to one silicon atom
which strongly affects glass properties. Cations are present in the vicinity of NBOs for
charge balancing (Figure 1.4).
Table 1.4: Classification of the oxides after Zachariasen.
Glass-formers Modifiers Intermediates
SiO2 Li2O Al2O3
GeO2 Na2O PbO
B2O3 K2O ZnO
P2O5 CaO CdO
As2O3 BaO TiO2
As2O5
V2O5
 


Figure 1.4: Rupture of a Si-O-Si bridge by the modifier oxide MO.
Qn Structure The Qn notation expresses the number of bridging oxygens per tetrahe-
dron, where n is the number of bridging oxygen [108]. A Q4 structure corresponds to a
silicon surrounded by four bridging oxygens and Q0 correspond to a silicon surrounded
by four non-bridging oxygens.
Dietzel’s Rule Dietzel used the strength of the bond between the cations in glasses and
oxygen to classify the role of the cation. The field strength, vr2 where v is the valance
and r the distance cation/oxygen, is used to determinate the role of the glass components:
network modifiers, intermediate oxides and network former (Table 1.5).
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Table 1.5: Characteristics of the common cations found in glass (adapted from Dietzel [5]).
Cation Valance, v Co-ordination
number, Z
Distance
between oxide
ions, r (nm)
Ionic potential,
v
r (nm
−1)
Field strength
of O ions, vr2
(nm−1)
Network modifiers: Z ∈ [6-8], vr <9.5, vr2 <44
K 1 8 0.277 3.61 13
N 1 6 0.230 4.35 18.9
Li 1 6 0.210 4.76 22.7
Ba 2 8 0.286 6.99 24.5
Pb 2 8 0.274 7.30 26.6
Sr 2 8 0.269 7.43 27.6
Ca 2 8 0.248 8.06 32.5
Mn 2 6 0.223 8.97 40.2
Fe 2 6 0.215 9.30 43.3
Intermediate oxides: Z ∈ [4-8], vr ∈ [9.5-20.5], vr2 ∈ [45-105]
Mg 2 6 0.210 9.52 45.4
4 0.196 10.20 52.1
Mn 2 4 0.203 9.85 48.5
Zr 4 8 0.228 17.54 76.9
Be 2 4 0.153 13.07 85.4
Fe 3 6 0.199 15.08 75.8
4 0.188 15.96 84.9
Al 3 6 0.189 15.87 84.0
4 0.177 16.95 95.8
Ti 4 6 0.196 20.41 104.1
Network formers: Z ∈ [3-4], vr >20, vr2 >130
B 3 4 0.150 20.00 133.3
3 0.136 22.06 162.2
Si 4 4 0.160 25.00 156.3
P 5 4 0.155 32.26 208.1
Amorphous Phase Separation Immiscibility phenomena can occur during glass pro-
cessing. Several non-crystalline phases can coexist in a complex heterogeneous structure.
The inhomogeneity results from the existence of immiscible liquids in the melt, stable un-
mixing or phase separation during cooling, which is called metastable separation [105].
In the case of phospho-silicate glasses, the role of P2O5 is controversial. In the classi-
fication of the oxides after Zachariasen [105], phosphorus pentoxide is a network for-
mer. However 31P Magic Angle Spinning Nuclear Magnetic Resonance (MAS-NMR)
results [109, 110] show a single resonance assigned to an orthophosphate-like environ-
ment. In this case, it does not go into the network, but creates orthophosphate species.
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Furthermore, dielectric spectroscopy studies [111] showed two different relaxation pro-
cesses corresponding to two different alkali metal ion hopping processes within the glass.
The author speculates that it is due to amorphous phase separation into silica rich and
orthophosphate rich phases. The relaxation processes would be due to ion hopping in the
two different phases. One mole of P2O5 in a silicate glass creates two orthophosphate
units and attracts three moles of network modifier which changes the connectivity of the
silicate glass network significantly.
Inorganic Polymer Model Holliday and Ray [112] presented glass as an inorganic
polymer, a substance of high molecular weight where chains are a sequence of oxygens
cross-linked with silicon atoms. This model can be used to predict the surface reactivity,
solubility and thermal expansion by introducing the notion of network connectivity (NC).
A fully cross-linked network will have a network connectivity of four and a glass with a
network connectivity of two will be analogous to a linear polymer. The network connec-
tivity can be calculated from the molar composition of the glass. The number of NBOs
created by the network modifying oxides is subtracted from the number of BOs formed by
the network forming oxides and this number is divided by the number of network former
oxides to obtain the network connectivity (Equation 1.1).
NC =
No. BOs−No. NBOs
No. network f ormer oxides
(1.1)
If phase separation occurs as previously reported in the previous subsection (Amorphous
Phase Separation) one mole of SiO2 forms four BOs. Na2O, CaO or SrO form two NBOs
per mole. One mole of P2O5 creates two orthophosphate units and attracts three moles of
network modifier to charge balance. Thus six BOs in the silicate network are created per
mole of P2O5.
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1.2.3.3 Bioactive Glass
In 1969, Hench discovered that some compositions of silicate-based glasses can bond
chemically with bone [113]. These glasses were called bioactive glasses and have been
used mostly as reconstructive materials for damaged hard tissues such as bone. The ad-
vantage of this group of materials is the possibility to tailor the glass to generate a different
reactivity and response with the body. Generally the rapid reaction at the surface leads to
fast bonding with the living tissue.
Hench explains the glass dissolution in several steps [4]. It starts with a rapid exchange
of Na+ with H3O+ from the solution leaving Si-OH groups in the glass structure. The Si-
O-Si bonds cleavage by hydroxyl ions releases Si-OH into the physiological environment
and Si-OH at the glass-solution interface. When the silica solubility limit is reached, Si-
OH condenses and forms a SiO2 rich layer on the surface. The migration of cations and
PO3−4 groups to the surface through the silica rich layer forms a CaO-P2O5 rich film. This
new top surface layer incorporates ions from the solution and crystallises with the incorpo-
ration of OH−, CO2−3 and F
− ions from the solution to form a mixed hydroxy-carbonated
apatite layer (HCA). This mechanism will be discussed later taking into account results
from recent studies.
New Insight Into Bioactive Glass Dissolution The mechanism proposed by Hench
and described in the previous section is widely accepted as being the mechanism of
degradation of bioactive glasses. However, Ohura et al. [114] produced bioactive glasses
without Na2O which is not possible according the first step of Hench’s mechanism. Fur-
thermore, network connectivity calculations show that glasses which are bioactive have a
network connectivity around 2 (NC = 1.90 for the 45S5 glass). This means that the glass
is mainly Q2 in structure. This glass structure can be thought of as linear chains, rather
than a three dimensional network. When immersed in physiological fluids, parts of the
glass can go directly into solution without any strong covalent Si-O-Si bonds breaking
as proposed in Hench’s mechanism. Hench’s model should therefore be corrected. The
first stage might be that the glass close to the surface with Q0, Q1 and Q2 structure will
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go directly into solution without breaking any Si-O-Si bonds. At the same time and rate,
ions in the glass partly go into solution as well. The process continues until the silica
solubility limit is reached and the silica gel layer then forms as proposed by Hench.
Influence of the Network Connectivity on the Glass Bioactivity Glass properties
such as viscosity, crystallisation rate and degradability change markedly around network
connectivity (NC) value of 2.0 corresponding to Q2 ring/chain silicate structure.
At a NC of 2.0 it is thought that linear silicate chains exist of infinite molar mass. As
the NC falls, there is a rapid decrease in the molar mass and length of the silicate chains.
As the NC goes above 2.0 the glass becomes a three dimensional network and thus, less
soluble in physiological fluids. Consequently, small changes in composition will have a
significant effect on reactivity and biological properties.
Also, the use of network connectivity, to predict the bioactivity of a glass, has to be used
with caution. Indeed, the network connectivity model takes into account only the struc-
ture of the glass without considering ionic interactions and hydrostability of the various
bonds. Even if the NC remains constant, a decrease in the ionic interactions between
NBOs directly would act on the dissolution behaviour of the glass in physiological flu-
ids. Furthermore, the model does not take consider the biological role of released ions on
bone cells (i.e. the effect of cell activity on bioactivity) regardless of their role in the glass
structure.
1.2.4 Glass Polyalkenoate Cements
Zinc polycarboxylate and glass polyalkenoate cements (GPC) first came to prominence
as dental cements in the late 1960s [115] and early 1970s [116]. Most of the cements in
use are based on calcium-fluoro-alumino-silicate glass. They are formed by mixing the
glass, poly(carboxylic acid) and water. It is worth noting that the term "glass ionomer"
often found in the literature is misleading, as the polymer used is not a ionomer but rather
a poly-electrolyte. A true ionomer will have around one ionisable group for every twenty
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monomer units on the chain. For the poly(carboxylic acid) used for GPC, every monomer
is potentially ionisable.
1.2.4.1 Setting reaction
Existing glass GPCs are formed by reacting aqueous poly(acrylic acid) (PAA) with a
fluoro-alumino-silicate glass. The reaction can be regarded as an acid-base reaction be-
tween a polymeric carboxylic acid and a basic glass, with the formation of a polyacrylate
salt (Figure 1.5). The metal ions from the glass serve to ionically cross-link the polymer
chains resulting in a hard ceramic cement like substance.
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Figure 1.5: Schematic of the setting reaction and resulting cement polysalt matrix containing the
remaining glass particles.
The setting reaction occurs in four steps [117]:
1. Decomposition of the powder: the surface of the glass particles are attacked by the
acid. This leads to the release of metal cations from the glass into solution and the
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formation of a silica gel layer at the glass surface.
2. Gelation: as the glass reacts, the pH rises and thus more carboxylic groups (COOH)
are ionised to carboxylate groups (COO−). The viscosity rises with charge repul-
sion and ionic bridges form leading to the gelation of the cement.
3. Hardening: the large scale ionisation of carboxylate groups, the release of metal
cations and the formation of ionic cross-links between these two species, result
in bulk desolvation/precipitation of the insoluble polyacrylate salt matrix. This is
considered the initial setting of the material.
4. Further maturation: even after 24 hours, the setting reaction continues through ionic
diffusion. As a result the hardness of the cement increases with time.
1.2.4.2 Role of the Glass Constituents found in GPCs and Al-free GPCs
The Role of Aluminium Polyalkenoate cements are usually made from fluoro-alumino
silicate glasses. Aluminium is a tri-valent ion and thus efficiently cross-links the poly-
acid chains. Furthermore, phosphorus can be added to the composition to compensate for
the charge of the aluminium, creating Al-O-P bonds, which decreases the glasses reactiv-
ity and protects it from the acidic attack. Hence, the structure and setting properties of
polyalkenoate cements are greatly affected by aluminium. But as reported previously, the
presence of aluminium causes local demineralisation and neurotoxicity [15]. Therefore
the release of aluminium from glass polyalkenoate cement needs to be inhibited.
The Role of Sodium Many bioactive glass compositions give excellent response in
vitro and in vivo as it will be discussed in Chapter 5. However, composition such as the
45S5 glass would not be appropriate in a cement system because of its high sodium con-
tent and lack of high charge cations. Indeed, the strength of the cement, resulting from the
acid-base reaction between the glass and the polyacid, is due to the efficient cross-linking
of the carboxylic groups by di- or tri-valent cations. Mono-valent ions such as sodium
or potassium, rather disrupt the ionic cross-linking of the polymeric chains, leading to
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cements with poor mechanical properties [118]. However, sodium has the advantage of
significantly decreasing the melting temperature of glasses, which is necessary to produce
the glass at reasonable temperatures (≈ 1450◦C). In order to produce aluminium-free
glass polyalkenoate cements, new glass compositions need to be investigated.
The Role of Magnesium and Zinc Aluminium-free glasses with low sodium content
were developed in a previous study [119] based on the molar composition: 45 SiO2, 6
Na2O and 44 CaO. Unfortunately the resulting cements dissolved once immersed in de-
ionised water. In this work, calcium was progressively replaced by magnesium, where
the later acted to increase the cement compressive strength. This study shows both that
it was possible to make glasses with low sodium content, and that high concentrations of
magnesium are beneficial for cement mechanical properties.
Previous work has shown that magnesium plays an intermediate role in the glass, and
enters the glass network more easily in composition with low silica content [120]. In Bio-
glass® doped with zinc, zinc appears also to enter the glass network, and creates Zn-O-Si
bonds [121]. These experimental results are in accordance with Zachariasen’s rules and
Dietzel’s criterion, where magnesium and zinc with their high charge to size ratio can act
as intermediate oxides, and switch their role from being a network modifier, to being an
intermediate oxide and entering the silicate glass network similarly to aluminium. There-
fore magnesium and zinc should be good candidates to replace aluminium. They would
also act to create hydrolysable bonds in an identical fashion to aluminium. Furthermore,
their high charge to size ratio compared with others divalent cations, could elicit a stronger
ionic cross-linking of the polycarboxylate chains.
Therefore the initial glass compositions designed in the present study were based on a
sodium-free composition containing fluorine and high levels of magnesium. Fluorine was
introduced in the glass composition in order to decrease the melting temperature and as
detailed in Section 1.2.1.7 for its potential effect on bone mineralisation.
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The Role of Iron (III) In another attempt to create aluminium-free GPCs, Al2O3 was
substituted with Fe2O3 in a SiO2-Al2O3-P2O5-CaO-CaF2 system [27]. Iron (III) is attrac-
tive because like aluminium, it is a 3+ cation that could be expected to more efficiently
ionically cross-link the polycarboxylate chains. Good in vitro biocompatibilty results
were reported but due to the high concentration of iron in the compositions, magnetite
(Fe3O4) crystallised from the glass. It would be therefore of interest to produce glasses
with lower iron concentrations.
The Role of Phosphorus It has been reported that P2O5 influences the working and
setting time of fluoro-alumino-silicate glass based cements by forming Al-O-P bonds,
as the phosphorus ion charge balances the aluminium [122]. These bonds are more sta-
ble than the Al-O-Si bonds and therefore decrease the degradation of the glass. In an
aluminium-free glass, on the other hand, the influence of phosphorus is different. In re-
cent studies [123], increasing the phosphorus concentration in bioactive glasses has been
shown to significantly reduce the pH rise associated with the dissolution of the glass. As
the setting reaction is an acid-base driven reaction, phosphorus content may have an im-
portant influence on cement rheology and mechanical properties. Phosphorus is present in
an orthophosphate environment in bioactive glasses as previously discussed in this Chap-
ter, but these glasses generally contain only small amounts of magnesium and/or zinc.
Therefore, it is essential to determine the role of phosphorus in rich magnesium / zinc
ionomer glasses because of the difference in composition from a bioactive type of glass
to a reactive glass for cement application.
The Role of Strontium In a recent study, strontium substitution for calcium in a SiO2-
CaO-ZnO polyalkenoate glass was shown to increase the reactivity of the glass [124].
Furthermore, strontium addition in GPCs has been shown to increase the radio-opacity of
the cements, therefore increasing the interest of having strontium containg glass in GPCs.
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1.2.4.3 Influence of Compositions on Glass Polyalkenoate Cement
Influence of the glass volume fraction Increasing the glass volume fraction (glass :
(PAA + 10% (w/w) tartaric solution)) elicits a general increase in compressive strength
and Young’s modulus of cements [125,126]. This is due to the increase of the overall glass
surface area being attacked by the acid and thus increases the amount of ions available for
cross-linking the PAA chains.
Influence of poly(acrylic acid) molar mass and concentration [126–128] The com-
pressive strength, the flexural strength, the fracture toughness and toughness increase
with molar mass of the polyacid. The Young’s modulus is independent of the molar mass.
When the chains are longer, they are more cross-linked and entangled.
Increasing the polyacid concentration increases the compressive strength and Young’s
modulus until PAA/water ratio reaches 50%. The flexural strength increases with the
concentration of polyacid. Greater concentrations of PAA might lead to a greater chain
entanglement density, as well as an increased number of carboxyl groups available for
ionic cross-linking. Simultaneously there will be a reduction in the water content of the
cement as the PAA concentration is increased. Water is likely to have a plasticising action
and therefore as the water content is reduced there will be fewer loosely bound water
molecules and this will contribute to the increase in the modulus observed.
The role of (+)-tartaric acid The (+) form of tartaric acid ((+)TA) has an important role
on the setting reaction. The concentration of (+)TA has a qualitative and quantitative effect
on the development of the cement viscosity [129]. With a fluoro-alumino-silicate glass
based cement, the change in viscosity does not change linearly with (+)TA concentration.
The (+)TA is more acidic than the PAA, therefore the ions released from the glass will be
preferentially attracted to the (+)TA. By this mechanism the cross-linking of PAA chains
is slowed down and thus increases the working time of the cements.
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Scope of Thesis
The aim of this research is to contribute to the development of novel solutions for the re-
pair and regeneration of bone. As described in Chapter 1 particular compositions of glass
have been shown to have excellent biocompatibilty by creating a favourable interface at
the implant-bone location. Furthermore, the control of their composition allows the re-
lease of biologicaly active ions, which can promote bone formation. The first objective of
this work is to study the effect of incorporating strontium in a bioactive type of glass on
glass structure, physical properties and ability to form an hydroxyapatite in vitro and in
vivo. The second objective of this thesis is to design novel aluminium-free glass compo-
sition for glass polyalkenoate cement application as aluminium has been shown to be the
major limiting factor for the medical use of GPC.
The purpose of Chapter 1 was to provide a comprehensive review on the properties of
bone as well as the strucure of bioactive glasses and glass polyalkenoate cements. The
experimental parameters and experimental techniques used will be described in Chap-
ter 3 and Chapter 4 - 8 will discuss the main experimental results of this thesis. Final
conclusions and general suggestions for future work are presented in Chapter 9.
The following section will highlight the particular scope and aspects of each results chap-
ter.
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2.1 Development of a Strontium Containing Bioactive Glass
The bioactivity of glasses has been shown to be closely linked to their compositions and
structures. The conventional way to produce a bioactive type of glass is to play on its
network connectivity in order to produce a glass with suitable dissolution profile in physi-
ological fluids. However, the aim of Chapters 4 and 5 is to study the possibilty to enhance
the bioactivity of a well characterised glass ICIE1 by simply substituting strontium for cal-
cium in the glass structure without changing its network connectivity. Chapter 4 focuses
on the relationship between composition - structure - physical properties of the glasses.
Dissolution behaviour and in vitro bioactivity of glass powders and discs were investi-
gated in Tris buffer and simulated body fluid in Chapter 5. Glass toxicity was assessed
by seeding osteoblast-like cells on the surface of glass discs. The formation of hydrox-
yapatite in vivo was also followed from samples provided to the University of Sheffield
where an osteoporotic rat implant study was carried out.
2.2 Development of an Aluminium-free Glass Polyalkenoate
Cement
The modification of the strontium containing bioactive glasses for GPC forming pur-
poses is discussed in Chapter 6. Six series of glasses were designed following the dis-
cussion done in Chapter 1, from the potential role of each elements usually found in glass
polyalkenoate cements and aluminium-free GPCs. Their characterisation was undertaken
in the same Chapter to study their structure. Following a preliminary study on the cement
forming ability of the designed glasses, a parametric study was done in Chapter 7 in or-
der to find suitable rheology and mechanical properties of cements without masking their
composition - property relationships. Some of the cements properties made from the glass
series developed in Chapter 6, namely working time, setting time, ultimate compressive
strength and bonding strength are presented in Chapter 8. A dissolution and toxicity study
was performed on selected cements to evaluate their potential for clinical use.
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Materials and Methods
3.1 Materials
3.1.1 Glass Design and Rationale
3.1.1.1 Strontium Containing Bioactive Glass
The work from Elgayar et al. [109], which explored the relationship between bioactive
glass network connectivity and structure, was used in the design of a strontium containing
bioactive glass. A glass composition, namely ICIE1 that is close to the 45S5 composition
both in terms of chemical composition and bioactivity. The motivations to use the ICIE1
composition rather than the more conventional 45S5 were driven first by the excellent
characterisation work done by Elgayar et al. [109] and by the lower P2O5 content of
ICIE1 compared to 45S5 as its role was controversial in the glass structure.
Strontium has ionic radius of 1.16 Å close to calcium at 0.94 Å. The small size differ-
ence allows the substitution of strontium for calcium in many crystal lattices. Stron-
tium has already been substituted for calcium in fluoro-alumino-silicate glasses [130].
Strontium has also been substituted into calcium hydroxyapatite forming solid-solutions
(Ca,Sr)10(PO4)2(OH)2 [131]. The unit cell lattice parameters increase due to the larger
size of the strontium ion. Furthermore the atomic weight and number increase with stron-
tium content, conferring greater X-ray radio-opacity on both the glasses and on apatite,
which is useful for dental and medical applications.
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Strontium was substituted for calcium with a ratio of 0.025, 0.10. 0.50 and 1 in the ICIE1
glass and the glass compositions studied are listed in Table 3.1.
Table 3.1: The Composition of the ICIE1 Sr glass series (mol.%).
     
     
     
     
     
     
3.1.1.2 Adaptation of Bioactive Glass for Application in Al-free GPCs
The role, advantages and disadvantages of the potential constituent of glass for Al-free
GPC application has been previously discussed in Section 1.2.4.2 and the rationale and
design of Al-free ionomer glasses is described bellow.
The inorganic polymer model has been used to design novel glasses based on SiO2-P2O5-
CaO-SrO-CaF2-SrF2-MgO-ZnO-Fe2O3 with varying network connectivities. All com-
positions have been made on a molar basis in order to look at the composition-property
relationship. In order to understand the influence of each element introduced in the glass
composition, it is necessary to eliminate any possible interference that could be attributed
to changing the value of the network connectivity. To study the compositional effect in
glass for GPCs systems, as well as the influence of varying network connectivity; six glass
series where made, with network connectivities between 1.78 and 2.97. Network connec-
tivity calculations are carried out using mole fraction or mole per cent values which have
more significance on a structural level. The glass series were designed with the hypothesis
in mind that phosphorus forms a separate orthophosphate phase and that iron is present as
Fe3+ and enter the silicate network, with cations present to charge-balance the PO3−4 and
FeO−4 structure, respectively.
• Series P1: glasses where P2O5 content increases in a charge-balanced series, with
a constant NC of 1.78.
56
CHAPTER 3. Materials and Methods
• Series P2: glasses where P2O5 content increases in a non-charge-balanced with
network connectivity in the range of 2.00 and 2.97.
• Series Zn1: glasses with fixed SiO2, P2O5, CaO and CaF2 content, where ZnO is
substituted for MgO with a constant NC of 1.78.
• Series Zn2: glasses with fixed SiO2, P2O5, CaO, SrO and CaF2 content, where ZnO
is substituted for MgO with a constant NC of 1.78
• Series NC: glasses where ZnO is substituted for SiO2 with a NC increasing from
1.78 to 1.83.
• Series Fe1: glasses where Fe2O3 content increases in a charge-balanced series, with
a constant NC of 1.83.
The compositions of the six different series of glasses are presented in Table 3.2. The
changes made in each series are highlighted in Table 3.3. The rationale for choosing the
composition of the first glass of each series will be detailed in Chapter 6. Two different
values of network connectivity are given: NC- represents the network connectivity of the
glass with MgO, and ZnO acting as a network modifiers and NC+ when their roles are
solely intermediate oxides and they go in the silicate network. The true NC values are
likely to be situated between NC- and NC+ depending on how much of these oxides enter
the silicate network. A NC value above four is impossible as it would imply that more
than four oxygens would be bonded to the network former species.
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Table 3.2: The composition of all the glasses studied (mol%) with their network connectivities
(NC).
            
            
           
           
           
           
           
           
           
           
           
           
          
           
           
           
           
           
           
           
           
           
           
           






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Table 3.3: Evolution of composition of all the glasses studied (mol%) with their network con-
nectivities (NC) as a function of the first glass of each series. C stands for constant and + for an
increase in NC.
            
       
       
       
       
       
        
        
        
        
        
        
        
        
        
        
        
       
       
       
        
        
        
        






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3.1.2 Glass Production
The glasses were prepared from reagent grade silica (SiO2), phosphorus pentoxide (P2O5),
calcium carbonate (CaCO3), strontium carbonate (SrCO3), magnesium oxide (MgO), zinc
oxide (ZnO), calcium fluoride (CaF2). strontium fluoride (SrF2) and imatite (Fe2O3) as
below.
• SiO2: ≥ 99.9% pure: Tilcon, Stoke on Trent, United-Kingdoms.
• P2O5: ≥ 98.0% pure, Sigma-Aldrich, Switzerland.
• CaCO3: ≥ 99.0% pure, Fluka - Sigma Alrich, United-Kingdoms.
• SrCO3: ≥ 98% pure, Sigma-Aldrich Inc., United States of America.
• MgO: ≥ 97% pure, based on calcinated substance, Fluka - Sigma Alrich, United
Kingdoms.
• ZnO: ≥ 99.0% pure, Sigma-Aldrich Laborchemikalien, Germany.
• CaF2: ≥ 99.0% pure, Sigma-Aldrich Laborchemikalien, Germany.
• SrF2: ≥ 97% pure, Riedel de Haen AG, Germany.
• Fe2O3: ≥ 97% pure, Riedel de Haen AG, Germany.
The glass powders were mixed in the required amounts and phosphorus pentoxide was
always added last due to its very hydrophilic nature. The composition were melted in a
platinium-rhodium crucible at 1400 - 1550◦C for 1.5 h. The molten liquid was rapidly
quenched into water to prevent phase separation and crystallisation. The glass frits were
ground by using Gyro Mill (Glen Creston Gyro Mill, Middlesex, England) and sieved in
a mechanical shaker to obtain < 38 µm, 38 < x < 100 µm and > 38 µm powders.
Rods of 10 and 20 mm diameter of the ICIE1 Sr series were obtained by re-melting for
30 minutes glass frit at the melting temperature + 50◦C (1450◦C) in order to avoid any
bubbles in the cast. The melt was poured in a graphite mould pre-heated around the
60
CHAPTER 3. Materials and Methods
glass transition temperature (550◦C). The cast was then allowed to cool slowly to room
temperature in a furnace overnight.
3.1.3 Hydroxyapatite Synthesis
3.1.3.1 Rationale
In order to compare the calcium phosphate layer formed on bioactive glass a series of
calcium substituted with strontium hydroxyapatite was produced by precipitation route
with the composition (SrxCa1−x)5(PO4)3OH, where x = 0.00, 0.25, 0.50, 0.75 and 1.00.
The synthesis and characterisation have been published and can be found in the litera-
ture [131]. In this thesis we only used the X-ray diffraction (XRD) traces and Fourier
transform infrared (FTIR) spectra for x = 0 and 1 corresponding to a Ca-HCA and Sr-
HCA. The synthesis employed to produce the two HCA is reported in the following sec-
tion.
3.1.3.2 HCA Synthesis
The HCAs were produced by wet precipation route according to US Patent No. 6312468
[132] and strontium was substituted for calcium on a molar basis.
Solution A preparation Calcium nitrate 4-hydrate, Ca(NO3)2, 4.H2O or strontium ni-
trate, Sr(NO3)2, were dissolved in 200 mL of de-ionised water. Table 3.4 gives the exper-
imental weights used in order to get each HCA compositions. The pH of the solution was
then adjusted to 11 using ammonia solution 30% (v/v). The solution was then toped up
with 400 mL of distilled water. The solution was constantly stirred.
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Table 3.4: Experimental composition of Ca-HCA and Sr-HCA expressed in g, weight% and
mole%.
Ca-Substituted HA Ca(NO3)2 Sr(NO3)2 (NH4)2HPO4
0% Sr 47.23 g - 15.85 g
74.87 wt.% - 25.13 wt.%
62.50 mol.% - 37.50 mol.%
100% Sr - 42.34 g 15.85 g
- 72.76 wt.% 27.24 wt. %
- 62.50 mol.% 37.50 mol.%
Solution B preparation Diammonium hydrogen orthophosphate, (NH4)2HPO4, was
dissolved in 120 mL of distilled water. The amount of (NH4)2HPO4 is given in Figure
3.4. The pH of the solution was adjusted to 11 using ammonia solution 30% (v/v) and
then, 160 mL of distilled water was added to the constantly stirred solution. The solution
was then filtered using a Buchner funnel, as described in [132].
Solution A – solution B mix Solution B was added drop wise to the constantly stirred
Solution A over a period of approximately 2 hours. The pHwas kept at 11. The precipitate
was stirred for 1 hour and left overnight. The precipitate was centrifuged and washed
twice with de-ionised water. Finally, it was dried for 20 hours at 85ºC. The dried material
was crushed using a Gyro-mill and sieved with a 38 µm sieve.
3.1.4 GPC Organic Constituents and Mixing
3.1.4.1 Organic Constituants
Poly(Acrylic Acid) The PAA used to form cement was suplied from Advanced Health-
care Ltd (Tonbridge, UK). The molecular weight was indicated to be between 60,000 and
80,000 and its molecular structure is represented in Figure (3.1 a.).
Tartaric Acid Tartaric acid solutions were used dissolving various amount of dry (+)-
tartaric acid (Hopkin & Williams Ltd, Chadwell Heath, UK) in de-ionised water. The
molecular strucure of tartaric acid is presented in Figure (3.1 b.)
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Citric Acid Citric acid solution was prepared by dissolving various amount of dry citric
acid (≥ 99.5% pure, Sigma-Aldrich) in de-ionised water. The molecular structure of citric
acid is represented in Figure (3.1 c.)



 

 

 
 

  
Figure 3.1: Molecular structure representation of: a. Poly(acrylic acid); b. Tartaric acid and c.
Citric acid.
3.1.4.2 Mixing
The cement samples were formed by hand mixing the glass powder with poly(acrylic
acid) and water at room temperature with a spatula on a Perspex sheet until a smooth
paste was achieved. Unless specified otherwise, cements were produced by mixing 2.5
parts glass, based on weight, with 1 part PAA and 1 part de-ionised water. For some
cements, solutions of tartaric acid or citric acid were used rather than pure de-ionised
water.
3.2 Methods
3.2.1 X-Ray Diffraction
X-ray diffraction (XRD) is generally used to characterise the crystal phase(s) of a solid.
When X-ray radiation penetrates in a material, the radiation interacts with the electrons
in the atoms, resulting in scattering of the radiation. In solids, atoms can be organized
in a crystalline structure based on planes of atoms. X-rays are diffracted at characteristic
angles based on the distance between these planes (d). Diffraction can occur when the ra-
diation interacts with the periodic structure whose repeat distance is about the wavelength
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(λ ) of the radiation (≈ 10−10m). As the wavelength is known and the angle of diffraction
(θ ) is measured then the interplanar distance can be calculated from the Bragg equation:
2 d sin(θ) = n λ (3.1)
If the atoms are arranged in a periodic fashion, as in crystals, the diffracted pattern will
consist of sharp maxima (peaks) corresponding to the symmetry of the distribution of
atoms. The intensity of the peaks, at a specific 2θ value, depends on the crystallinity of
the material. Thus, an amorphous solid, i.e. free of any crystal phase, does not exhibit
sharp peaks in an X-ray pattern but a characteristic amorphous halo.
XRD analysis was performed on Philips Powder Diffractometer with a copper (Cu K )
x-ray source (Philips PW 1700 series diffractometer, Leiden, Netherlands). The powder
samples (< 38 µm particle size) were scanned between 2θ = 10-80o with a step size of
2θ = 0.04.
3.2.2 Fourier Transform Infrared Spectroscopy
A Perkin Elmer spectrometer was used in absorption within a range of 3000 - 500 cm−1
with a resolution of 8 cm−1. The analysis was performed directly on the< 38 µm sample
powders using a golden gate set up.
3.2.3 Magic Angle Spinning - Nuclear Magnetic Resonance (MAS-NMR)
Spectroscopy
Magic Angle Spinning Nuclear Magnetic Resonance (MAS-NMR) is used to study the
response of the nuclei of specific atoms under high magnetic field (several Tesla) when
a second electromagnetic field is applied. The nuclear magnetic resonance frequencies
of the nuclei depends on its electronic environment and is compared with the frequency
of a reference sample, specific for each atoms. The difference, called chemical shift, is
sensitive to short and medium range order of the atoms. Therefore it is very useful for
studying the structure of amorphous materials. The change in chemical shift determines
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the Qn proportions as well as the influence of the charge balancing cations in the vicinity
of the studied atom. 29Si and 31P MAS-NMR were used to study the changes in the
silicate and orthophosphate phases in the glass, respectively.
29Si and 31P Magic Angle Spinning - Nuclear Magnetic Resonance (MAS-NMR) was
used to analyse the different glass samples using a 200 MHz Bruker FT-NMR spectrom-
eters operating at the Larmor frequencies of 39.8MHz and 242.9MHz respectively. Pow-
dered samples were packed into a 4 mm zirconia rotor and spun at the magic angle to
remove anisotropy effects. The 29Si and 31P MAS NMR spectra of the glasses were
recorded at spinning frequencies from 4-7 kHz using π2 pulse for both silicon and phos-
phorus nuclei. The 29Si and 31P NMRmeasurements were done using 30 s and 120 s recy-
cle delays respectively with initial dummy scans. All spectra were recorded at an ambient
probe temperature with 29Si chemical shift referenced relative to tetrakis trimethylsilyl
methane (C(Si(CH3)3)4) as a secondary standard material giving signal at -1.5 ppm rel-
ative TMS. The 85% (v/v) solution H3PO4 was used for referencing the 31P chemical
shift.
3.2.4 Density
3.2.4.1 Density Measurement
The density of each glass was calculated using Archimedes’ principle with water as the
immersion fluid. The measurements were performed at room temperature with glass rods
20 mm in diameter and free of bubbles. Thin copper wire was used for immersing the
rods into water. The density was obtained from Equation 3.2.
ρ = Ma
Md−Mi ×ρw (3.2)
where: Ma is the mass of glass in air, Md is the mass of dry glass, Mi is the mass of
immersed glass and ρw is the density of water at the measurement temperature (ρw(20oC)
= 0.998 g.cm−3). All of the cast samples were bubble free and were fully wetted when
immersed in the de-ionised water.
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3.2.4.2 Calculation of Density using Doweidar’s Model
The measurements were then compared to density calculated with Doweidar’s model
[133]. Doweidar used the Qn structure model to calculate the glass density. The model
predicts from the molar composition the Qn distribution. Then from the mass and volume
of the different Qn, the density can be calculated.
The composition of a Qn unit is the following:
• one Si4+
• n2 bridging oxygens (BO)
• (4-n) non-bridging oxygens (NBO)
• (4-n) alkali metal ions or 4−n2 alkaline-earth cations to equilibrate the electronic
charge if NBOs are present.
The addition of oxide R2O/RO creates NBOs in the SiO2 network. Thus the number of
NBOs depends on the concentration of modifier oxide. Doweidar made the following
hypothesis: all Q4 are transformed in Q3 before Q2 form, all Q3 are transformed into Q2
before the formation of Q1. Table 3.5 defines the compositional regions and type of units
within the specified compositional ranges.
Table 3.5: Qn species within the different compositional regions.
Composition region Qn unit formation
Up to 33.3 mol% R2ORO Q
4↔ Q3
33.3 mol% < R2ORO < 50.0 mol% Q
3↔ Q2
50.0 mol% < R2ORO < 60.0 mol% Q
2↔ Q1
60.0 mol% < R2ORO < 66.7 mol% Q
1↔ Q0
In the region 33.3 mol%< R2ORO < 50.0 mol% relevant to bioactive glasses, the conversion
of Q3 units into Q2 can be given as:
xaNa2O+xbSrO+xcCaO+(1−xt)SiO2−→ (2−4xt)(∑
i
xi
xt
Q3i )+(3xt−1)(∑
i
xi
xt
Q2i ) f or i= a,b,c (3.3)
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where xa, xb, xc are the molar percentage, Qna, Qnb and Q
n
c , the Qn units of Na2O, SrO and
CaO respectively and xt = xa + xb + xc.
Doweidar makes the hypothesis that in alkaline-silicate glasses the volume of Qn units
depends only on the type of alkali ions present in the structure. This volume is indepen-
dent of the concentration of modifier ions. Table 3.6 shows the unit volumes of Q3 and Q2
containing sodium or calcium species. No data can be found for strontium. Thus values
for calcium are taken for strontium, as the difference in size between the two ions is rel-
atively small. Furthermore the phosphate content is not taken into account in the model.
The small amount (1.07 mol%) in the glass is assumed to have a negligible effect on the
density.
Table 3.6: Unit volumes of the components of the glass.
Ions V3 (10−24 cm3) V2 (10−24 cm3)
Na+ 605 79
Ca2+ 545 66.4
The density is calculated with the following equation:
ρ =
(2−4xt)(∑i xixt M3i )+(3xt−1)(∑i xixt M2i )
(2−4xt)(∑i xixt V 3i )+(3xt−1)(∑i xixt V 2i )
f or i= a,b,c (3.4)
where: M3a, M3b, M
3
c are the molar masses, V 3a, V 3b, V
3
c the volume of Na2O, SrO and CaO
Qn units respectively.
3.2.4.3 Oxygen Density
Oxygen density was calculated to measure the compactness of the glass network. The
oxygen density is calculated by dividing the mass of oxygen from the molar composition
by the volume of the glass, which is given by the experimental density.
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3.2.5 Differential Thermal Analysis
Thermal properties and phase changes for the ICIE1 Sr series were studied with a Stanton
Redcroft DTA 1600. Alumina was used as reference and both reference and < 38 µm
particle size glass powder were contained within platinum–rhodium alloy crucibles. The
measurements were taken in the range of 20 to 1050oC at a rate of 10oC.min−1.
The glass transition temperature (Tg) and crystallization peaks temperatures (Tp) for
each glass were then obtained from the corresponding traces, with Tg represented by a
small negative change in the slope of the baseline and Tp is the peak of a crystallisation
exotherm.
3.2.6 Differential Scanning Calorimetry (DSC)
All glasses used for GPCs were analysed using a Polymer Laboratories Thermals Sciences
Division DSC instrument. The experiments were carried out on the < 38µm powder at a
heating rate of 10◦C.min−1 from 25◦C to 1050◦C. 50 mg of glass were analysed in Plat-
inum/Rhodium alloy crucibles using analytical grade alumina powder as a reference. The
glass transition temperature (Tg) and the crystallisation temperature (Tp) were determined
for all glass compositions with the same method as for the DTA analysis.
3.2.7 Dilatometry
Dilatometry measurements were carried out using a Netzsch Dil 402oC dilatometer in a
range of temperature of 20 to 680oC at a rate of 10oC.min−1. The thermal expansion
coefficient (TEC) was determined between 40 and 460oC, as well as the glass transition
temperature (Tg) and softening point (Ts).
3.2.8 Dielectric Thermal Analysis
APolymer Laboratories Dielectric Thermal Analyser, (Polymer Laboratories, EpinalWay,
Loughborough UK) was used for obtaining the real part of the dielectric constant ε’ and
68
CHAPTER 3. Materials and Methods
the dielelectric loss factor tan δ . Frequencies of 0.1, 1, 10, 25, 50 and 100 kHz were
used with a heating rate of 2oC.min−1 over a temperature range from 30 to 500oC. The
activation for ion hopping was calculated from:
f = Ae
−Ea
RT (3.5)
where: f is the frequency in Hz, A is the pre-exponential factor, T is the maximum
temperature in K, Ea is the activation energy and R is the gas constant. The experiments
were carried out for the 50% Sr substituted glass and compared to the all calcium glass
[111, 134].
3.2.9 Particle Size Analysis
The ionomer glass powder were analysis using a CILAS 1064 particle size analyser. The
measurements were performed immersing 1 spatula of powder in de-ionised water with a
drop of a multi-purpose detergent TEEPOL as a dispersive agent.
3.2.10 Cement Rheology and Mechanical Testing
Determination of Working and Setting Times The working time is the interval be-
tween the mixing of the reagents and the time when the mix has lost plasticity, stiffening
to a certain degree. It marks roughly the end of the period when the wet mix can be
molded into shape. A longer working phase gives to the surgeon a longer time for appli-
cation. The setting time is the interval between the mixing of the cement and the time the
cement becomes hard.
The oscillating rheometer used was made by Advanced Healthcare Ltd and consists of two
plates, one of which is fixed whilst the other is oscillating by means of an eccentrically
driven spring. The apparatus is schematically represented in Figure 3.2. The amplitude
of the oscillation is measured and plotted against time on a chart recorder. The rheometer
is switched on at the same time as the begining of the mixing of the powder and liquid.
Once mixed, the cement paste is transferred to the apparatus, being placed between the
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two plates, which are 1 mm apart from each other. The system is kept at 37◦C. The
oscillation length is measured from this point until the oscillations, decreasing during the
setting reaction, stop. The working time (WT) is taken when the oscillation length is 95%
of the initial length and the setting time (ST) 5% of the initial length.
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Figure 3.2: Schematic representation of the oscillating rheometer. A transducer is used to record
the oscillations of the rheometer (Left) caused by the motion of a moving spring. The working
time (WT) and setting time (ST) are taken when the oscillation lengths (Right) are 95% and 5%,
respectively, of the initial oscillation length corresponding to the beginning of the mixing of the
glass, poly(acrylic acid) and liquid.
Compression test The compression tests were performed according to the interna-
tional standard ISO 5833 9917-1:2003 on cement cylinders 4.0 mm in diameter by 6.0
mm in height. The specimens were formed by pressing wet cement into stainless steel
mould of the above dimensions. The moulds were then clamped between two steel plates
and placed in a preheated oven at 37◦C for one hour. The set cements were then removed
from the mould and stored in de-ionised water for 24 hours, 1 weeek and 3 weeks at 37◦C.
The samples were loaded using a Zwick/Roell Z010 servo-hydrolic testing instrument at a
constant crosshead displacement of 5 mm.min−1 with 10 kN load cell. Then the ultimate
compressive strength was calculated according to the formula 3.6:
σ = F
A
(3.6)
where σ is the compressive strength (MPa), F is the applied load at failure (N) and A is
the area (mm2).
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The ultimate compressive strength (UCS) was determined by taking the highest strength
withstood by the sample before fracture.
Bonding Strength The evaluation of the bonding strength was performed using a ten-
sile shear bond strengths model with the use of a single metal-to-metal lap joints. The
bonding strength was determined as a function of adhesive layer thickness [3]. The ap-
paratus consisted of pairs of rectangular stainless steel plates and the lap joints were sus-
pended by a pair of holes which ensured self-alignment during testing and thus allowed
shear conditions to predominate. The overlap surface of the lap joints was designed to be
40 ± 30 mm. The adhesive thickness was measured with a micrometer before testing.
The samples were loaded using a Zwick/Roell Z010 servo-hydrolic testing instrument
at a constant crosshead displacement of 5 mm.min−1. Then the bonding strength was
calculated according to the formula 3.6.
3.2.11 Dissolution Study for the ICIE1 Sr Series
Dissolution studies were carried on all glass compositions. 75 mg of < 38 µm glass
powder was immersed in 50 ml of solution (Tris-buffer or Simulated body fluid (SBF)) at
pH 7.40 and placed in an orbital shaker at 1 Hz for time periods of 5, 15, 30, 60, 120, 240
and 480 min unless otherwise specified. The solution was filtered and acetone was poured
on the collected powder to stop any further reaction. The pH of the filtered solutions
were measured and the silicon, calcium, strontium and phosphorus concentration were
determined by inductively coupled plasma (ICP) - optical emission spectroscopy (ICP-
OES, ARL machine).
3.2.11.1 Tris Buffer Preparation
For the making of tris(hydroxymethyl)aminomethane (Tris or THAM) buffer, a standard
preparation procedure was taken from USBiomaterials Corporation (SOP-006).
A graduated flask was filled with 400 ml of Milli-Q (or double deionized) water. The flask
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was then put on a water bath with magnetic stirrer and set at 37oC. After that, 7.545 g of
THAM was transferred slowly into the flask. Once the THAM dissolved, 22.1 ml of 2N
HCl was added and the pH of the solution was adjusted to 7.40. The flask was then topped
up to 1 L with Milli-Q water and adjusted to pH 7.4. The solution was transferred into
a polyethylene container and stored in a refrigerator (4oC). Since the pH of Tris buffer
is temperature sensitive (pH = 7.4 at 37oC increases to pH = 7.6 at 25oC) all the testing
solution temperatures were controlled to be at 37oC.
3.2.11.2 Simulated Body Fluid Preparation
The preparation of simulated body fluid (SBF) was carried out according to the method
proposed by Kokubo et al. [135]. A plastic beaker (whose Tg >> 37oC) was filled with
700 ml of Milli-Q (or double deionized ) water. The beaker was then put in a water bath
with stirring bar and set at 37oC. The reagents shown in Table 3.7 were then added in
order. The beaker was then topped to 900 ml and the pH was checked and adjusted to pH
7.40 with 1N HCl. The beaker was then topped to 1 L and the pH adjusted to 7.40 once
again.
Kokubo added several notes and indications, which should be followed in order to prevent
the precipitation of calcium phosphate species before sample testing [136].
Table 3.7: Reagents for the preparation of SBF.
Order Reagent Amount
1 NaCl 7.996 g
2 NaHCO3 0.350 g
3 KCl 0.224 g
4 K2HPO4.3H2O 0.228 g
5 MgCl2.6H2O 0.305 g
6 1N HCL 35 ml
7 CaCl2.2H2O 0.368 g
8 Na2SO4 0.071 g
9 THAM 6.057 g
10 1N HCl 5 ml
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3.2.12 Scanning Electron Microscopy and Energy Dispersive X-Ray Spec-
troscopy
A JEOL JSM-840A scanning electron microscope was used to carry out the scanning
electron microscopy (SEM) analysis (operating voltage 20 kV). Electron micrographs
of the samples were taken with secondary and backscattered electrons on polished cross-
sections of glass discs. The secondary electrons allowed for a good resolution but contrary
to the backscattered electrons gave no chemical contrast. A chemical analysis was also
carried out to determine the composition of the different layers observed as a function of
the distance from the surface. SEM energy dispersive X-ray (EDX) spectroscopy analysis
was used to look at HCA formation on glass discs in SBF and samples retrieved from
animal study.
3.2.13 Cell Culture
SaOs-2 cells, an immortalised human osteosarcoma cell line was selected as a model
system for osteoblastic cells. These cells are particulary interesting to monitor the effect of
bioactive materials as they exhibit the entire differentiation sequence of osteoblastic cells
[137]. Furtheremore, their rapid proliferation [138] and resistancy to culture infection
compared to primary osteoblast cells [139] made them good candidates in order to get
rapid and reproductive information on the biocompatibility of potential bone replacement
materials.
The cells were expanded in RPMI 1640 with 10% (v/v) fetal bovine serum (FBS), 1%
(v/v) L-glutamine and 1% (v/v) penicillin/streptomycin (antibiotics). This medium was
used throughout all experiments in this study. Initial culture was performed in 75 cm2
flasks at 37oC in a humidified atmosphere of 95% air with 5%CO2 and supplied with fresh
medium every 2 - 3 days. Cells were detached using trypsin - EDTA at 90% confluence,
and a haemocytometer was use to determine cell count [140]. Cells were resuspended to
the appropriate concentration for seeding in complete medium.
Cell proliferation on the surface of glass discs of the ICIE1 Sr series (0%, 10%, 50%
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and 100% strontium substitution for calcium) was evaluated by live/dead stain. Glass
samples were 1 cm in diameter and 1 mm thick and were sterilised by UV light (2 hrs per
side) in 24 well plates. Glasses were pre-conditioned for 72 hours with a media change
every 24 hours in 1 ml RPMI 1640 media to minimise the effect sudden burst of ions
from glass (and accompanying pH change). After pre-conditioning, discs were seeded at
30,000 cells.cm−2 (23,500 per disc) with SaOs-2 cells. Cells were allowed to attach for
30 minutes before media was added. After 24 hours, 7 days and 14 days, cells on glass
discs were examined with live/dead stain, which is detailed in Section 3.2.13.1.
SaOs-2 cells were also used to assess toxicity of the cements in vitro. Cells were seeded at
30,000 cells.cm−2 on the cements disks and at 50,000 cells.cm−2 on the remaining wells
tissue culture plastic and cultured for 1 or 7 days at 37oC, 5% CO2. The medium was
changed every 2 days. The cell activity of seeded cells was assessed with Live/Dead, al-
kaline phosphatase (ALP) and lactate dehydrogenase (LDH) assays. PMMA and Sereno-
cem cements were used as a control. At the end of the incubation period, the media was
collected and the cement disks were moved into new wells for live/dead stain. Then, 500
µl of lysis buffer (0.9% (v/v) TRITON-X solution) was added on each wells where the
cells were incubated. The well plates were placed on an orbital shaker for 30 minutes at
room temperature. Sample supernatants were collected and distributed into 96 well plates
(50 µl/well) for LDH and ALP assays. Inductively coupled plasma spectroscopy (ICP-
OES, iCAP 6000, Thermo Scientific, Waltham, MA, USA) was run on the media from
the cell culture experiment at day 1 and day 7 to monitor the release of the following
elements: Si, P, Ca, Sr, Mg, Zn and Fe.
3.2.13.1 Live/Dead Assay for Cell Viability
Live/Dead Assay for Cell Viability (AfCS Procedure Protocol PP00000023) is used to
measure cell viability. It is a two-color fluorescence assay that simultaneously determines
[141]:
• Live cell number - Live cells have intracellular esterases that convert non-fluorescent,
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cell-permeable calcein acetoxymethyl (calcein AM) to the intensely fluorescent cal-
cein. Cleaved calcein is retained within cells.
• Dead cell number - Dead cells have damaged membranes; the ethidium homodimer-
1 (EthD-1) enters damaged cells and is fluorescent when bound to nucleic acids.
EthD-1 produces a bright red fluorescence in damaged or dead cells.
3.2.13.2 Cytotoxicity Analysis
A colorimetric assay (CytoTox 96® Non-Radioactive Cytotoxicity Assay, Promega) was
used to measure cytotoxicity caused by the cements dissolution products. Lactate dehy-
drogenase (LDH) is a stable cytosolic enzyme that is released upon cell lysis. Released
LDH in culture supernatants is quantitatively measured with a coupled enzymatic assay.
The enzyme action results in the conversion of tetrazolium salt (INT) to a red formazan
product and the amount of colour formed is proportional to the number of lysed cells.
Therefore, cell culture supernatants (containing dead cells) were collected and adherent
cells (live cells) were lysed. 50 µL of reconstituted substrate mix were added to both 50
µL of cell lysates and incubated for 30 min. The reaction was stopped with 50 µL of
10% (v/v) citric acid solution and the absorbance read at 492 nm. The number of cells
was then determined using a standard absorption-cell number curve as shown in Figure
3.3.
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Figure 3.3: LDH standard curve: Absorbance at 490 nm as a function of the number of cells
corresponding to a 30 minute incubation time. Data provided by Dr. E. Gentleman.
3.2.13.3 Alkaline Phosphatase Activity
The alkaline phosphatase activity (ALP) assay depends upon the hydrolysis of p-nitrophenyl
phosphate by the alkaline phosphatase enzyme, producing p-nitrophenol and inorganic
phosphate. The assay was used to examine cell differentiation such as osteogenesis,
which is associated with increased expression of ALP. The ALP solution was prepared
as follows: a 5 mg 4-Nitrophenyl phosphate disodium salt hexahydrate (pNPP) tablet
(Sigma, N9389100) was added for every 5 ml of a solution of 100 mM Glycine, 0.1 mM
ZnCl2 and 0.1 mM MgCl2 in de-ionised water. The pH was adjusted to 10.4 at 37oC.
50 µL of ALP solution was added to the supernatants and after an incubation of 5 min-
utes and 12 minutes, The reaction was stopped by addition of 100 µL of 1 M NaOH and
the absorbance was subsequently read at 405 nm using a microplate spectrophotometer.
The standard curve, shown in Figure 3.4 was used to determine the number of moles of
p-nitrophenol.
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Figure 3.4: ALP standard curve: Absorbance at 405 nm as a function of number of mole of
p-nitrophenol. Data provided by Dr. E. Gentleman.
3.2.14 Assessment of HCA Formation and Osseo-integration in an Osteo-
porotic Rat Implant Study
The animal study was carried out at the University of Sheffield by Dr, Christine Freeman,
Kristy Franklin and Prof. Ian Brook. Cylindrical rods (1.6 mm diameter and 2 mm long)
of ICIE1, ICIE1 Sr10 and ICIE1 Sr50 were implanted into the femur of osteoporotic
rats. A radiography picture was taken of each femur before being prepared for histology.
Femurs were demineralised and processed to paraffin embedded blocks which were cut to
produce thin sections stained with haematoxylin and eosin. Sections were viewed using
a conventional light microscope and digital images captured. One femur from each test
group was kept before demineralisation and was dehydrated through ascending grades of
alcohol and embedded in resin (LR White hard grade) prior to cutting ground sections for
scanning electron microscopy and EDX. Two samples from each glass composition were
provided for SEM-EDX analysis to look at osseo-integration and formation of HCA and
silica gel layers after in vivo implantation.
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The positive biological effect of strontium on bone formation coupled to the ion release
and osseointegration of bioactive glasses leads to interest in producing a strontium con-
taining bioactive glass. To our knowledge, little has been done to study the influence on
the structure and physical properties of strontium-containing bioactive glasses. Hill et
al. studied the influence of substituting calcium with strontium in an phospho-alumino-
silicate glass for applications in dental cementation [130]. The presence of strontium was
motivated by its anti-bacterial effect and radio-opaque property. The authors found that
the substitution of Ca with Sr ellicited little change in the glass structure with identical
29Si, 31P and 29F MAS-NMR spectra. Other studies evaluated the osteoconductivity of
strontium containing 45S5 glass particles [142]. However the substitution of strontium for
calcium was done in weight% and as strontium is heavier than calcium, the molar concen-
tration of strontium is lower than necessary to maintain constant the glass network con-
nectivity. The authors found similar osseointegration betwen 45S5 and strontium doped
45S5, which is not giving any answers on the role of strontium because of the wrong glass
design.
A new series of glass was designed here to elucidate on the role of strontium in the struc-
ture of a bioactive glass. Strontium has ionic radius of 1.16 Å close to calcium at 0.94 Å
and according to Zachariasen and Dietzel, both are network modifiers [1, 5]. Therefore,
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the substitution of strontium for calcium does not change the network connectivity of the
glass as far as the substitution is done in mole%. The present Chapter investigates the
effect of strontium substitution for calcium on the glass structure and physical properties
of one previously studied composition ICIE1 [109] that is close to the 45S5 composition
both in terms of chemical composition and bioactivity.
4.1 X-Ray Diffraction
All the glasses gave optically clear glass frits on pouring into water and gave optically
clear glass rods on casting. The XRD spectra showed the glasses to be amorphous and
free of any significant crystalline phases (Figure 4.1). The diffraction maximum of the
amorphous halo progressively moved to smaller two theta values (i.e. larger d-spacing)
with increasing strontium substitution, indicating an increase in the average spacing in
the glass structure consistent with the larger size of the Sr2+ cation relative to Ca2+ with
a ionic radius of 0.94 Å and 1.16 Å, respectively.
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Figure 4.1: X-ray diffraction pattern of the ICIE1 Sr series.
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4.2 Fourier Transform Infrared Spectroscopy
A common characteristic of bioactive silica based glasses is their open silicate network
structure, which enables the accommodation of alkali and alkali earth cations. Alkali and
alkali-earth cations act as network modifiers and reduce the degree of connectivity in the
network promoting the replacement of bridging oxygens (BOs) by non-bridging oxygens
(NBOs). Fourier transform infrared (FTIR) measurements can be used to determine the
change in the ratios of silicate species with different number of NBOs as function of the
change in composition.
FTIR spectra of silicate based bioactive glasses are characterised by two transverse optical
modes of the Si-O-Si groups: the bending Si-O(b) vibration identified at 800 - 700 cm−1,
and the asymmetric stretching mode Si-O(s) located in the range 1200 - 800 cm−1 [143–
145]. Within the Si-O(s) range, two bands can be observed; the band between 975 and
890 cm−1 associated with the Si-O(s) with one NBO per SiO4 tetrahedron (Q3 groups)
and the band centred at 840 cm−1 which is assigned to the Si-O(s) with two NBOs per
SiO4 tetrahedron (Q2 groups) [143].
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Figure 4.2: Fourier transform infrared spectra of the ICIE1 Sr series.
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FTIR spectroscopy cannot be used for fully quantitative analysis. The different types
non-bridging species (made with sodium or strontium or calcium ions) cannot be distin-
guished nor can the exact proportions of different Qn species. Indeed the stretching mode
and bending modes will have different frequencies and intensities as a function of the
local environment and the nature of charge balancing cations (Sodium, Strontium or Cal-
cium). However all the glasses have almost identical spectra (Figure 4.2). This suggests
that there is the same number of Si-O bonds and the same proportion of Qn species in
each glass; these structural units have specific absorption coefficients related to the con-
centration in the glass (Beer-Lambert law). This information confirms the fact that all the
strontium substituted glasses have essentially same structure and network connectivity.
The only major difference in the spectra is observed in the range of 1560 - 1370 cm−1.
This region corresponds to carbonate species [146, 147] arising from the slight surface
reaction between the bioactive glass and carbon dioxide in the atmosphere and the forma-
tion of small quantities of calcium/strontium carbonates. However it is worth pointing out
that these phases were not detected in the XRD, possibly due to them being amorphous,
nanocrystalline and or being present in very small amounts. The carbonate ion is also
highly polarisable and strongly absorbs in vibrational spectroscopy. It is worth noting that
the intensity of the 1560 - 1370 cm−1 signal are strongest for the two highest strontium
substitutions suggesting that strontium incorporation is making the glasses more surface
reactive. Furthermore, the expansion of the network due to strontium incorporation may
facilitate the permeation of carbonate.
4.3 Magic Angle Spinning Nuclear Magnetic Resonance
The 29Si NMR spectra for the all calcium glass and the 100% strontium substituted glass
(Figure 4.3 a.) were almost identical with chemical shifts of -80 ppm indicating a pre-
dominantly Q2 silicate structure. This indicates that substituting strontium for calcium
had no significant influence on the network connectivity of the glass. Interestingly the
peak widths and positions did not shift. This indicates that the structural disorder of the
81
CHAPTER 4. Strontium Containing Bioactive Glass – Structure and Properties
glass does not change significantly with strontium addition and the similarity of field
strength of Sr and Ca does not result in any significant shielding / de-shielding of the
29Si nuclei in the experiment. The 31P spectra (Figure 4.3 b.) were also identical with a
single Gaussian peak with chemical shift of 9 - 10 ppm indicating a mixed Ca/Sr sodium
orthophosphate (Q0) species. The results indicate that strontium substitution for calcium
has little influence on the glass structure.
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Figure 4.3: MAS-NMR spectra of ICIE1, ICIE1 Sr50 and ICIE1 Sr100: a. 29Si MAS-NMR
spectra; b.31P MAS-NMR spectra. Data provided by Dr. N. Karpukhina.
4.4 Density Measurement and Calculation
The density is defined as the mass of the substance per unit of volume, it has a strong
dependence upon its composition. Doweidar [133] presented a model to analyse quanti-
tatively the density data of many glass systems (see section 3.2.4.2). Doweidar calculated
the volume of the structural units using available structural information of the glass. This
volume does not change with composition in alkali silicate glasses and depends only upon
the type of alkali ion; not on the concentration in which they are present. This, therefore,
enables the use of Doweidar’s model to determine the densities of alkali and mixed alkali
silicate glasses [148]. Furthermore, the determination of the oxygen molar volume from
density data can provide information on different aspects of the glass structure, such as
the degree of anionic packing.
The density of the glass increased from 2.71 g.cm−3 for the all calcium glass linearly
with strontium substitution to 3.20 g.cm−3 for the 100% strontium substituted glass. Fig-
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ure (4.4 a.). shows the density data and the calculated density using Doweidar’s model.
There is very good agreement between the experimental density and that calculated by
Doweidar’s model for the all calcium glass thus confirming that the glasses are predom-
inantly Q2 in structure and all the assumptions made when calculating the volume of
strucural units can be accepted. Using Doweidar’s equation 3.3 related to silica content
between 33.3 and 50 mol%, it is found that the proportion of Q2 occupies 95.7% of the
Qn distribution, the rest being Q3.
However, there is a progressive deviation with strontium substitution. Doweidar’s model
overestimates the density. One explanation for this could be that the volume occupied by
Q2 and Q3 units in the glass structure are larger as the ionic volume of Sr is 55% more
than Ca. This is supported by the oxygen density data (see below). There was no evidence
of mixed alkali earth effect as glasses would have densities intermediate between those
for the equivalent single eath-alkali containing glasses.
The oxygen density is a measure of the compactness of the glass network. The oxygen
density (Figure 4.4 b.) decreased with strontium substitution indicating an expansion of
the glass network and a less rigidly bonded glass network. This is thought to be a result
of the larger Sr2+ cation attracting non-bridging oxygens less readily than Ca2+ cation.
This is consistent with larger volumes for Q2 and Q3 units in the presence of strontium as
discussed previously.
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Figure 4.4: Density measurement and calculation of the ICIE1 Sr glass series as a function of
the strontium substitution for calcium. a, Experimental glass density and density calculated using
Doweidar’s model; b, Oxygen density.
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4.5 Differential Thermal Analysis
Differential thermal analysis was used to measure the glass transition Tg and the crys-
tallisation peaks Tp temperatures. As described in Section 1.2.3.2, a glass can be viewed
as giant inorganic molecules composed of silicon and oxygen. Accordingly, its Tg can
be taken as the temperature when a significant length of chains receives enough thermal
energy to undergo a "crankshaft" motion and thus, above this temperature undergo signif-
icant structural changes. The Tg is largely influenced by the network connectivity of the
glass. For a bioactive glass, which contains a large amount of network modifiers species,
the ionic bridges strength formed between non-bridging oxygens influence the Tg as well.
Figure (4.5 a.) shows a typical DTA trace showing the observed glass transition tem-
perature, the first and second peak crystallization temperatures. Figure (4.5 b.) shows
the glass transition temperature and peak crystallization temperatures plotted against per-
centage strontium substitution. The glass transition temperature was found to decrease
with increasing strontium substitution. Both the first and second peak crystallization tem-
peratures also decreased with increasing strontium substitution. Alkali and alkaline earth
oxides serve to modify the silicate network structure; they reduce the degree of connectiv-
ity in the network by replacing bridging oxygen (BO) by non-bridging oxygens (NBO). A
reduction in glass transition temperature is generally achieved by increasing the amount of
network modifying oxides relative to the network forming oxides; which in turn depoly-
merises the network increasing the amount of NBO to BO and reduces the glass network
connectivity. In this series however, the network connectivity is constant as strontium and
calcium are both network modifiers. The reduction in Tg as SrO replaces CaO results
from their different ionic bonding strength with NBOs.
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Figure 4.5: DTA analysis of the ICIE1 Sr glass series. a. DTA traces; b. Evolution of the glass
transition temperature (Tg) and first (Tp1) and second (Tp2) crystallization peak as a function of
the substitution of calcium by strontium; c. Tg, Tp1 and Tp2 values.
4.6 Dilatometry Analysis
The thermal expansion curve for a glass gives important information, such as the thermal
expansion coefficient (TEC), the glass transition temperature (Tg) and the dilatometric
softening temperature (Ts). The TEC indicates the relationship between the volume of a
glass and its temperature. The need to control the thermal expansion of bioactive glasses
in order to use them as implant coatings has been noted previously by Gomez-Vega et al.
[149,150] and by Bloyer et al. [151]. It is a difficult process to achieve the right expansion
coefficient of a glass whilst at the same time not affecting the bioactivity. The dilatometric
softening point is related to the glass transition, it is the temperature at which the glass
network loses cohesion and begins to flow under the force applied during dilatometry.
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Figure 4.6: Dilatometry analysis of the ICIE1 Sr glass series. a. Dilatometry traces; b. Evolution
of the glass transition temperature (Tg), the softening point (Ts) and thermal expansion coefficient
(TEC) as a function of the substitution of calcium by strontium; c. Tg, Ts and TEC values.
The glass transition temperature and the softening point decrease with increasing stron-
tium content, whilst the thermal expansion coefficient increases. All these results are
consistent with the expansion of the glass network determined from the oxygen density
results and a less rigidly cross-linked glass network established in the DTA analysis. The
less rigidly cross-linked the glass network the lower the activation energy barriers to both
segmental motion of the glass network associated with the glass transition temperature
and viscous flow associated with the softening point. Similarly the less rigidly cross-
linked the glass network the easiest it is for the glass network to expand on heating. It
is worth pointing out that conventionally in silicate glasses mixing alkaline earth cations
results in a decrease in the glass transition temperature and an increase in the thermal
expansion coefficient compared to that predicted from a simple rule of mixtures. For ex-
ample Roling and Ingram [152] found such behaviour for Na2O - 2 CaO - 4 SiO2 glasses,
when SrO was substituted for CaO. It is thought that in the highly disrupted bioactive
glasses studied here, where there are very few bridging oxygens, the silicate chain struc-
ture is largely held together by the attractive forces between the divalent cations and the
non-bridging oxygens attached to Q2 silicons. This contrasts with higher silica content
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glasses of higher network connectivity that are held together principally by Si-O-Si bonds
between the silicate chains.
4.7 Dielectric Thermal Analysis
Dielectric thermal Analysis (DETA) showed two sets of relaxations (Figure 4.7) with two
maxima in the dielectric loss factor tan δ at each frequency. The first is thought to corre-
spond to sodium ion hopping in a silicate phase and the second to sodium ion hopping in
a nano dispersed orthophosphate phase. The activation energy values for the first and sec-
ond relaxation processes corresponding to sodium ion hopping were obtained and found
to be -76 and -87 kJ.mol−1 for the all calcium glass [134] and -88 and -93 kJ.mol−1 for the
50% strontium glass. The barrier energy for sodium ion hopping increases for the higher
strontium glass, which could be resulting from the increased distance between NBOs due
to the expansion of the glass network with strontium substitution for calcium. Therefore,
the distance that the sodium ions have to travel increases for ICIE1 Sr50 compared to
ICIE1.
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Figure 4.7: Dielectric thermal analysis of the ICIE1 Sr 50 glass at frequencies from left to right
of 0.1, 1, 10, 25, 50 and 100 kHz. Data provided by Prof. R. G. Hill.
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4.8 Conclusion
In this chapter the role of strontium in a bioactive glass type structure was studied. It has
been found that strontium substitution for calcium has little influence on the Q2 silicate
and Q0 phosphate environments. However, the glass network is expanded and the ionic
bond strength between NBOs is affected as the ionic bond between strontium and a NBO
is weaker than with calcium. This is in accordance with the bigger size of the strontium
ion compared to calcium. Carbonate peaks present on the FTIR spectra would be an
evidence of the higher surface reactivity of the glass with strontium substitution.
88
Chapter 5
Strontium Containing Bioactive Glass - Dissolution
and Bioactivity
A bioactive glass dissolves when immersed in an aqueous fluid. Therefore, it is funda-
mental to study how the substitution of strontium for calcium affects the glass dissolution
kinetics and the products of this dissolution. This chapter looks into the behaviour of
the glass in Tris buffer and simulated body fluid (SBF). Whereas the formation of an
hydroxy-carbonated apatite in SBF is often a good indication of the bioactivity in vivo,
there is a considerable debate about stating a material as being "bioactive" by this test
alone [136, 153]. Therefore, cell culture and an in vivo study were also carried out.
Osteoblast-like cells line, SaOs-2, were seeded on to the surface of glass discs and a
live/dead cell viability assay was used to evaluate the toxicity. Finally, an osteoporotic rat
animal model study was used to control the osseointegration of glass rod implants.
5.1 pH Measurements
The change in pH of Tris buffer and Simulated Body Fluid (SBF) is taken as a measure of
glass dissolution (Figure 5.1). In SBF the pH increases with time for all the glasses, but the
pH change is greater with increasing strontium substitution. There is a slight reduction in
pH for the longest time period studied. The pH changes for the Tris Buffer study showed
the same trends, but the overall pH change was lower and there was no reduction in pH
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for the longest time period studied. It is thought that the reduction in pH following long
time periods in SBF is due to the formation of carbonates once the phosphate content of
the SBF is used up for forming HCA. This is supported by the observation of a strong
carbonate absorption band in the FTIR studies and the observation of a strong diffraction
line for a mixed calcium/strontium carbonate in the XRD patterns discussed later.
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Figure 5.1: pH changes after immersion of < 38 µm powder particle from the ICIE1 Sr glass
series. a. In Tris buffer; b. In simulated body fluid (SBF).
The faster and greater pH increase found on increasing the strontium content of the glass
indicates an increased dissolution rate of the glasses, accompanying strontium substitution
for calcium that can be explained on the basis of the more weakly bonded network and
a more expanded network observed in Chapter 4. It is also worth commenting that since
a fixed amount of glass (75 mg) was used in these experiments and the atomic weight of
strontium is 87 compared to 40 for calcium, in molar terms less glass is being used with
increasing strontium substitution and a reduced pH rise with increasing strontium would
have been expected if the glasses all dissolved at the same rate.
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5.2 Ion Release Profile
5.2.1 Ion Release in Tris Buffer
Figure 5.2 shows the silicon, phosphorus, calcium, and strontium release into Tris buffer
as a function of time. The results are plotted in ppm, which facilitates comparison with
values in the literature and in molar terms. The concentration of all these species increases
with time. The initial release kinetics of calcium, strontium and silicon (Figure 5.3) have
a linear dependence with square root time up to approximately 90 minutes indicating
a diffusion controlled process. Similar release kinetics were found for all the glasses
studied.
91
CHAPTER 5. Strontium Containing Bioactive Glass - Dissolution and Bioactivity











        


















   











        


















   



























        


















   











        


















   











        


















   

 
 
 
 
 
 
 
 
 
 
        












  
   

 
 
 
 
 
 
 
 
 
 
        












  
   

 
 
 
 
 
 
 
 
 
 
        












  
   

 
 
 
 
 
 
 
 
 
 
        












  

 
 
 
 
 
 
 
 
 
 
        












  
   









        















   









        















   









        















   









        















   









        















   
Figure 5.2: ICP results: ion release profile after immersion of < 38 µm glass powder from the
ICIE1 Sr series in Tris buffer in ppm (Left) and mmol/L (Right). Increasing Sr content from top
to bottom.
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Figure 5.3: ICP results: ion release as a function of square root of time for the ICIE1 and ICIE1
Sr100 glasses after immersion of < 38 µm glass powder in TRIS buffer.
Figure 5.4 presents the influence of the strontium substitution for calcium in the glass
on its ion release kinetic. The results plotted in part per million (ppm) would indicate
that this substitution increases the ion release from the glass, however when taking into
account the molar mass of the different elements and results are presented in millimoles
per litre, all the glasses appear to release a similar amount. Indeed, approximately 140
ppm of Ca is released after 240 minutes from the all calcium glass compared to 315 ppm
of Sr from the all strontium glass and converting these figures to micromoles gives 0.17
micromoles of Ca and 0.18 micromoles of Sr in 50 milliliters of solution. However, this
is without taking into account that we used a fixed weight of glass in these experiments,
therefore the amount of the strontium glass in molar terms is smaller than that used for the
all Ca glass. From the glass composition in weight%, there is 0.29 moles of Ca and 0.24
moles of Sr in 75 milligrams of the ICIE1 glass and ICIE1 Sr100, respectively. Correcting
for this indicates that 59% of Ca in the initial glass goes into solution in 240 minutes for
the all calcium glass, whereas the all strontium glass is dissolving 75% of its Sr molar
content. Furthermore, the calcium ion concentration increases at the lowest strontium
substitution, ICIE1 Sr2.5, despite the fact that the calcium content is lower in the glass.
Hence, the calcium released is not proportional to the calcium content of the glass. This
is thought to be a result of the effect of strontium on the glass structure and substituting
even small amounts of strontium for calcium makes the NBOs in the glass network less
rigidly linked. In contrast the amount of strontium released is directly proportional to the
strontium content of the glass at all the time points studied. All together this indicates
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that the glasses are dissolving faster and this is probably a result of a glass network that
is more disrupted when strontium is substituted for calcium. This is a very significant
finding that indicates that strontium substitution for calcium facilitates glass degradation.
Usually, bioactive glasses are made more bioactive by reducing the silica content and
network connectivity, but this is often at the expense of making the glass much more
susceptible to crystallisation during synthesis, or processing [2]. Here, the reactivity of
the glasses is changed by modifying only the ratio of strontium to calcium.
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Figure 5.4: ICP results: ion release as a function of the strontium substitution for calcium after
immersion of < 38 µm glass powder from the ICIE1 Sr series in Tris buffer for 240 min in ppm
(Left) and mmol/L (Right).
5.2.2 Ion Release in Simulated Body Fluid
SBF solution differs from a Tris buffer in its initial ionic concentration, which is sim-
ilar to that for human blood plasma and was used to monitor the ability of the glasses
to form an hydroxy-carbonated apatite (HCA). Figure 5.5 shows the ICP analysis of the
SBF solutions. After 30 minutes, the silicon concentration rises to about 70 ppm, which is
approximately the solubility limit of Si(OH)4 under these conditions. Similar Si concen-
trations are found with other studies of bioactive glasses [109, 154]. In all cases the time
point of saturation of Si in solution that would be expected to coincide with the precipita-
tion of a silica gel on the surface of the glass, which correlates with phosphate loss from
the SBF and the presumed formation of a calcium/strontium phosphate layer on the sur-
face of the glass. The phosphorus concentration fell to zero after 120 minutes immersion
time. Beyond this point, the fluctuation of the concentrations of calcium and strontium
corresponds to further dissolutions and precipitation of Ca/Sr carbonates species as no
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phosphate ions are now available to form HCA. This results fits notably with the pH data.
A concern arises here regarding the amount of strontium released from the glass dissolu-
tion. The concentration of strontium found in blood plasma for therapeutic doses of stron-
tium ranelate (oral administration of 2 g per day) varies between 15 and 20 mg/L [155],
thus is 30-fold less than the strontium concentration in SBF after 8 hours for the ICE1
Sr 100 glass. To our knowledge, toxicity due to overdosing of Sr has not been reported
in man. However, strontium has a dose-related effect on the development of osteoma-
lecia in chronic failure rats (CFR) [156]; notably a strontium concentration of 34 mg/L
in the serum of CFRs led to osteomalacic lesions [157]. In primary rat osteoblast cul-
ture, concentrations above 20 mg/L medium (representative of in vivo therapeutic dose
of strontium) decreased osteoblast mineralisation [81]. These findings are worthwhile
consideration for potential application of strontium containing glass powder in vivo.
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Figure 5.5: ICP results: ion release profile after immersion of < 38 µm glass powder from the
ICIE1 Sr series in Simulated body fluid in ppm (Left) and mmol/L (Right). Increasing Sr content
from top to bottom.
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5.3 Characterisation of the Surface Precipitated Layers
5.3.1 Fourier Transform Infrared Spectroscopy
There are four vibrational modes theoretically present for orthophosphate ions: ν1, ν2,
ν3 and ν4 [158, 159]. We can see two of these in the FTIR spectra: the antisymmetric
P-O stretch ν3 mode appears at 1082 cm−1 and the antisymmetric P-O bending ν4 mode
appears in the range of 660 - 520 cm−1. The broad peak corresponding to the ν3 vibration
mode tends to be sharper with time indicating crystallization of a phoshate deposited
layer [160]. Si-O-Si stretching frequencies are characterized in the range of 1190 - 1180
cm−1. The phosphate modes and Si-O-Si modes overlap in this region of the spectra
complicating the analysis of the spectra.
Carbonate ions have also four vibrational modes, three of which are observed in the in-
frared spectra. The ν4 bands have a very low intensity so are seldom seen in the infrared
spectrum. But ν2 and ν3 vibrational modes can be easily observed in the range of 1650
- 1300 cm−1 and 890 - 870cm−1, respectively. Carbonate ions can occupy two differ-
ent site in the apatite lattice. The occupancy of the ν3 carbonate bands depends on the
competition between the phosphate and carbonate ions, whereas the occupancy of the ν2
sites is considered to occur competitively between the OH− and carbonate groups at the
interface of the growing crystal [159]. The ν3 mode into two peaks centered at 1566 and
1339 cm−1 depending on the maturation and formation of apatite crystals.
Figure (5.6 Right) shows the FTIR spectra for the all Sr substituted glass after different
time periods in SBF with synthetic HCA and Sr substituted HCA for comparison. When
strontium is substituted for calcium in the glass structure, the carbonate peaks and the
main phosphate peaks become sharper as shown in Figure 5.6 with a good correlation
with the peaks present on the synthetic HCAs. The presence of strontium seems to en-
hance the formation of the calcium(strontium) phosphate layer (Ca(Sr)P layer). However,
compared with other papers [161, 162] the carbonate peak at about 1500 cm−1 is very
pronounced compared to the main phosphate peak about 1050 cm−1. Furthermore peaks
corresponding to the ν4 phosphate vibrational mode should be seen more clearly in the re-
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gion of 660 and 520 cm−1 and these should be clearly split on forming a crystalline HCA
layer [160], but they are not. Thus the results don’t show clear evidence of the formation
of a crystalline HCA layer. The carbonate peaks could correspond to strontium/calcium
carbonate peaks and not carbonated apatite. But the fact that the peak corresponding to
the phosphate ν3 vibrational mode becomes sharper provides evidence that a phosphate
layer has formed and crystallized. The absence of a clear split peak in the 550 cm−1
may well be a result of a mixed Ca/Sr hydroxycarbonated apatite being formed and the
disordered apatite that results may lead to broadening of the phosphate vibrational modes
and the loss of the characteristic splitting at about 550 cm−1 characteristic of a crystalline
orthophosphate or apatite.
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Figure 5.6: XRD traces (left) and FTIR spectra (right) of the remaining powder from the SBF
degradation study of the ICIE1 Sr glass series. 1: Synthetic HCA produced by precipitation route;
2: Synthetic HCA with all the Ca substituted by Sr in the apatite lattice.
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5.3.2 X-Ray Diffraction
X-ray powder diffraction of the glasses showed (Figures 5.6, Left) that an apatite formed
on the surface of the glasses in SBF. The non-reacted glass as seen previously is com-
pletely amorphous. After 120 minutes, time corresponding to the decrease of the phos-
phate concentration from the SBF data (Section 5.2.2), we start to see peaks at about 2θ =
26o, 28o, 36.4o, 41.5o, 44.32o and 47.76o. They tend to become sharper with time in SBF
and strontium content in the glass as seen in the 480 minute data. The 480 minute diffrac-
tion pattern shows three peaks in the range 29o - 37o and three in the range of 40o - 45o.
These peaks are characteristic of an HCA (JCPDS file No: 74-0565). The peak at 26o is
also present in the pattern of synthetic HCA and was found on the XRD traces of HCA
formed on the surface of bioactive glasses [161,162] but in the case of the ICIE1 Sr series,
it is much more intense. The reason for this is most likely to be a reaction between carbon
dioxide from the atmosphere and the solution to form here calcium/strontium carbonate
as summarised in the FTIR analysis.
The diffraction lines of the synthetic Sr-HCA are more intense and are at lower two theta
values than the synthetic Ca-HCA (Figure 5.6, bottom-left). This is to be expected as
strontium is an heavier cation than calcium and contains more electrons, therefore more
effectively scatters the X-rays. Furthermore, strontium as been shown to form a solid
solution with calcium in the apatite structure. The lattice parameters (a and c) linearly
increase with strontium substitution for calcium [131], consistent with the larger size of
strontium. As the d-spacing increases, the peaks shift toward lower two theta values.
The diffraction lines for the apatite formed from the all Sr-substituted glass are sharper
and are at slightly lower two theta values than 100% calcium glass. This suggests that
a mixed Ca/Sr solid solution apatite is forming in the 100% strontium substituted glass.
This is supported by the lower Sr concentrations in SBF relative to those found in Tris
buffer at the early time points (Section 5.2).
The apatites formed from the glass gave broad diffraction lines compared to the synthetic
ones (Figure 5.6, bottom-left) and this probably a result of three factors:
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• Small nanometer sized crystals.
• Solid solution formation as a result of carbonate substituting for phosphate in the
apatite lattice.
• Solid solution formation as a result of the formation of a mixed Ca/Sr apatite.
5.3.3 31P Magic Angle Spinning Nuclear Magnetic Resonance
Figure 5.7 shows the spectra of the ICIE1 Sr100 before SBF test and after 480 min in
SBF. The peak of the un-reacted glass centred at 9.6 ppm shifts to 3.4 ppm after SBF,
which corresponds to the chemical shift observed for the 31P NMR spectra of a synthetic
fully strontium substituted apatite. However, the width of the peaks is broader for the SBF
glass than the synthetic apatite. A mixed substituted apatite is expected to have a broader
peak than the corresponding pure apatites, as a reflection of the presence of different
cations around the orthophosphate ion and local changes in lattice parameters. Together,
these data confirm that the phosphorus environment moves from a mixed Sr/Ca sodium
orthophosphate, as seen in section 4.3, to a mixed calcium/strontium hydroxy-carbonated
apatite.
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Figure 5.7: 31P MAS-NMR spectra of the ICIE1 Sr100 glass; unreacted, after 480 min in SBF
and spectrum of a fully Sr-substituted HCA.
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5.3.4 Scanning Electron Microscopy - Energy Dispersive X-Ray Spectroscopy
Scanning Electron Microscopy (SEM) analysis was carried out on discs of the ICIE1 Sr50
composition which had been in SBF for 1 week using secondary electron imaging (Figure
5.8 a.) and with backscattered imaging (Figure 5.8 b. and 5.8 c., three different phases
or zones can be seen. The black area corresponds to the mounting epoxy resin which
was used to hold the sample. The backscattered electron micrograph shows a bright layer
at the surface corresponding to the interface of the glass and the simulated body fluid,
corresponding to a phase with a high concentration of high atomic number elements. The
chemical analysis (Figure 5.8 d.) shows that this external layer labelled Zone 1 (5.4± 0.7
µm thickness) is rich in alkaline earth cations (strontium and calcium) and in phosphorus.
The middle layer (Labelled Zone 2, 68.5± 0.9 µm thickness) has high silica content and a
poor alkali earth and phosphorus content, which corresponds to a silica-gel layer. Sodium
is present in relatively low concentrations in the glass (Zone 3) but sodium concentrations
are higher further away from the surface interface and deeper into the glass.
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Figure 5.8: SEM-EDX analysis of the cross-section of a disc of ICIE1 Sr50 after 1 week in SBF.
a. Secondary electron image; b. and c. Backscattered electron images. The graph shows the
atomic composition along the cross-section.
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Table 5.1: EDX analysis on the cross-section of a discs of ICIE1 Sr50 after 1 week in immersion.

          
          
          
     
    
Table 5.1 gives the molar percentage of the elements in the three zones compared to the
initial glass composition before SBF test. It is worth noting that there is the same pro-
portion of strontium and calcium in the external layer, reflecting the original glass com-
position despite the fact that initially largely only calcium is present in the SBF solution.
That means that the creation of the external HCA layer probably forms initially from cal-
cium and strontium in the glass, rather than from the SBF solution. During the process
of dissolution of the bioactive glass, the alkali earth cations released from the glass seem
to stay close to the surface and seem to precipitate at the surface, rather than diffusing
into the SBF and then the SBF precipitating HCA onto to surface. The ratio between
the Earth alkali cations and phosphorus is: Ca+SrP = 1.18 ± 0.23 compared to 1.67 for a
stochiometric apatite. The lower ratio indicates the formation of a mixed calcium (stron-
tium) deficient apatite (CDA). It is CDAs which are present in bone and formed when a
synthetic precipitation method is used [163].
5.4 Cell Culture
SaOs-2 cells were routinely cultured on the surface of discs of the ICIE1 Sr series for 1,
7 and 14 days. A live/dead cell viability assay was used to monitor the proliferation of
the cells. Figure 5.9 shows that live cells are present on all the discs and the cell number
increases with time. There is a greater number of cells on the highest strontium containing
glass discs showing a positive role of strontium on cell proliferation. On day 1, some dead
cells can be spotted and might be the result of the changes in pH during the first hours of
immersion as shown in the pH data.
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Figure 5.9: Live/dead images of discs of the ICIE1 Sr glass series after 1,7 and 14 days in culture
with SaOs-2 cells. The live cells fluoresces green and the dead cells in red. The scale bar represents
200 µm. Data provided by Dr. E. Gentleman.
5.5 Assessment of HCA Formation and Osseo-integration in
an Osteoporotic Rat Implant Study
5.5.1 Fracture and Histology report
The in vivo assessment of the behavior of cylindrical rods from the ICIE1 Sr series into
the femurs of 18 osteoporotic rats, was performed by Dr. Christine Freeman, Kirsty
Franklin and Prof. Ian Brook. At 4 weeks the animals were sacrificed and the femurs
excised and processed for histological examination. According to their report, seven fe-
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murs fractured and there was evidence of callus formation and bone healing. In the intact
limbs the materials were well tolerated by bone, marrow and overlying soft tissues with
no chronic inflammation. Osseointegration was seen to a limited extent and was seen
most consistently in the animals implanted with rods containing 10% strontium. The
large number of fractured femurs created difficulty with interpretation and it is not pos-
sible to say whether or not the composition of the implants contributed to the fractures.
However, there were no fractures seen in 6 non-ovariectomised control animals. None of
the sham operated animals with or without ICIE1 Sr50 (n=6 per group) presented frac-
tures. Amongst the ovariectomised animals, ICIE1 and ICIE1 Sr50 groups, presented 3
fractures each, whereas the ICIE Sr10 presented only one.
From these results it can be concluded that the osteoporotic nature of the bones increases
the fracture risk as expected. The ICIE1 Sr10 glass seems to lead to better osseointegra-
tion and fracture reduction compared to the ICIE1 and ICIE1 Sr50. It needs to be pointed
out here that all the diameters of the implanted cylinders was 1.6 mm compared to the
requested implanted diameter of 1 mm. There was consequently a huge reduction in the
cross-sectional area of bone and relatively little bone in which to constrain/contain the
implants resulting in some fractures and almost certainly extensive flexing of the bone,
particularly in thin sections resulting in poor mineralisation at the interface in these areas.
5.5.2 Scanning Electron Microscopy - Energy Dispersive X-Ray Spectroscopy
One femur from each test group was dehydrated and embedded in resin. We carried
out scanning electron microscopy (SEM) analysis on cut ground sections. The second
electron imaging (Figure 5.10 a. and Figure 5.11 a.) shows the glass rods, rectangular and
oval for the ICIE1 Sr10 and ICIE1 Sr50, respectively, surrounded by the rest of broken
femur pieces. There is evidence of considerable movement and break up of the interfaces,
fracturing of the glass, plus fracturing of the bone. These problems are probably due
the points discussed previously and the fact that bone is difficult to section at the best of
times and sectioning through a glass osteoporotic bone interface without some damage
to the interfaces is not easy. Because of this it is not possible to measure the percentage
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osseointegration, i.e. the percentage of bone covering the implant surface, with any degree
of accuracy.
Despite these problems, where there is a reasonable thickness of bone to constrain the im-
plants, there is clear evidence of osseointegration, with what appears to be a well bonded
interface with the bone forming on the surface of the HCA layer. There is also evidence
of osseoinduction with bone growing out onto the end of the bioactive glass implants.
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Figure 5.10: SEM images of a rod of ICIE1 Sr10 after 4 weeks implantation in the femur of
an osteoporotic rat. a. Secondary electrons images; b, Backscattered electrons image; c. and d.
Backscattered electron images of zone of interest for EDX analysis.
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Figure 5.11: SEM images of a rod of ICIE1 Sr50 after 4 weeks implantation in the femur of
an osteoporotic rat. a. Secondary electrons images; b. Backscattered electrons image; c. and d.
Backscattered electron images of zones of interest for EDX analysis.
Similarly to the disc soaked in SBF (Section 5.3.4), the backscattered imaging (Figures
5.10b., 5.10 c., 5.10 d. , 5.11 b. , 5.11 c. and 5.11 d.) shows three different zones in the
glass. The black area corresponds to the mounting epoxy resin. From edge to core, the
backscattered electron micrograph shows a bright layer all around the rods, corresponding
to the HCA, then the silica gel layer and finally the remaining glass in the core. The apatite
layers measure 54.7± 14.3 µm and 112.6± 13.7 µm for the ICIE1 Sr10 and ICIE1 Sr50
glasses, respectively. The silica gel layer measures 82.5 ± 16.8 µm and 79.46 ± 16.55
µm for the ICIE1 Sr10 and ICIE1 Sr50 glasses, respectively. Strontium substitution for
calcium in the glass enhances the apatite formation, which correlates with observation in
SBF study data.
The thickness of apatite for the ICIE1 Sr50 glass after 4 weeks in vivo is more than 20
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times thicker than after 1 week in SBF. However the thickness of the silica gel layer is sim-
ilar in the two studies. In the SBF close system, there is a limited amount of phosphorus,
which is used in the first few hours to form apatite. As seen previously, carbonate species
precipitate after this point. In vivo, there is a constant fluid flow, hence the orthophosphate
is replenished and more apatite can be formed.
Brink et al. studied the bioactivity of different glass composition in the system Na2O-
K2O-MgO-CaO-B2O3-P2O5-SiO2 implanted in rabbit tibia for 8 weeks [2]. They mea-
sured the osseointegration and the apatite layer thickness for each glass. Figure 5.12
shows these results as well as the HCA thickness for the ICIE1 Sr10 and ICIE1 Sr50
glasses. There is a thicker HCA layer formed after 4 weeks in ICIE1 series glasses com-
pared to most of the bioactive glasses at 8 weeks studied by Brink. This is probably a
result of the greater degradability of the glasses. It was not possible to measure the os-
seointegration for the ICIE1 Sr glasses but there is a good a good correlation between
osseointegration and HCA thickness. We would expect to have excellent osseointegration
values for the strontium glasses according to their thick HCA layer.
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Figure 5.12: Osseo-integration as a function of the thickness of HCA. The blue circles represent
the values found by Brink et al. [2] and the dash lines represent the measured HCA thickness of
the present SEM analysis of the ICIE1 Sr10 and ICIE1 Sr50 glasses.
Brink et al. introduced an index of surface activity (ISA) as an indication of the depen-
dence between the glass surface activity in vivo, as determined by SEM-EDX, and the
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glass composition. An ISA value of 3 is necessary for a glass to be bioactive, i.e., bone
bonding. Their most reactive glass has an ISA of 3.6 counter 4.85 for the ICIE1 Sr se-
ries. Furthermore, the ISA doesn’t take into account the effect of strontium on the glass
degradability. Therefore, it is not surprising to see thicker HCA formation on the ICIE1
Sr glasses surface.
The chemical analysis (Table 5.2 and 5.3) gives the molar percentage of the elements in
the three zones compared to the initial glass composition before implantation. The HCA
has a high concentration of alkaline earth cations (strontium and calcium) and phosphorus.
The silica gel layer has high silica content and a poor alkali earth and phosphorus content.
Sodium is present in relatively low concentrations in the HCA and silica gel layer. The
bone adjacent to the implants contains high concentration of phosphorus and calcium with
low amount of strontium, silicon and sodium.
Table 5.2: EDX analysis on the cross-section of rod of ICIE1 Sr10 after 4 weeks implantation
into the femur of an osteoporotic rat.

          
          
          
          
     
    
Table 5.3: EDX analysis on the cross-section of rod of ICIE1 Sr50 after 4 weeks implantation
into the femur of an osteoporotic rat.

          
          
          
          
     
    
The ratio between strontium and calcium is 0.11 in the original ICIE1 Sr10 glass com-
pared to 0.06 in the HCA formed in vivo. The difference is even greater for the HCA
formed from the ICIE1 Sr50 glass with SrCa = 0.23 rather than 1.00 in the original glass.
Under dynamic flow, the HCA composition changes as influenced by three factors: the
solubility of the HCA, the ionic exchanges between apatite and media and the ionic con-
centration around the apatite nucleation points. The solubility of strontium containing
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HCA is greater than a calcium containing one [164], therefore we can hypothesise that
HCA with a greater amount of strontium is forming at the early stage of the implantation,
due to the high concentration of strontium released from the glass. Under dynamic flow
with calcium rich media, the strontium concentration will decrease in the apatite via sim-
ple ionic exchange and apatite dissolution into Ca-rich apatite. This hypothesis explains
the low concentration of strontium in the HCA surrounding the implant and fits with the
SBF chemical analysis, where the static condition leads to a 50/50 strontium calcium
apatite.
5.6 Conclusion
The weaker glass network when strontium is substituted for calcium, established in Chap-
ter 4, increases the dissolution rate of the glass. The pH changes are increased as well as
the concentration of ions in solution in Tris Buffer. In that particular buffer, the early
stage of the glass degradation is marked by the rapid diffusion controlled process of sil-
ica, strontium and calcium. Consequently, the calcium (strontium) phosphate rich layer
is formed faster in SBF. The Ca(Sr)P layer has been characterised and corresponds to a
nano-crystalline calcium/strontium deficient hydroxyapatite. The phosphorus of the SBF
is consumed within the first few hours, followed by the precipitation of strontium/calcium
carbonate species. In vivo, a much thicker apatite layer was formed than in SBF, due
to the replenishment of calcium and phosphorus by dynamic flow of body fluid. Relative
low amounts of strontium were found in the apatite layer in vivo suggesting that strontium
is washed away with time and fluid circulation. In vitro, strontium was shown to have a
positive effect on cell proliferation.
5.7 Further Work
The sectioning of the femur at the glass rod location prior to the SEM-EDX analysis
resulted in breakages at the implant-tissue interface. Sectioning is particularly difficult as
the bone was osteoporotic and relatively small in size to constrain the implant. A more
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advantageous method, which can be employed to assess osseointegration without having
to cut bone is X-ray microtomography. However, the standard equipments are usually
limited by the balance between resolution and size of the sample that can be looked at.
A recent set-up available at Queen Mary University, London allows now to run X-ray
microtomography of important sample size (above 1 cm3) with a resolution of 5 µm.
This technique would allows to run the entire femur without sectioning and therefore
have a more relevant method to assess osseointegration.
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Chapter 6
Design and Characterisation of Glasses for Glass
Polyalkenoate Cements
Bioactive-type glasses with high sodium content such as the 45S5 composition or ICIE1
composition are not suitable for producing cements with desirable properties for medical
applications because the high sodium content will result in hydrolytical instability of the
cement. The role of compounds likely to enter the formulation of ionomer aluminium-
free glasses has been detailed in Section 1.2.4.2. In this Chapter, the characterisation of
ionomer aluminium-free glass will be study and discussed.
This study is focused on five main points when investigating the glass composition - glass
structure - cements property characteristics. These are:
• The effect of varying phosphorus content
• The effect of varying the magnesium content
• The effect of varying the zinc content
• The effect of varying network connectivity
• The effect of varying the iron content
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6.1 Glass Characterisation
6.1.1 P1 Glass Series
The P1.1 glass is based on the sodium-free version of MGI45N6, where CaF2 is added
to decrease the melting temperature of the glass. Glasses with different amounts of P2O5
were produced. Magnesium and calcium were added to the composition to charge balance
the new orthophosphate units which were created by adding P2O5, and keep the network
connectivity of the silicate phase constant.
6.1.1.1 X-Ray Diffraction
All the glasses from the P1 series were amorphous, presenting no sharp crystalline peaks
(Figure 6.1). Moreover, there were no differences in XRD traces through the series.
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Figure 6.1: XRD traces of the P1 glass series.
6.1.1.2 Fourier Transform Infrared Spectroscopy
FTIR analysis was carried out in Chapter 4 and 5 (Sections 4.2 and 5.3.1), where the
absorption bands of interest for the study of phosphosilicate bioactive glasses were indi-
113
CHAPTER 6. Design and Characterisation of GPCs
cated. Figure 6.2 shows the FTIR spectra of the glasses from the P1 series. The glasses
have a very similar spectra to the ICIE1 series (Q2 glass) with a strong absorption band at
840 cm−1, corresponding to stretching vibration of Si-O(s)-2NBOs bonds. The intensive
bands between 1100 and 900 cm−1 are a combination of vibrations from P-O(s) and Si-
O(s), which make analyses of these glasses difficult. As all the spectra of the series have
similar shapes, it can be concluded that the design of the glasses was successful in main-
taining the charge-balance of the orthophosphate species, thus not significantly modifying
the silicate network.
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Figure 6.2: FTIR spectra of the P1 glass series.
6.1.1.3 Magic Angle Spinning - Nuclear Magnetic Resonance
The 31P MAS-NMR spectra of the P1 glass series (Figure 6.3) exhibits a single peak cen-
tred between 1 and 1.4 ppm. These peaks correspond to a mixed magnesium/calcium or-
thophosphate environment as the phosphorus chemical shift of a Ca3(PO4)2 andMg3(PO4)2
are equal to 2.5 ppm and 0 ppm, respectively [165]. The first three glasses of the P1 series
present a symmetric Gaussian peak, whereas a small shoulder around 10 ppm appears for
the P1.4 glass. This suggests that the high phosphorus content of this glass leads to the
formation of pyrophosphates.
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Figure 6.3: 31P MAS-NMR of the P1 glass series. * respresenting spinning side bands.
The chemical shift increases with increasing P2O5 indicating a change in the ratio between
calcium and magnesium around the orthophosphates. Using the chemical shift value of
each peak, the cationic distribution around the PO3−4 anions was calculated and is given
in Table 6.1. The calcium to magnesium ratio in the phosphate phase increases with
increasing P2O5 from 0.7 up to 1.3, which is higher than expected from the composition
of the glass with a ratio of 0.5. This suggests that either Mg2+ has a weaker affinity for
charge-balancing PO3−4 than Ca
2+, or that it is used for another structural role, such as
going into the silicate network. It is worth pointing out that the concentration of silica
decreases along the series to keep the network connectivity constant as more P2O5 is
added. This decrease in silica content has been shown to help magnesium to switch its
role of modifier to intermediate [166].
Table 6.1: Calculation of the orthophosphate environment MgXCaY (PO4)2 according to 31P NMR
data of the P1 glass series.
    
    
    
    
    
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6.1.1.4 Differential Scanning Calorimetry
Figure 6.4 shows that the Tg value is not influenced by the P2O5 content in the P1 series,
which is expected for a charge balanced series.
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Figure 6.4: DSC analysis of the P1 glass series. a. DSC traces; b. Evolution of the glass transition
temperature (Tg) and first crystallization peak (Tp1) as a function of the P2O5 content; c. Tg and
Tp1 values.
The NMR data suggested that one explanation for the increase for the chemical shift of
the glass is that more magnesium enters the silicate network on increasing the phospho-
rus content. As more Si-O-Mg bonds are created, the number of Q3 silicate species, and
therefore the cross-linking of the network, increases. Furthermore, magnesium attracts a
divalent cation to charge balance its structure when entering the network. The resulting
deficiency of network modifier cations should more efficiently cross-link the glass net-
work and an increase in Tg would be expected. On the other hand, the strength of a Mg-O
bond is weaker than that of a Si-O bond, which should weaken the glass network. Conse-
quently, there is a competition between the creation of weak Mg-O bonds and an increase
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in network connectivity, which could explain the lack of variation of Tg.
To conclude on the structure-properties characteristics of the P1 series, the glasses are
expected to have similar reactivity, since their Tgs are similar. However, the increased
amount of orthophosphates could influence the setting reaction of cement, as it has been
shown to influence the pH changes during the dissolution of other glass systems. Further-
more, the addition of P2O5 increased the magnesium to calcium ratio in the silicate phase,
as shown by 31P MAS-NMR. This would suggest an increase of Mg-O-Si bonds forma-
tion, hence magnesium may play a similar role to aluminiun during the setting reaction of
the cement by creating acid hydrolysable bonds within the silicate network.
6.1.2 P2 Glass Series
The second series P2 was designed to have a higher NC than the P1 series with 2.37
mole% of MgO being replaced by SiO2. The increase in the cross-linking of the glass
network and the increased NC would be expected to decrease reactivity and consequently
the cements made from the P2 series are expected to have longer working and setting times
than the P1 series. Furthermore, zinc release has been shown to have a beneficial effect
on bone formation (Section 1.2.1.7) and therefore, 1.07 moles of ZnO was substituted for
MgO in the glasses.
The P2 series, was not charged-balanced, which means that neither magnesium nor cal-
cium was added to charge balance the increased P2O5 content. Consequently, the network
connectivity increases with phosphorus content.
6.1.2.1 X-Ray Diffraction
All the glasses from the P2 series are amorphous (Figure 6.5). The amorphous halo of the
P2.3 glass is not symmetrical and a shoulder emerges around 25◦. This suggests that the
high amount of phosphorus leads to an increase of the amount of phosphate phase or that
nano-crystals are formed with a size below than 50 nm, which is the lower limit to give
sharp crystalline peaks with the X-ray diffractometer used.
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Figure 6.5: XRD traces of the P2 glass series.
6.1.2.2 Fourier Transform Infrared Spectroscopy
The Figure 6.6 shows that the spectra from the P2 series are similar to the P1 series, but
with a decrease in the absorption ratio between SiO-2NBOs at 840 cm−1 and Si-1NBO at
930 cm−1. Since no cations were added to charge-balance the new orthophosphate units,
the network modifier species are entering the phosphate phase increasing the polymerisa-
tion and NC of the silicate matrix,instead of forming non-bridging oxygens in the silicate
network.
There is no evidence of P-O-P bonds (750 - 810 cm−1) in the glasses but in the IR spectra,
the corresponding bands are superimposed on the Si-O-Si bridges [145].
118
CHAPTER 6. Design and Characterisation of GPCs
        






















Figure 6.6: FTIR spectra of the P2 glass series.
6.1.2.3 Magic Angle Spinning - Nuclear Magnetic Resonance
The 31P MAS NMR spectra of the P2 series is presented in Figure 6.7. The chemical
shift of P2.1 is higher than that observed in P1.1. As the SiO2 content of the P2 series
is higher, we would expect less magnesium to go into the network, leaving it available to
charge-balance the orthophosphate units. Therefore P2.1 should have a lower chemical
shift than P1.1. However, P2.1 contains small amount of zinc, whose Zn3(PO4)2 structure
is evident at 4.2 ppm. We can conclude therefore that there is a high affinity for zinc to
charge-balance the PO3−4 .
The P2.3 glass chemical shift increases compared to P2.1, indicating that the ratio Ca/Mg
increases in the phosphate environment, as it did in the P1 series, with increasing P2O5
content. The reason for the low chemical shift of the P2.2 glass is uncertain.
The shape of the peaks for the P2.2 and P2.3 glasses is not completely symmetrical. There
is a small shoulder around -10 ppm, which correspond to the creation of P-O-P bonds as it
appears that there are not enough cations to maintain the phosphorus in an orthophosphate
environment.
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Figure 6.7: 31P MAS-NMR of the P2 glass series.
6.1.2.4 Differential Scanning Calorimetry
The DSC traces of the P2 series (Figure 6.8) show that the first two glasses have similar
Tg. However, there is a much lower glass transition temperature for the highest P2O5
content glass. As it is not a charge-balanced series, we should expect the Tg to increase as
the network connectivity of the glass increases (NC = 2.97 for the P2.3 glass). This incon-
sistency has been previously reported for a bioactive-type glass (ICIE1) with increasing
phosphate content, in both charge balanced and non-charged balanced series [167]. The
authors explained that the observed Tg was a composite Tg and once the phosphate phase
reaches a critical size, it affects the Tg value. For the P2.3 glass, 31P MAS-NMR analysis
suggesting that two significant phases are present: a magnesium-rich silicate phase and a
zinc/calcium-rich orthophosphate phase, the later containing some pyrophosphate units.
The first phase, being largely Q3, would have a high Tg, which would coincide with the
crystallisation of the glass around 750oC. The Tg at 557oC would therefore correspond to
the phosphate phase.
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Figure 6.8: DSC analysis of the P2 glass series. a. DSC traces; b. Evolution of the glass transition
temperature (Tg) and first crystallization peak (Tp1) as a function of the P2O5 content; c. Tg and
Tp1values.
To conclude on the structure-properties characteristics of the P2 series, P2.1 and P2.2
are expected to have similar reactivity, since their Tgs are similar. However, due to the
sharp decrease in Tg for the P2.3 glass, we could expect the working time of cement to
be smaller than for the other two. Similarly to the P1 series, the increased amount of
orthophosphates could influence the setting reaction of cement by affecting the pH of the
glass dissolution and the number of Mg-O-Si bonds.
6.1.3 Zn1 Glass Series
The Zn1.1 glass composition is the same as for the P1.1 series. The previous glass com-
positions contained only magnesium oxide as a potential intermediate oxide. Zinc was
then substituted for magnesium.
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6.1.3.1 X-Ray Diffraction
All the glasses from the Zn1 series were amorphous (Figure 6.9). A shift of the amorphous
halo toward higher 2θ values were noticeable when zinc was substituted for magnesium.
This trend is the opposite of what has been found when strontium was substituted for
calcium in Section ICIE1 Sr. The shift here corresponds to a decrease of spacing in
the glass network. Table 6.10 gives the ionic radii of zinc and magnesium as 4 and 6
coordinated cations. If zinc and and magnesium have the same coordination number then
zinc substitution for magnesium should expand the glass network, suggesting that zinc
has a lower coordination number than magnesium.
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Figure 6.9: XRD traces of the Zn1 glass series.
Figure 6.10: Ionic radii of magnesium and zinc 4 and 6 coordinated ions.
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6.1.3.2 Fourier Transform Infrared Spectroscopy
The analysis of the spectra of the Zn1 series (Figure 6.11) is difficult as magnesium and
zinc can both switch their roles and therefore introduce a wide range of new bond vi-
brations. The spectra are almost identical, with the exception that the intensity of the
absorption bands between 1050 and 1000 cm−1 is stronger for the 100% Mg glass. A
small shoulder appears around 800 cm−1, which could correspond to an increase of the
number of NBOs or to absorption of a new bond type such as Mg-O-Si. The FTIR spectra
do not provide a clear answer.
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Figure 6.11: FTIR spectra of the Zn1 glass series.
6.1.3.3 Magic Angle Spinning - Nuclear Magnetic Resonance
Figure 6.12 indicates that the phosphorus is in an orthophospahte environment for the all
the glasses. As zinc is substituted for magnesium, the NMR peak moves to higher chem-
ical shift in a linear fashion from 1.0 ppm to 4.1 toward the chemical shift of Zn3(PO4)2
at 4.2 ppm. This suggests that the orthophosphate environment is preferentially charge
balanced by zinc rather than calcium or magnesium.
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Figure 6.12: 31P MAS-NMR of the Zn1 glass series.
6.1.3.4 Differential Scanning Calorimetry
Figure 6.13 shows a lower Tg with increasing zinc content. If zinc enters into the glass
network more than magnesium, then the increase of Zn-O-Si bonds weakens the silicate
network. On the other hand, if zinc has a more modifying role then the glass network is
more disrupted. Both hypotheses would explain a decrease in Tg and an increase of the
reactivity of the glass.
As an interesting feature, the DSC trace of the Zn1.3 glass shows that high zinc content
inhibits crystallisation.
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Figure 6.13: DSC analysis of the Zn1 glass series. a. DSC traces; b. Evolution of the glass tran-
sition temperature (Tg) and first crystallisation peak (Tp1) as a function of the zinc for magnesium
substitution; c. Tg and Tp1 values.
The decrease in Tg may correlate with an increase in glass reactivity as zinc is substituted
for magnesium. The working time of the cements are then expected to decrease.
6.1.4 Outlook on Properties of Cement made from P1, P2 and Zn1 Glass
Series
Cements were made from the three first series and as it will be reported in Chapter 8, only
P1.4, Zn1.2 and Zn1.3 led to water stable cements, indicating that zinc or high phosphorus
content are essential to obtain good mechanical properties for the cements. Consequently,
the next three series were based on high zinc content and/or high phosphate content.
6.1.5 Zn2 Glass Series
The Zn2.1 glass is based on a high P2O5 content version of Zn1.1 with half of CaO
substituted with SrO to benefit from the positive effect of strontium on bone formation.
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Furthermore, the glasses were produced without fluorine as the working time of the first
cements were relatively short around 15 seconds and fluorine has been shown to decrease
the working time [168].
6.1.5.1 X-Ray Diffraction
XRD was carried out only on Zn2.1, Zn2.3 and Zn2.5 (Figure 6.14) and all the glasses
were amorphous. The shift of the amorphous halo, observed on the XRD traces of the Zn1
series is not present for the Zn2 series, which could be due to the higher amount of P2O5
of the latter. Indeed, as magnesium and zinc have different affinity to charge-balance the
orthophosphates, their distributions in the silicate and phosphate phases will be different
in the two series.
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Figure 6.14: XRD traces of the Zn2 glass series.
6.1.5.2 Fourier Transform Infrared Spectroscopy
The FTIR spectra of the Zn2 series is presented in Figure 6.15 were very similar to each
other. As for the Zn1 series, there is a slight decrease in the absorption at high wavenum-
bers and an increase at lower wavenumbers. Similarly, as for the previous zinc series, it
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is difficult to draw any conclusion from the FTIR spectra.
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Figure 6.15: FTIR spectra of the Zn2 glass series
6.1.5.3 Magic Angle Spinning - Nuclear Magnetic Resonance
The 31P MAS-NMR spectra of the Zn2 series are shown in Figure 6.16. The substitution
of zinc for magnesium increased the chemical shift similarly as in the Zn1 series. How-
ever, the chemical shift of the Zn2.1 glass (2.0 ppm) is higher than for the Zn1.1 glass (1.5
ppm), which can be explained by the presence of strontium in the orthophosphate struc-
ture. Indeed, the chemical shift of Sr3(PO4)2 is higher than for Ca3(PO4)2, with values of
3.9 ppm and 2.5 ppm, respectively.
A small shoulder can be observed between -10 and 0 ppm for all the compositions, which
would suggest the presence of some pyrophosphate within the glasses.
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Figure 6.16: 31P MAS-NMR of the Zn2 glass series.
6.1.5.4 Differential Scanning Calorimetry
As already seen with the substitution of zinc for magnesium in the Zn1 series, the glass
transition temperature decreases for the Zn2 series (Figure 6.17). The same conclusion as
for the Zn1 series can be applied here as well, which is that either zinc enters into the glass
network more than magnesium, then the increase of Zn-O-Si bonds weakens the silicate
network, either zinc has a more modifying role than magnesium then the glass network is
more disrupted. Both hypotheses would explain a decrease in Tg and an increase of the
reactivity of the glass.
The substitution of magnesium with zinc is likely to affect the working time of the cement
as the glasses become more reactive. Furthermore, the high phosphorus content of these
glasses could elicit significant difference in cement properties compared to the Zn1 series.
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Figure 6.17: DSC analysis of the Zn2 glass series. a. DSC traces; b. Evolution of the glass tran-
sition temperature (Tg) and first crystallization peak (Tp1) as a function of the zinc for magnesium
substitution; c. Tg and Tp1 values.
6.1.6 NC Glass Series
In a bioactive type of glass, changes in network connectivity (NC) lead to important
changes in the reactivity. It is therefore of interest to study the effect of network con-
nectivity on the setting reaction of the cements. The glasses of the NC series are based
on high zinc content, and P2O5 was removed to simplify the composition. Zinc oxide
was then substituted for silica, which leads to a decrease in NC. No 31P MAS-NMR are
presented as P2O5 was not part of the glass composition.
6.1.6.1 X-Ray Diffraction
The XRD traces of the NC series is shown in Figure 6.18. The NC 1.83 glass is com-
pletely amorphous, however the two others present some crystalline peaks corresponding
to Willemite (Zn2SiO4). Nevertheless, the area under these peaks is small compared to
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the area of the amorphous halo, the glasses are almost completely amorphous.
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Figure 6.18: XRD traces of the NC glass series.
6.1.6.2 Fourier Transform Infrared Spectroscopy
The FTIR spectra, plotted in Figure 6.19 show that the glasses are mainly Q2, with a
strong band at 850 cm−1. There are no significant differences between the spectra. The
changes in the NC values are relatively small (from 1.79 to 1.83), which could explain
why the ratio between SiO-1NBO and SiO-2NBO does not increase significantly.
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Figure 6.19: FTIR spectra of the NC glass series.
6.1.6.3 Differential Scanning Calorimetry
The DSC traces (Figure 6.20) shows a slight increase in the value of Tg, which fits with
the increase in NC. Therefore, the glasses are expected to be less reactive from NC1.79 to
NC 1.83. The working time of the cements are therefore likely to increase with increasing
NC. The presence of crystallinity in NC1.78 and NC1.81 glasses is probably too small to
have a significant effect on cement properties.
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Figure 6.20: DSC analysis of the NC glass series. a. DSC traces; b. Evolution of the glass transi-
tion temperature (Tg) and first crystallization peak (Tp1) as a function of the network connectivity
of the glass; c, Tg and Tp1 values.
6.1.7 Fe1 series
In the Fe1 series, Fe2O3 was added to the glass composition. Iron was assumed to enter
the glass network as Fe3+. Therefore, to keep the network connectivity constant, for
one mole of Fe2O3 added, 2 moles of SiO2 was removed and a mole of CaO and SrO
were added to charge balance the expected FeO−4 . The amount of Fe2O3 was kept low
to avoid any crystallisation of Fe3O4 (magnetite) species, found by Hurrell-Gillingham et
al., where the concentration of hematite was around 20 mole% [27]. No 31P MAS-NMR
are presented as P2O5 was not part of the glass composition.
6.1.7.1 X-Ray Diffraction
All the glasses of the Fe1 series were completely amorphous, and XRD showed no shift
of the amorphous halo (Figure 6.21). This series shows that it is therefore possible to
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produce Fe2O3 containing glass up to 3 mol.%, without crystallisation. A recent study
showed the production of amorphous iron containing glass with Fe2O3 concentration up
to 8 mol% in a bioactive type of glass, which confirms the possibility of incorporating
iron in small amounts and avoiding crystallisation.
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Figure 6.21: XRD traces of the Fe glass series.
6.1.7.2 Fourier Transform Infrared Spectroscopy
Figure 6.22 shows that the spectra of the glasses from the Fe1 series are all very similar.
This suggests that the ratio between bridging and non-bridging oxygens does not change,
confirming the hypothesis that iron is mainly present as Fe3+ and goes into the silicate
network. A small increase in the absorption intensity centered at 700 cm−1 can be seen
with increasing iron content and could correspond to the creation of Fe-O-Si bonds [169].
However a similar increase should be seen at 900 cm−1 due to the creation of these bonds,
which could be masked by the decrease in stretching vibration of Si-O bonds as SiO2 is
substituted with Fe2O3. FTIR is not sufficient here to give a clear answer on the role of
iron in the glass.
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Figure 6.22: FTIR spectra of the Fe1 glass series.
6.1.7.3 Differential Scanning Calorimetry
The glass transition temperature decreases in a linear fashion (Figure 6.23) with increas-
ing iron content. If iron enters in the network, then the formation of Fe-O-Si bonds may
be responsible for the weakening of the network. However, if the hypothesis made for the
design of the glass is incorrect and the iron is actually a network modifier and exists as Fe
(II), then the network connectivity of the glass would also fall, leading to lower Tg values.
In any case, the decrease in Tg likely indicates that the setting time of the cements will be
faster.
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Figure 6.23: DSC analysis of the Fe1 glass series. a. DSC traces; b. Evolution of the glass
transition temperature (Tg) and first crystallization peak (Tp1) as a function of the Fe2O3 content;
c. Tg and Tp1 values.
6.2 Conclusion
The compositions of glasses for cement applications are very different from those of
bioactive glasses and aluminium-containing glass for GPC systems. The novelty of the
various glasses produced in this Chapter comes from the absence of aluminium and
sodium, and from their high concentrations of magnesium and/or zinc. All of the glasses
studied here were amorphous, with the exception of two compositions presenting very low
crystallinity. Furthermore, Fe2O3 containing glasses were successfully produced without
any apparent magnetite.
The effect of phosphorus was investigated and was found to be present as orthophosphate
with some pyrophosphate for high P2O5 containing glasses. No significant changes were
observed for the P1 series as the PO3−4 were charged-balanced, and the reactivity of the
glasses amongst this series were expected to be similar. On the other hand, the FTIR
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analysis of the P2 series showed an increase in polymerisation of the silicate network,
as network modifiers were not used to charge-balance the orthophosphates. However,
contrary to what would be expected for a more cross-linked silicate network, there was a
decrease in Tg, which may be explained by the contribution of the phosphate phase to the
disruption of the glass. In these two series, 31P MAS-NMR showed that calcium more
effectively charge-balances the orthophosphate than magnesium. Furthermore, there were
some indications of magnesium switching its role and creating Mg-O-Si bonds, which
weaken the glass network.
Analyses of the two zinc series was difficult due to the presence of two intermediate
oxides, ZnO and MgO. The FTIR spectra were not influenced by the substitution of zinc
for magnesium. However, the decrease of the glass transition temperature indicates that
the glasses were more disrupted. Increasing the zinc content rather than magnesium will
result in more reactive glasses. The NMR showed that zinc has a high affinity for charge-
balance the orthophosphates.
For the the NC series, we observed few changes, with the exception that decreasing the
network connectivity slightly decreases the glass transition temperature.
The FTIR spectra of the Fe1 series supported our hypothesis that iron is present as Fe3+
and goes into the silicate network. The decrease in Tg would then be explained by the
creation of weak Fe-O-Si bonds. Increasing Fe2O3 content, therefore, would be expected
to make the glasses more reactive.
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6.3 Further Work
29Si MAS-NMR could be performed on the GPC glasses. It would be particularly interest-
ing for the P1 and P2 series, where non significant changes in spectra would be expected
for the charge-balanced series, whereas a shift toward more negative values would be
expected for the non-charge-balanced series. However, 29Si MAS-NMR analysis would
be rather difficult for the zinc series, where the substitution of zinc for magnesium could
result in different SiO-Znx-Mgy environment, where silicon could be surrounded by a
varying amount of zinc and magnesium if these species enter the glass network.
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Glass Polyalkenoate Cements – Parametric Study
The main disadvantages of the commercially available cements have been described in
Chapter 1. The aim of this work, therefore, is to develop a novel cement for orthopaedic
applications and overcome these disadvantages by focusing on several criteria:
• The mechanical properties should match the surrounding bone. In this study, ce-
ments were evaluated by their resistance to compression by determining the value
of the ultimate compressive stress (UCS). The lower limit for a cement to be use for
orthopaedic application was fixed at 50 MPa after storage in de-ionised water for
24 h (according to the original DTI plan of the project).
• The handling properties need to be adequate for a surgeon to mix and apply the
cement paste in the zone of interest. The maximum cement handling time is called
working time (WT) with ideal values about 3 minutes.
• The hardening of the cement, or setting time (ST), needs to be fast enough to pro-
vide load bearing capacity for the implant in a time window suitable for an or-
thopaedic surgery. The ideal upper limit is around 15 minutes.
A preliminary study was carried out on the ability of glasses developed in Chapter 6 to
form a cement when mixed with a dry poly(acrylic acid) powder, and de-ionised water.
It was found that cements with suitable working times were either not setting, or not
stable once immersed in water. On the other hand, water stable cements had WTs of
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approximately half a minute with mechanical properties from a few MPa (similar to a
rubber) to UCS of 50 MPa. In this Chapter, we decided to select Zn1.3 and NC1.78 glass
compositions with promising mechanical properties and try to increase their WT to meet
all three criteria listed above.
To increase the WT, several methods were investigated:
• Heat treatment of the glass
• Increase the particle size of the glass powder
• Acid washing the glass
• Addition of chelating agents to the water used in the formation of cements.
7.1 Heat Treatment of the Glass
It has been shown that heat treatment is a suitable method for decreasing glass reactivity
and improving the handling characteristics of mixed cements [170]. Annealing the glass
close to Tg decreases the surface residual strain caused by the grinding process, and con-
sequently the reactivity of the glass decreases. Therefore all the glasses tested in this study
were annealed at Tg - 50◦C for 30 min and allowed to cool slowly to room temperature.
7.2 Effect of Glass Particle Size on the Setting and Resistance
to Compression of Al-free GPCs
Glass powder particle size plays a prominent role in the rheology of the setting reaction.
Prentice et. al. showed that for conventional GPCs, a decrease in the particle size of the
glass results in decrease of the WT and increase in UCS of the cement [171]. Therefore,
this section seeks to determine if an increase in particle size can increase the working time
of cements made from Zn1.3 glass without comprising their mechanical properties.
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After grinding, the glass powder was sieved through a 38 µm mesh for 1 h and the < 38
µm particles put aside. Half of the > 38 µm glass powder was sieved through a 100 µm
mesh. At the end, three different glass powder batches were produced: < 38 µm, 38 < x
< 100 µm and > 38 µm. Cements were formed mixing the following weight ratio: 0.25
glass, 0.1 PAA and 0.1 de-ionised water.
The D10, D50 and D90 particle size distributions of the glass powders (Table 7.1) increase
with sieve size, with a mean diameter moving of 6.66 µm for < 38 µm, 24.24 µm for
the 38 < x < 100 µm and 33.76 µm for the > 38 µm. In the two latest batches, < 38
µm particles were found despite the sieving, which were probably due to small particles
adsorbed onto the surface of larger particles.
Table 7.1: Particle sizes of <38 µm, 38<x<100 µm and >38 µm glass powder for the Zn1.3
glass.
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Figure 7.1 shows the evolution of the WT, ST and UCS of the cements as a function of
the glass particle size used. It was found that increasing the particle size from < 38 µm
to 38 < x <100 µm increased the WT and ST of the cements. However, there was no
significant difference between the 38 < x < 100 µm and > 38 µm batches, probably
due to the smaller difference in the particle sizes. As the paste set very quickly for the
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smaller size particles, it was impossible to form a cylinder for compression testing. The
compressive strength of the two other batches were similar. Similar results were found by
Prentice et al. where the increased of particle mean diameter from 9.60 µm to 3.34 µm
led to higher strengths and increase in viscosity of the unset cement [171].
In conclusion, the smallest particle size powders are too reactive to be used to form ce-
ments. The two others present similar rheological and mechanical properties. It was
decided to use the 38< x< 100 µm particles because of the more controlled particle size
distribution, where the agglomerates and macroscopic particles were removed.
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Figure 7.1: Influence of the particle size of the Zn1.3 glass powder on the working and setting
times (left) and ultimate compressive strength (UCS) (right). For the < 38 µm glass powder, the
cement set too quickly to be able to form a rod with controlled shape to be use to measure the
resistance to compression. Statistical differences were assessed using a one-way ANOVA test and
the following symbols were used to display non-significant differences (p < 0.05) with (￿) < 38,
(￿) 38 < x < 100 and (￿) > 38 µm glass powders.
7.3 Effect of Acid Washing on the Setting and Resistance to
Compression of Al-free GPCs
Acid washing is used in order to decrease the reactivity of the glasses by creating a cation-
depleted layer on their surface [172]. It has been shown to increase the working time
of conventional GPCs without affecting the mechanical properties significantly. In this
section, < 38µm NC1.78 glass powder was immersed in a 5% (w/w) aqueous solution of
acetic acid for different period of time. The acid-washed powder, once washed and dried
was mixed as follows to form cements: 0.25 glass, 0.1 PAA and 0.1 de-ionised water by
weight.
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It was found that longer acid washing times increase the working and setting times (Figure
7.4), and increases significantly (p < 0.05) their mechanical properties (Figure 7.5). The
increase in compressive strength is likely due to the longer working time, as better mixing
time leads to more homogeneous specimens. However, past a certain length of time in
acid (between 60 and 90 minutes), the glass is not reactive enough to release sufficient
cations to cross-link efficiently the carboxylic groups of the polymeric chains. As a result,
cements made from the glass soaked for 90 minutes in acid didn’t set in 1 hour.
Our results demonstrate the potential for acid washing to increase the handling properties
of one Al-free GPCs. We also found similar trends for other glass compositions but acid
washing times differed. For example, the cements made from the Zn2.1 glass did not set
after 20 minutes in acid but the setting was too fast after only 10 minutes acid washing.
Acid washing treatment needs to be adapted for each individual glass compositions, which
would give the disadvantage of masking their compositional influence on the cements
properties.
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Figure 7.2: Influence of the immersion time of NC 1.78 glass powder in a solution of 5% (w/w)
of acetic acid on the working and setting times (left) and ultimate compressive strength (UCS)
(right) of cements. After 15 minutes immersed in acid, the cement set too quickly to be able to
use the oscillating rheometer. When immersed for 90 min, the setting time of the cement is more
than to 1 h. Statistical differences were assessed using a one-way ANOVA test and it was found
that the differences in UCS were all significant. The values presented for the working and setting
times are based on single experiments. Therefore, no standard deviation nor significance of the
results could be presented.
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7.4 Effect of Additives on the Setting and Resistance to Com-
pression of Al-free GPCs
The influence of various additives on the setting of conventional GPCs has been studied
previously [129] and (+)tartaric acid was found to be the most important additive influ-
encing the setting reaction. It was found that there was an optimum concentration at (￿
10%) for which the addition of tartaric acid induces a time lag period in the setting process
when the viscosity of the cement paste remained constant. This lag period was followed
by a sharp increase in viscosity and rapid setting.
Tartaric acid contains two carboxylic groups within its structure. The mechanism of action
of tartaric acid is not clear, but it is thought to act as a chelating agent, binding cations
released from the glass in the early stages of mixing [173]. In this section the role of
(+)tartaric acid solution on the setting of Al-free GPCs was investigated.
Boyd et al. [124, 174] produced an Al-free glass polyalkenoate cement using 0.27 g of
< 45 µm glass powder based on 48 SiO2, 16 CaO and 36 ZnO (mol%), 0.1 g of dry-
PAA (E9) and 0.1 g of de-ionised water. The working time of this cement was about
0.3 - 0.7 minutes, which is comparable to the Zn1.3-based cements made with the same
ratio (Section 7.2). The authors used 15% (w/w) trisodium citrate (TSC, Na3C6H5O7)
to increase the working time up to 1.7 minutes. Citrate ions has been shown to form
complexes with matrix-forming cations [175] and decrease the formation of stable ionic
bridges. Such an effect leads to the retardation of the setting reaction. The compressive
strength of the cements was about 70 MPa after 1 day storage in water and decreased
to 20 MPa after 7 days. After 30 days, their compressive strength increased again to 60
MPa. This modulation in the mechanical properties may be explained by the presence of
sodium, as already discussed in Chapter V, as sodium may decrease the cross-linking of
the PAA chains. In this study, we investigate the role of citric acid (C6H8O7), the acid
form, as it doesn’t contain sodium ions unlike TSC.
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7.4.1 Effect of Tartaric Acid Solution
The effect of adding (+)tartaric acid in the concentration range 0% - 10% (w/w) was
studied on the setting of cements made from > 38 µm particles of the NC1.78 glass. It
was found that increasing the tartaric acid concentration decreased the working time of
the cement. Indeed, it was impossible to form a paste for the highest concentration.
Our results differ from the findings of Hill and Wilson [129], where tartaric acid was
found to inhibit the gelation at the begining of the setting reaction. Crisp and Wilson
[176] postulated that tartaric acts as an accelerator that aids the ionic extraction from
the aluminosilicate glass and facilitates their binding to the polyanion chains. Although,
tartaric acid was found to increase the binding of calcium ions into the gel-matrix, the
working time was not increased as some of the released cations were initially present as
complexes. The authors found that the organic anions, tartrate in this instance didn’t affect
calcium extraction, with which it forms weak complexes (Stability constant: pk1= 2.17)
but involved a more extensively extraction of aluminium (pk1 = 6.35). The binding of the
calcium ions to the polyanion took place more rapidly than with aluminium ions as for the
later, bonds in the tartrate complexes needs to be ruptured before salt fomation can occur.
Therefore, the increase of working time is principally due to the chelation of aluminium
by tartrates. The Al-free glass NC1.78 contains large amount of zinc and the stability
constant of zinc tartrate (pk1 = 2.0 [177]) is inferior to the one of calcium, suggesting that
zinc extraction would not be affected by the presence of tartaric acid. Here, our results
suggest that the addition of tartaric acid decreases the working time, which correlates with
the faster integration of calcium in the gel-matrix of the Al-containing cements. This may
possibly be attributed to the fomation of binuclear complexes, where tartaric acid could
act as a flexible bridge structure linking carboxylic groups from the PAA, offering a steric
advantage over a simple salt bridge [178].
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7.4.2 Effect of Citric Acid Solution
Citric acid solution was found to increase the working time and injectibility of calcium
phosphate cements [179] but its effect on GPCs has never been studied in detail. In
this section the influence of different concentration of citric acid in de-ionised water was
monitored on the working, setting times and UCS of an Al-free cements. Two different
glass powder particle sizes were used to verify that the choice to use 38 < x < 100 glass
particles from the results obtained in Section 7.2 is not affected by the use of citric acid
solution.
7.4.2.1 Effect of Citric Acid Solution with > 38 µm Glass Particles
Figure 7.4 shows the effect of increasing the concentration (w/w) of citric acid (CA) (up
to 17%) on cements properties made from NC1.78 > 38 µm glass particles. Increasing
CA concentration up to 10% increased the working and setting times of the cement. The
WT and ST decreased for the 12% concentration and increased again up to 17%. The
resistance to compression remains constant near 50 MPa until 10% For higher concentra-
tion of CA, the UCS fell. CA acts as a chelating agent, attracting cations released during
the early stage of the mixing, increasing the WT. Above 10%, however it is likely that CA
chelates too many cations making them unavailable to cross-link the PAA chains, which
results in a decrease in the mechanical properties of the cements.
In conclusion, 10% is the optimum CA concentration in the cement to increase working
time without affecting cement mechanical properties.
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Figure 7.3: Influence of the citric acid concentration on the working time (WT), setting time (ST)
(left) and ultimate compressive strength (UCS) (right) of cements made from > 38 µm powder
of the NC 1.78 glass. Statistical differences were assessed using a one-way ANOVA test and the
following symbols were used to display non-significant differences (p < 0.05) with cement made
with (￿) 0%, (￿) 5%, (￿) 10%, (￿) 12%, (￿) 15% and (￿) 17% (w/w) citric acid solution.
7.4.2.2 Effect of Citric Acid Solution with 38 < x < 100 Glass Particles
Section 7.2 showed that it was possible to narrow the range of > 38 µm glass particle
size by removing the> 100 µm particles without apparently affecting the rheological and
mechanical properties of the resulting cements. Therefore, the influence of the addition of
citric acid was tested on cements made from 38 < x < 100 glass particles of the NC1.78
composition. In this study, different ratios between glass, PAA and water were used.
WT increased for the different glass : (PAA + CA solution) ratios with increasing CA
concentration up to 10% as presented in Figure (7.4, left) with statistical differences pre-
sented separately in Table 7.2. No major differences were found between the 10% and
15% concentration. The changes in glass : (PAA + CA solution) ratio did not have a large
effect on the WT of the cements.
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Figure 7.4: Influence of the citric acid (CA) concentration and ratio between glass/poly(acrylic
acid) (PAA)/liquid on the working time (left) and setting time (right) of cements made from < x
< 38 µm powder of the NC 1.78 glass. For the following sample, the setting time was superior to
1 h: ratio 0.4-0.2-0.2 and [CA] = 15%; ratio 0.35-0.2-0.2 and [CA] = [5%, 10%, 15%].
Table 7.2: Statistical differences in working times shown in Figure (7.4, left) using a one-way
ANOVA test. The following symbols were used to display non-significant differences (p < 0.05)
inside two cement groups: with cements made with various concentrations (w/w) of citric acid (￿)
0%, (￿) 5%, (￿) 10%, (￿) 15% and with cements made from different mixing ratio: (￿) 0.50 0.1
0.1, (￿) 0.45 0.1 0.1, (￿) 0.40 0.1 0.1, (♦) 0.35 0.1 0.1.
Ratio Citric acid concentration (w/w)
0% 5% 10% 15%
0.50 0.1 0.1 ￿ ￿￿ ￿￿ ￿
￿￿♦ ￿￿ ￿￿♦ ￿￿♦
0.45 0.1 0.1 ￿ ￿
￿￿♦ ￿￿ ￿￿♦ ￿￿
0.40 0.1 0.1 ￿ ￿
￿￿♦ ￿￿ ￿￿♦ ￿￿♦
0.35 0.1 0.1 ￿￿ ￿￿ ￿￿
￿￿￿ ￿￿￿ ￿￿
The setting times of the cements (Figure (7.4, right) with statistical differences presented
separately in Table 7.3) made with CA were longer than that of cements made with PAA
and pure water. For the two highest glass : (PAA + CA solution) ratio cements, the
increase in CA concentration didn’t influence the ST, however, there was a large increase
in the ST with low glass : (PAA + water) ratio cement. Some of these cements didn’t set
in 1 hour.
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Table 7.3: Statistical differences in setting times shown in Figure (7.4, right) using a one-way
ANOVA test. The following symbols were used to display non-significant differences (p < 0.05)
inside two cement groups: with cements made with various concentrations (w/w) of citric acid (￿)
0%, (￿) 5%, (￿) 10%, (￿) 15% and with cements made from different mixing ratio: (￿) 0.50 0.1
0.1, (￿) 0.45 0.1 0.1, (￿) 0.40 0.1 0.1, (♦) 0.35 0.1 0.1.
Ratio Citric acid concentration (w/w)
0% 5% 10% 15%
0.50 0.1 0.1 ￿￿ ￿￿ ￿￿
￿￿♦ ￿￿ ￿ ￿
0.45 0.1 0.1 ￿￿ ￿￿ ￿￿
￿￿♦ ￿￿ ￿ ￿
0.40 0.1 0.1
￿￿♦ ￿￿
0.35 0.1 0.1
￿￿￿
The UCS of cements decreased with decreasing glass : (PAA + CA solution) ratios, which
is likely to be due to the smaller release of cross-linking cations from the lower glass
content (Figure 7.5 with statistical differences presented separately in Table 7.4). For
the highest ratio, increasing CA concentration up to 10% didn’t affect the compressive
strength, which remain above 50 MPa. For the lower ratio, increasing CA concentration
results in a significant decrease of the resistance to compression.
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Figure 7.5: Influence of the citric acid (CA) concentration on the ultimate compressive strength
(UCS) of cements made from 38 < x < 100 µm powder of the NC 1.78 glass.
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Table 7.4: Statistical differences in UCS shown in Figure (7.5) using a one-way ANOVA test. The
following symbols were used to display non-significant differences (p < 0.05) inside two cement
groups: with cements made with various concentrations (w/w) of citric acid (￿) 0%, (￿) 5%, (￿)
10%, (￿) 15% and with cements made from different mixing ratio: (￿) 0.50 0.1 0.1, (￿) 0.45 0.1
0.1, (￿) 0.40 0.1 0.1, (♦) 0.35 0.1 0.1.
Ratio Citric acid concentration (w/w)
0% 5% 10% 15%
0.50 0.1 0.1 ￿￿ ￿￿ ￿￿
￿￿ ￿
0.45 0.1 0.1 ￿ ￿￿ ￿
￿￿♦ ￿
0.40 0.1 0.1 ￿ ￿
￿￿♦
0.35 0.1 0.1
￿￿
7.5 Conclusion
Cements made from 38 < x < 100 µm glass particles have the advantages of longer
workability and enhanced UCS compared to those made from smaller glass particle size
distribution. Removing the > 100 µm particles, did not affect the working time, nor the
resistance to compression while offering a more homogeneous powder in particle size.
Acid washing of the glass was shown to increase the working and setting times and
the mechanical properties of the cements. However, the acid washing time needs to be
adapted to each glass composition, incompatible with a glass compositional influence
study on cement properties.
The effect of different additives was investigated on the properties of the cement. Up
to 10%, tartaric acid decreased the working time of the cement. It was suggested that
tartrate complexes could facilitate the binding of zinc and calcium ions in the cement
matrix. Interestingly, it was found that citric acid used as a 10% solution increased the
working time without affecting the mechanical properties of cements as a result of a more
stable complexation of the cross-linking cations at the early stage of mixing.
The aim of this Chapter was to find a standard experimental procedure to make cements
with optimised working time and resistance to compression. According to this study, the
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standard mixing ratio that will be used from now on to compare cements made from the
glass developed in Chapter 6 will be 0.25 part of 38 < x < 38 µm glass powder, 0.1 part
of dry-PAA powder and 0.1 part of aqueous solution of 10% citric acid based on weight.
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Chapter 8
Aluminium-free Glass Polyalkenoate Cements -
Rheology, Mechanical Properties and Toxicity
This chapter focus on the properties of cements made from the glass series developed in
Chapter 6. All the cements were made from 0.25 part of 38 < x < 100 µm glass powder,
0.1 PAA (E9) and 0.1 water (10% citric acid), all by weight. This ratio will be referred
as the standard mixing ratio. The rationale for the cement compositions was studied in
Chapter 6. Any changes in mixing ratio will be specified.
The working time (WT) and setting time (ST) will be measured as well as the ultimate
compressive strength (UCS) to evaluate the setting rheology and the mechanical proper-
ties of the cements. The results obtained in Chapter 6 will be used to find relationships
between glass structure and cement properties. Then, the bonding strength of selected
cements will be measured to evaluate the potential for the cements to be use as adhesives.
To finish this Chapter, cell proliferation and alkaline phosphatase (ALP) activity will be
monitored up to 7 days and the results will be compared with the ion release profiles
collected from inductively coupled plasma (ICP) spectroscopy.
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8.1 Rheology and Mechanical Properties
8.1.1 P1 Cement Series
The P1 series was mixed using the standard ratio but the resulting cements were not
mechanically stable once immersed in water. Therefore, the results on the working and
setting times and ultimate compressive strength were measured from cements made from
0.25 part of < 38 µm glass powder, 0.1 PAA (E9) and 0.1 water, all by weight, as the
use of larger glass particle size and the addition of citric acid resulted in water soluble
cements.
Particle size analysis on the glass of the P1 series (Table 8.1) showed that there are some
differences in particle size distribution. P1.1 and P1.4 glasses have smaller particle sizes
than P1.2 and P1.4. As a result of the increase of surface area the working time is expected
to increase with greater ion release from the glass particles.
Table 8.1: Particle size of < 38 µm glass powder for the P1 glass series.
    
     
     
     
     
    
     
     
     
     
    
     
     
     
     
    
     
     
     
     




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Figure 8.1: Working and setting times of the P1 cement series (left) and ultimate compressive
strength (UCS) after 1 day, 1 week and 3 weeks of immersion in water at 37◦C (right). For the
P1 cement, the setting time was superior to 1 h. Statistical differences were assessed using a one-
way ANOVA test and the following symbols were used to display non-significant differences (p
< 0.05) with (￿) P1.1, (￿) P1.2, (￿) P1.3, (￿) P1.4 cements and (￿) 1 day aged cements, (￿) 1
week aged cements and (￿) 3 weeks aged cements in de-ionised water.
Figure (8.1, left) shows the evolution of WT, ST and UCS with changes in glass composi-
tion. All the cements had a short WT of about 30 seconds. No specific trend could be seen
for the ST. The rheology of the setting reaction appears not to be affected by the increased
amount of phosphorus in the glass, this fits with the DSC analysis done in Section 6.1.1.4,
where the glasses of the P1 series were shown to have similar Tg values, which is often an
indication of the reactivity of the glass. The differences in particle size seen earlier could
have the effect of masking the glass composition - cement property relationships.
Regarding the mechanical properties, the cements made from the three lowest P2O5 con-
taining glasses had similar rubbery behaviour, with very low compressive strengths (< 2
MPa). Surprisingly, the P1.4 cement had a significant greater UCS of around 30MPa. The
glass analysis in Chapter 6 predicted equivalent reactivity for all the glasses, however, the
NMR analysis (Section 6.1.1.3) showed that increasing phosphorus content suggested an
increase in the ratio of magnesium to calcium in the silicate phase due to calcium cations
being preferentially used to charge balance the orthophosphate units. We speculated that
the glass network would be more cross-linked with the creation of more Mg-O-Si bonds.
Hence, the higher P2O5 content in the glass, the greater number of hydrolysable bonds,
which should result in an increase in the release of magnesium. Our results suggest that a
threshold exists between the P1.3 and P1.4 compositions, where the glass releases enough
magnesium to efficiently cross-link the PAA chains. A decrease of the amount of cations
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available for cross-linking further explains why the standard mixing ratio could not be
used as larger glass particle size and citric acid decrease reactivity and number of avail-
able cations.
Figure (8.1, right) shows a decrease in compressive strength of the cements with time
(significant between 1 day and 3 weeks storage in water), which could be the result of
having a very short WT, limiting the number of carboxylic groups capable of reacting.
The resulting cements, which would not be fully cross-linked, absorb water and dissolve
with time. It is worth pointing out here that these cements were stored in de-ionised water.
The behaviour in vivo is likely to be different.
8.1.2 P2 Cement Series
The standard mixing ratio used for the P2 series results in water soluble cements. Decreas-
ing the particle size and/or removing citric acid did not enhance the mechanical properties
of the cements made from P2.1 and P2.2. Compared to the P1 series, the P2 glasses have
a higher SiO2 content, which probably results in less magnesium enters into the network.
Furthermore, the increased P2O5 content in the P2 series is not charge-balanced, so it
follows that there is a consequent amount of modifying cations removed from the silicate
phase to compensate for the charge of the orthophosphate units. This suggests that the
glass slicate network is more rigidly cross-linked, having a higher NC and does not con-
tain substantial amounts of Si-O-Mg bonds. Consequently, the P2.1 and P2.2 glasses are
not reactive enough during the setting reaction, leading to water soluble cements.
The P2.3 glass was too reactive to form a cement paste regardless of the mixing ratio
and addition of additives. The high phosphorus content of the P2.3 glass was shown to
markedly decrease the Tg compared to the P2.1 and P2.2 glasses (Section 6.1.2.4). We
suggested that it is likely associated with the influence of the phosphate phase and the low
Tg, taken as an indication of glass reactivity would explain the impossibilty of forming
any cement paste from the P2.3 glass powder.
Figure 8.2 shows the WT and ST of P2.1 and P2.2 cements when mixed with the same
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ratio as for the P1 series. The two cements have similar values (no significant differences),
which concords with the similar Tg values of their glasses. No effect due to the increase of
phosphorus content could been seen in the setting reaction. The NC values in the P2 glass
series are higher than the P1 glass series, therefore the P2 series was expected to have
longer working time than the P1 series. This could be due to a difference in the role that
magnesium has in the glass structure, which is dependent on the silica and phosphorus
contents.
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Figure 8.2: Working and setting times of the P2 cement series. Statistical differences were
assessed using a one-way ANOVA test and the following symbols were used to display non-
significant differences (p < 0.05) with (￿) P2.1 and (￿) P2.2 cements.
The particle size distributions of the glass of the P2 series were similar and therefore this
parameter was not taken into account for the analysis of the cements properties.
155
CHAPTER 8. Aluminium-free GPCs - Rheology, Mechanical Properties and Toxicity
Table 8.2: Particle size of < 38 µm glass powder for the P2 glass series.
    
     
     
     
     
    
     
     
     
     
    
     
     
     
     



8.1.3 Zn1 Cement Series
The particle size values for the three glasses of the Zn1 series are presented in Table 8.3.
The two first glasses have similar particle size distribution, when the Zn1.3 glass shows
an increase in mean particle diameter.
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Table 8.3: Particle size of 38 < x < 100 µm glass powder for the Zn1 glass series.
    
     
     
     
     
    
     
     
     
     
    
     
     
     
     



No significant differences were found between the WT of the cements of the Zn1 series
(Figure 8.3, left). However, the DSC analysis of the glasses (Section 6.1.3) showed an
increase in glass reactivity due to the decrease in Tg with zinc for magnesium substitu-
tion. This would suggest a decrease in WT and ST of the cements. It is possible that
short working time (∼1 minute) is masking the glass composition - cement property rela-
tionship. Furthermore, the bigger particle size of the Zn1.3 glass could contribute to the
non-significant difference between the WT values.
Figure (8.3, right) presents the evolution of the resistance to compression of the Zn1
cement series. There is a sharp increase in UCS for the highest zinc containing cement
compared to the others. Zinc appears to more efficiently cross-link the carboxylate groups
of the polymeric chains leading to higher UCS. These results are in accordance with
higher values of bond stability constant of zinc polyacrylate (pK = 3.3) than magnesium
polyacrylate (pK = 1.8) [180].
The UCS significantly increased between day 1 and day 7 ageing time in water for the
Zn1.3 cement, suggesting that the setting reaction is not complete in 24 hours. However,
the compressive strength drops significantly after 3 weeks ageing in water. This could
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be the result of a possible ion exchange taking place between the GPC and ageing media
with possible hydrolysation of some of the carboxylate ionic bridges.
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Figure 8.3: Working and setting times of the Zn1 cement series (left) and ultimate compressive
strength (UCS) after 1 day, 1 week and 3 weeks of immersion in water at 37◦C (right). Statistical
differences were assessed using a one-way ANOVA test and the following symbols were used to
display non-significant differences (p < 0.05) with (￿) Zn1.1, (￿) Zn1.2, (￿) Zn1.3 cements and
(￿) 1 day aged cements, (￿) 1 week aged cements and (￿) 3 weeks aged cements in de-ionised
water.
8.1.4 Zn2 Cement Series
Cements were made from three glasses of the Zn2 series to see if the cement properties
were in a suitable range for biomedical applications. The standard mixing ratio was used
to form cements for the three selected glasses.
The particle size values for the glasses from the Zn2 series are presented in Table 8.4. The
Zn2.1 and Zn2.5 glasses had similar particle size distributions but the Zn2.3 composition
had an increase in mean particle diameter compared to the two other glasses.
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Table 8.4: Particle size of 38 < x < 100 µm glass powder for the Zn2 glass series.
    
     
     
     
     
    
     
     
     
     
    
     
     
     
     



The Zn2.1 and Zn2.2 cements have similar WT and ST (Figure 8.4, left). As for the Zn1
glasses, a decrease in Tg was also observed on the DSC traces of the Zn2 series (Section
6.1.5.4) and it is difficult to explain why a similar trend inWT and ST is not oberved. Here
as well we assume that the short WT and small difference in particle size distributions of
the glass could mask the glass composition - cement property relationship. However, the
complete substitution of zinc for magnesium in the Zn2.5 glass made the setting reaction
too fast to be able to form a cement paste. This would tend to prove that zinc when
substituted for magnesium in the glass has a decreasing effect on the WT of the cements.
As seen for the Zn1 cement series, increasing the zinc content in the glass increases sig-
nificantly the UCS of the resulting cements (Figure 8.4, right). The mechanical properties
of these cements were low anf for the Zn2.1, the cement dissolved in water between 1 day
and 1 week storage. There were no significant differences in UCS for the Zn2.3 cement
with ageing time in water, suggesting that the setting reaction is over within 24 hours and
produces a cement with enough cross-linking to avoid absorbtion of water.
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△▽Figure 8.4: Working and setting times of the Zn2 cement series (left) and ultimate compressive
strength (UCS) after 1 day, 1 week and 3 weeks of immersion in water at 37◦C (right). Statistical
differences were assessed using a one-way ANOVA test and the following symbols were used to
display non-significant differences (p < 0.05) with (￿) Zn2.1, (￿) Zn2.3 cements and (￿) 1 day
aged cements, (￿) 1 week aged cements and (￿) 3 weeks aged cements in de-ionised water.
It is interesting to compare the P1.1, Zn1.1, P1.4 and Zn2.1 cements properties. For ease
of comparison, their glass compositions are repeated here in Table 8.5. According to our
results (Section 8.1.1 and 8.1.4), P1.4 and Zn2.1 were the only zinc-free cements stable in
water, whereas P1.1 and Zn1.1 disintegrated. From their main compositional differences,
we can see that high P2O5 and low SiO2 contents lead to more stable cements. All the
compositions contain high amounts of magnesium and it has been previously suggested
that increasing phosphorus and decreasing silica results in a greater number of Mg-O-Si
bonds. The hydrolysability of these bonds would explain the increase in water stability of
the cement, as the release of more cations during the setting reaction would increase the
number of cross-links between the carboxylic groups.
Table 8.5: Molar composition for the P1.1, P1.4 and Zn2.1 glasses. P1.1 and Zn1.1 are two
different names for the same composition.
           
       
       
       
8.1.5 NC Cement Series
The glass particle size of the NC series were very similar as shown in Table 8.6, therefore
this parameter will not be taken into account in the analysis of the resulting cements.
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Table 8.6: Particle size of 38 < x < 100 µm glass powder for the NC glass series.
    
     
     
     
     
    
     
     
     
     
    
     
     
     
     



Cements were produced using the standard mixing ratio. The values of WT and ST are
plotted in Figure (8.5, left) and were not influenced by the variation of NC as expected
from the glass characterisation analysis, where the Tg was not significantly changing
amongst the series.
The UCS of the cements (Figure 8.5, right) did not vary significantly with NC, except
for the NC1.81 cement after 1 day ageing time in water, which had a lower UCS than
the two other cements. However, the difference in compressive strength was small (∼
10 MPa) and could be due to the small amount of crystallinity detected by the XRD
analysis of the glass (Section 6.1.6.1). This would have the effect of reducing the glass
reactivity and consequently decreasing the release of cross-linking cations, explaining the
lower UCS value. XRD also showed crysalline peaks on the NC1.78 glass traces but their
intensity were lower, indicating a lower crysallinity and the relative decrease in reactivity
was probably compensated by the lower NC value.
A decrease in UCS appeared after 7 days ageing time in water for the NC1.83 cement,
which could be explained by the effect of ionic exchange between cement and media.
The NC1.78 cement did not present any significant variation in compressive strength with
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ageing time, suggesting a completion of the setting reaction in 24 hours. A small increase
in UCS appeared after 1 day for the intermediate composition, which could be an effect
of a slower degradation of the glass due to the presence of crystals discussed earlier. The
NC1.81 compressive strength was then stable up to 3 weeks ageing.
The lack of significant changes with NC may be a result of the small overall change in
NC from 1.83 to 1.78 and possible effect of the presence of crystals on glass reactivity.
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Figure 8.5: Working and setting times of the NC cement series (left) and ultimate compressive
strength (UCS) after 1 day, 1 week and 3 weeks of immersion in water at 37◦C (right). Statistical
differences were assessed using a one-way ANOVA test and the following symbols were used to
display non-significant differences (p< 0.05) with (￿) NC1.78, (￿) NC1.81, (￿) NC1.83 cements
and (￿) 1 day aged cements, (￿) 1 week aged cements and (￿) 3 weeks aged cements in de-ionised
water.
8.1.6 Fe Cement Series
The particle size distribution analysis (Table 8.7) shows that the Fe0 composition had a
lower particle size distribution compared to the rest of the glasses.
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Table 8.7: Particle size of 38 < x < 100 µm glass powder for the Fe1 glass series.
    
     
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     
     
     
     
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     
     
     
    
     
     
     
     




The WT and ST evolutions for the Fe1 series are shown in Figure (8.6, left) and did
not exhibit any significant trend. Again, short WT and small particle size distribution
differences could mask the evolution of the cement properties with with increasing Fe2O3
content in the glass. As the Fe3 glass was too reactive, no cement paste could be formed
and it suggests that increasing iron content in the glass decreases the WT and ST of the
cement.
The variation of the cement UCS (Figure 8.6, right) was only significant between Fe1 and
Fe2 at day 1, which could mean that the cross-linking of the carboxylate groups is more
efficient with higher concentration of iron in the glass. However, there was a significant
decrease of UCS for the Fe2 cement as for the Fe0 cement between day 1 and day 7
ageing time in water. The characterisation of the glass did not give a clear answer on the
role of iron. The glasses were designed with the hypothesis in mind that iron is present
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as Fe3+ and enter the network. The decrease in Tg could be the result of the ceation of
weak Fe-O-Si bonds or of a change in oxidation state to Fe2+. The difference in UCS
between the different compositions are therefore not easy to interprete and are probably
influenced as well by inhomogeneity in the samples due to short working time and particle
size distribution differences.
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Figure 8.6: Working and setting times of the Fe1 cement series (left) and ultimate compressive
strength (UCS) after 1 day, 1 week and 3 weeks of immersion in water 37◦C (right). Statistical
differences were assessed using a one-way ANOVA test and the following symbols were used to
display non-significant differences (p < 0.05) with (￿) Fe0, (￿) Fe1, (￿) Fe2 cements and (￿) 1
day aged cements, (￿) 1 week aged cements and (￿) 3 weeks aged cements in de-ionised water.
8.2 Bonding strength
The bonding strength was measured for the following selected cements: Zn1.2, Zn1.3,
Fe0, Fe1 and Fe2 cements and compared to a commercial zinc polycarboxylate cement
[181]. The results are presented in Figure 8.7. The short working time of cements makes
creating a thin, homogeneous adhesive layer difficult, complicating the comparison be-
tween the different compositions because of their different thicknesses. However, the
bonding strengths for the cements are close to suitable values for bone cement purposes
(> 1 MPa).
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Figure 8.7: Bonding strength of selected cements compared to a commercial zinc carboxylate
cement [3]as a function of the adhesive layer thickness.
8.3 Cell Culture
SaOs-2 cells were seeded on cement discs made from selected glass compositions: NC1.78,
NC1.81, NC1.83/Fe0, Fe1, Fe2, Fe3, Zn1.2 and Zn1.3, as these cements were relatively
stable in water with suitable mechanical properties to be use as medical cements. Sereno-
cem® and Depuy Radio-opaque PMMA cement were used as controls. Analysis were
carried out at day 1 and day 7 after seeding.
8.3.1 Ion release in Culture Media
Inductively coupled plasma (ICP) spectroscopy was run on the cell culture media col-
lected at day 1 and day 7. As the media was changed every day, the ion profiles correspond
to the ion release during the previous 24 h.
Figure 8.8 shows the ion release concentration during the first 24 h of incubation. The
results are plotted in ppm rather than mol/L to facilitate further comparisons with the lit-
erature. The phosphorus concentrations are similar for all the cements and controls and
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correspond to the concentration from the cell culture media, indicating that little phospho-
rus was released from the cements. The silicon and calcium concentration were similar
for all the Al-free cements but higher than Serenocem, suggesting that the former dissolve
more. Strontium was released from all the strontium containing cements at similar con-
centrations to calcium. It is worth pointing out that the release of strontium and calcium
over 24 h are more than three times lower than that released from a ICIE1 Sr50 composi-
tion in 8 h, suggesting that the bioactive glass dissolution is much faster than the cement.
The release of zinc was apparent from all the Al-free cements with values between 150
and 200 ppm. The resistance to compression of the Zn1.2 cement (Section 8.1.3) was low
and zinc and magnesium profiles confirm that this cement is poorly cross-linked, and thus
undergoes water absorption and partial dissolution with ageing time in water.
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Figure 8.8: ICP Analysis - Ion release profiles of cell culture media in contact for 24 hrs with
cement disc and SaOs-2 cells collected at day 1.
The ions released into the media collected at day 7 (Figure 8.9), are all largly lower than
for day 1 except from the Zn1.2 cement. Only the phosphorus figure were high due
to the change of media at day 6. The decrease in ion release can be explained by two
phenomena:
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• As the cements are setting and their crosslinking increasing, the surface water ab-
sorption decreases, which decreases the leaching of ions.
• The Al-free cements have a short working time (1 - 2 min) compared to Serenocem
(3 to 4 minutes). Hence, it is possible that the former are less homogeneous and un-
reacted glass particles may be stuck on the surface at the end of the mixing. This
would contribute to the high ion release at day 1, and as the glasses are reactive, it
wouldn’t be surprising if the glass particles on the surface dissolved before day 7.
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Figure 8.9: ICP Analysis - Ion release profiles of cell culture media in contact for 24 hrs with
cement disc and SaOs-2 cells collected at day 7.
8.3.2 Toxicity Assessment
8.3.2.1 Live/dead assay
The live dead assay shows that live cells are present on all cement discs at day 1 (Figure
8.10) and day 7 (Figure 8.11). Only cells seeded on Serenocem and PMMA proliferate.
The Al-free glass based cements are more reactive and dissolve more than the controls;
as a result pH changes may cause cell death. Secondly, in order to get good mechanical
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properties, the Al-free glasses contain a large amount of zinc. The ICP analysis revealed
zinc release from the Al-free GPCs to be above 150 ppm after 1 day in culture. As
discussed in Section 1.2.1.7 zinc release at high concentration can elicit a toxic response.
Ito et al. [96] studied the cytocompatibility of zinc-releasing calcium phosphate ceramics.
They found that zinc doped ceramics releasing more than 15 ppm of zinc in cell culture
media affected the growth rate of mouse osteoblastic MC3T3-E1 cells to a cytotoxic level.
The zinc release from the Al-free GPCs being 10-fold level above this value is likely
to be the source of the non-proliferation of cells on their surface. Cell culture being a
closed system, better results would be expected in a fluid circulation model, which would
mimic more efficiently the in vivo conditions. Rámila and Vallet-Regí [162] studied the
bioactivity of sol-gel glass in SBF with or without exchange of solution. The calcium
release under constant fluid circulation was approximately 5 times lower than in static
condition. Furthermore, no rise in pH was observed during the dynamic experiment.
Therefore, the toxicity observed from Al-free GPCs would not necessarily be observed in
vivo.
The change in NC doesn’t affect the cell viability (NC series); which is however increased
with increasing iron concentration in the glass (Fe series). Increasing zinc concentration
in the glass decreases the cell viability at day 1 (Zn1 series) but not at day 7. The low
mechanical properties of the Zn1.2 cement suggested that it is poorly cross-linked. The
ICP analysis showed that this cement dissolved over time in the cell culture media and
therefore, the decrease in cell number can be associated with a longer release of toxic
amount of ions.
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Figure 8.10: Live/dead images of cement discs after 1 day in culture with SaOs-2 cells. The live
cells fluoresces green and the dead cells red. The scale bar represents 200 µm.
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Figure 8.11: Live/dead images of cement discs after 7 days in culture with SaOs-2 cells. The live
cells fluoresces green and the dead cells red. The scale bar represents 200 µm.
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8.3.2.2 Cell Number
As shown by the live/dead assay, the cell viability was low on the surface of the cement
discs and as a result, no specific absorption could be detected for the Al-free GPCs related
to LDH and ALP assays. Therefore, the results presented here are from the behaviour of
the cells seeded on the tissue culture plastic inside the wells containing the cement discs.
The results illustrate the effect of the dissolution product from the cement at their vicinity
on cell number and activity.
The number of cell present in the culture wells was measured at day 1 and day 7 by LDH
assay (Figure 8.12).
There was no significant differences between Serenocem, NC1.81 and Zn1.3 and between
NC1.78, NC1.83/Fe0, Fe1 and Fe2 at day 1. No toxic response was therefore detected,
except from the culture with the Zn1.2 cement. At day 7, the number of cell was sig-
nificantly higher for controls than for all the Al-free GPCs, which did not show any cell
proliferation. Significant decrease (p< 0.05) of cell number was monitored for all the Al-
free GPCs. The number of cell did not vary significantly with time for the Zn1.2 cement
as it had a toxic effect before day 1.
Ion release as determined by ICP (Section 8.3.1) can explain some of the cell data. All
of the Al-free cements released high concentrations of zinc, which may explain the lower
cell numbers than controls at day 7. Interestingly, no toxic response was measured at day
1 and this seems to indicate that only a prolongated period of culture with Al-free GPCs
is affecting cell proliferation.
The cements that release less zinc: NC1.81 and Fe2 had higher cell numbers as deter-
mined from the LDH assay results. It can be assumed that the high zinc release and
possibly pH changes as well are responsible for the death in majority of the cell popula-
tions during day 1. As the number of cell is very low from day 1, proliferation is affected,
which would explain the low cell number at day 7.
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Figure 8.12: LDH Assay - Cell number at day 1 and 7. Statistical differences were assessed
using a one-way ANOVA test and the following symbols were used to display non-significant
differences (p < 0.05) with (￿) Serenocem, (￿) PMMA, (￿) NC1.78, (￿) NC1.81, (￿) NC1.83,
(♦) Fe0, (￿) Fe1, (￿) Fe2, (￿) Zn1.2 and (￿) Zn1.3 cements.
8.3.2.3 Cell Activity
The ALP assay shows that the mineralization activity of the osteoblasts is significantly
higher for the controls than for the Al-free cements at day 1 and 7 (Figure 8.13). Only
NC1.81 cement at day 1 had non-significant difference with PMMA. There is a decrease
in activity for all the Al-free cements at day 7 compared to day 1, which suggest that
they have a toxic effect on osteoblast cells. The ALP activity per cell, calculated from the
number of cell determined by the LDH assay (Figure 8.14) gives similar results.
Iron concentration in cement did not have significant efect on cell numer nor cell activity.
Furthermore, the effect of strontium, present in the NC and Fe1 series was not shown to
have an effect neither compared to the Zn1 series. The toxicity of high release of zinc is
likely to predomine on the potential positive effect othese two ions.
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Figure 8.13: ALP Assay - p-nitrophenol concentration per hour at day 1 and 7. Statistical dif-
ferences were assessed using a one-way ANOVA test and the following symbols were used to
display non-significant differences (p < 0.05) with (￿) Serenocem, (￿) PMMA, (￿) NC1.78, (￿)
NC1.81, (￿) NC1.83, (♦) Fe0, (￿) Fe1, (￿) Fe2, (￿) Zn1.2 and (￿) Zn1.3 cements.
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Figure 8.14: P-nitrophenol concentration per cell per hour at day 1 and 7.
8.4 Conclusion
Aluminium free glass polyalkenoate cements were successfully produced with working
times in the range of 0.5 to 2 minutes and setting times in the range of 3 to 15 minutes.
It was found that the addition of zinc is a major factor in achieving suitable mechanical
properties. Several cements have an ultimate compressive strength above 50 MPa, which
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is the bottom limit for usable cements.
Zinc substitution for magnesium increases the mechanical properties and water stability of
cements and it was suggested that the WT of such cements decreases as the Zn2.5 glass
was too reactive to be able to form a cement paste . Zinc-free, magnesium containing
cements were all soluble in water apart from those made from high phosphorus containing
glasses. The working times of these zinc-free cements were in the lower range of those of
Al-free cements produced, as < 38 µm glass powder had to be used and citric acid could
not be used as chelating agent.
The bond strength of the cements was in the range of 0.5 to 2 MPa, which is suitable for
orthopaedic cements.
The assessment of cement toxicity via the culture of SaOs-2 osteoblast-type cells showed
that cells were living on the surface of all the cements after 24 hours. However, the
cell number and ALP activity were lower than on Serenocem and PMMA, suggesting a
possible toxic effect from high ion release from the cements. The zinc concentration was
notably high, which may be responsible for the toxicity noted in these studies.
8.5 Further Work
A possible explanation for some of the variation on UCS with ageing time in water is
a ionic exchange between cement and de-ionised water. Monitoring the ion concentra-
tion over time with ICP could confirm this hypothesis. In the case of significant ionic
exchange, SBF could be preferred as ageing media as its ionic concentration is close to
that of blood plasma and therefore, give a better indication of the evolution of cement
properties with time in vivo.
Zinc content in GPC glasses is clearly a predominant factor influencing water stability
and compressive strength of Al-free cements. However, regarding the toxicity analysis
performed on cement discs, zinc seems to be the main cause of cell death in in vitro
culture and it would therefore be of interest to monitor the zinc release - cell activity
relationship in a dynamic system as presented in other studies [162].
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The variation of the thickness of the adhesive layer in the bonding strength experiments
made the comparison between cement compositions difficult. It would be of interest to
repeat these experiments with a different system set-up involving controlled thickness
layers.
Another approach that could be exploited and therefore be the subject of further works
is the effect of the crystallisation of the glasses on the setting, mechanical properties and
cytotoxicity of resulting GPCs. This approach has been shown already to have an effect
on the in vitro biocompatibility of Al-containing GPCs [182].
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General Conclusion
Progress made to understand the various interactions between biomaterials and their envi-
ronment in the body has given birth to a new generation of intelligent systems which can
be tailored to fulfill specific roles once implanted. Notably, a great advance has been made
in the stabilisation of the interface between implant and bone tissue, and it was in this do-
main that the study described in this thesis aimed to provide input. The first approach
employed was to utilise the ability of bioactive glass to bond chemically to bone through
the formation of an hydroxyapatite layer and to release biologically active ions or species.
The second part of this thesis focused on the adaption of a dental glass polyalkenoate
cement for medical use to provide an adhesive system capable to both bond to bone and
metals.
The first generation of bioactive glasses was developed 40 years ago. Since then, their
composition and structure have been modified to enhance their osseo-integration and
medical applications. This work has been the first effort to incorporate strontium into
a bioactive glass and was driven by the positive results and European approval of stron-
tium containing drugs for treatment of osteoporosis. Strontium was then substituted for
calcium on a molar basis in ICIE1 compositions. Structural changes in the glass were
characterised and it was found that strontium substitution has little influence on the lo-
cal environment of either the Q2 silicate phase and orthophosphate phase. However, the
glass network expanded as the result of the larger ionic size of strontium when compared
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with calcium. Furthermore, the ionic bridges formed between strontium and NBOs were
weaker than those formed with calcium. In a Q2 glass, these ionic interactions are a
determinant factor influencing the strength of the network, therefore the substitution of
strontium for calcium led to a weaker glass network. This was a significant finding as
strontium substitution for calcium managed to change the physical properties of a bioac-
tive glass without changing its network connectivity.
Following the characterisation of the strontium doped bioactive glasses, research efforts
were made to understand their dissolution process in Tris buffer and SBF. The ability to
monitor the glass dissolution with time allowed us to follow the precipitation of a CaP
layer on the surface of glass particle and discs. The weakening of the glass network
due to strontium substitution for calcium led to a greater dissolution rate coupled with
an increase in pH in Tris Buffer and CaP formation in SBF. This formation which was
identified to be a nano-crystalline mixed calcium/strontium HCA. There is considerable
debate in the literature in taking the HCA formation in vitro as a sufficient proof for bioac-
tivity, thus the analysis was taken further. First a simple cell culture in vitro assay was
used on osteoblast-like cells seeded on the surface of glass discs. Even if no quantita-
tive experiments were carried out, it was clear that the two highest strontium containing
glasses led to greater cell proliferation. Furthermore, an implant study was carried out at
the University of Sheffield using an osteoporotic rat model. The thickness of the HCA
was found to be larger in vivo than in SBF. Our conclusions were drawn based on the dif-
ference between static and dynamic systems. The constant replenishment of calcium and
phosphate occurring naturally in vivo provided extended resources for apatite formation.
Strontium was found to be present in the apatite layers suggesting that it enters the crystal
lattice forming a solid solution with calcium. The thickness of this HCA layer in vivo
is larger than those observed in current literature, despite histology and fracture analysis
proving the increase in HCA layer was not consistent with either increased better osseo-
integration and fracture reduction. However, the ICIE1 Sr 10 glass showed better results
than the strontium-free glass. The overall conclusion on the development of strontium
containing bioactive glasses is that bioactivity can be increased without changing its net-
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work connectivity, which has been the main approach of the first generation of bioactive
glass development. The glasses produced do not yet possess the ideal biological effect
and the pH rise from their dissolution continues to be an issue. In the further development
of strontium containing glasses it would be interesting to design compositions containing
higher phosphate as it has been shown to reduce the pH rise without decreasing the HCA
formation abilities.
GPCs were first introduced by Wilson et al in the early 1970s. Since then, their utilisation
for medical application has been limited due to release of aluminium, which is however a
key element in the setting reaction and mechanical properties of those cements. The aim
of the research presented in this thesis was to be able to identify potential substitutes to
aluminium to produce biomedical GPCs. Therefore, several glass were designed based
on bioactive glass compositions, which were modified to also include the potential ben-
eficial role of phosphorus, magnesium, zinc and iron(III) on cement properties. A major
challenge encountered in this project was to find a balance between glass reactivity and
cement working and setting times. Indeed, to obtain suitable cement mechanical proper-
ties, the release of cations from the glass had to be sufficient to cross-link efficiently the
polycarboxylic chains but had to be hampered to increase the time when the cement could
be moulded or injected. To find the best compromise, a parametric study was realised
and it was found that the simultaneous use of specific particle size distribution, specific
ratio between glass, PAA and liquid and citric acid as a chelating agent could increase the
working time of cements without negative effect on their mechanical properties.
Generally, the relationships between glass composition and cement properties were diffi-
cult to draw. Multicomponent glasses, variation in glass particle size distribution, sample
inhomogeneity due to short mixing time were factors influencing the cement properties.
However, water stability and resistance to compression of the cements were found to be
significantly dependant on the zinc content in the glass and only at the highest concentra-
tion tested were the mechanical requirements fulfilled for use as bone cement. It appeared
that varying the zinc to magnesium ratio in the glass could lead to variation of UCS in a
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wide range up to 70 MPa. Therefore, cements could be tailored through their composition
to accomplish a different role or be used at a different location in the skeleton. Regarding
the zinc-free GPCs, it was suspected that increasing amount of phosphorus increased the
number of magnesium switching its role and entering the silicate network, conferring a
better water stability to the cements. The ability of zinc to cross-link more efficiently
the carboxylic groups of the polyacid compared to magnesium was similar to zinc poly-
carboxylate cements where zinc oxide is used to increase the mechanical properties and
magnesium oxide to slow down the setting reaction.
The potential benefit of adding a trivalent cation, iron(III) in the glass composition had
little effect on cement properties. Our hypothesis is that iron is mainly present as Fe3+
and enters the glass network and this was difficult to confirm and it is likely that there is
a mixture of iron forming Fe-O-Si bonds and iron reduced into Fe2+.
It is hoped that the results presented in this thesis will encourage researchers to further
explore the potential of Al-free GPCs. The discussion brought by this research showed
that high zinc content is necessary to confer suitable mechanical properties for their use
as medical cement. However, the new challenge rising from the conclusion of this work
is to be able to limit the zinc release from cement as this was revealed to be cytotoxic,
without compromising the mechanical properties of Al-free GPC for application as bone
cement.
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